TW202432530A - Resist composition, resist pattern forming method, compound and acid generator - Google Patents

Resist composition, resist pattern forming method, compound and acid generator Download PDF

Info

Publication number
TW202432530A
TW202432530A TW112146884A TW112146884A TW202432530A TW 202432530 A TW202432530 A TW 202432530A TW 112146884 A TW112146884 A TW 112146884A TW 112146884 A TW112146884 A TW 112146884A TW 202432530 A TW202432530 A TW 202432530A
Authority
TW
Taiwan
Prior art keywords
group
carbon atoms
alkyl group
lactone
substituent
Prior art date
Application number
TW112146884A
Other languages
Chinese (zh)
Inventor
慶信 阮
Original Assignee
日商東京應化工業股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商東京應化工業股份有限公司 filed Critical 日商東京應化工業股份有限公司
Publication of TW202432530A publication Critical patent/TW202432530A/en

Links

Abstract

本發明係採用含有藉由酸的作用對於顯影液的溶解性產生變化的基材成分,與一般式(b0)所示化合物之阻劑組成物。式(b0)中,R b為鹼分解性基。L 03為2價連結基。Rl 0為環狀有機基。L 02為2價連結基。R m1為取代基。L 01為2價連結基或單鍵。Vb 0為伸烷基、氟化伸烷基或單鍵。R 0為氟化烷基、氟原子或氫原子。nb1為1~4的整數,nb2為1~4的整數,nb3為0~3的整數。2≦nb1+nb2+nb3≦5。M m+表示m價有機陽離子。m為1以上的整數。依據該阻劑組成物,可在形成阻劑圖型時達到高感度化,且提高圖型尺寸之面內均勻性及微細解像性等光刻特性。 The present invention uses a substrate component that changes its solubility in a developer solution by the action of an acid, and an inhibitor composition of a compound represented by the general formula (b0). In the formula (b0), R b is an alkali-decomposable group. L 03 is a divalent linking group. Rl 0 is a cyclic organic group. L 02 is a divalent linking group. R m1 is a substituent. L 01 is a divalent linking group or a single bond. Vb 0 is an alkylene group, a fluorinated alkylene group or a single bond. R 0 is a fluorinated alkylene group, a fluorine atom or a hydrogen atom. nb1 is an integer of 1 to 4, nb2 is an integer of 1 to 4, and nb3 is an integer of 0 to 3. 2≦nb1+nb2+nb3≦5. M m+ represents an m-valent organic cation. m is an integer greater than 1. According to the resist composition, high sensitivity can be achieved when forming a resist pattern, and photolithography characteristics such as in-plane uniformity of pattern size and fine resolution can be improved.

Description

阻劑組成物、阻劑圖型形成方法、化合物及酸產生劑Resist composition, resist pattern forming method, compound and acid generator

本發明係關於阻劑組成物、阻劑圖型形成方法、化合物及酸產生劑。 本案依據2022年12月6日於日本申請之特願2022-195214號主張優先權,該內容皆沿用於此。 The present invention relates to a resist composition, a resist pattern forming method, a compound and an acid generator. This case claims priority based on Special Application No. 2022-195214 filed in Japan on December 6, 2022, and the contents are hereby applied to.

近年來,在半導體元件或液晶顯示元件之製造中,藉由光刻技術之進歩,圖型之微型化正急速地進行著。作為微型化之方法,一般進行曝光光源之短波長化(高能量化)。In recent years, in the manufacture of semiconductor devices or liquid crystal display devices, the miniaturization of patterns is progressing rapidly due to the advancement of photolithography technology. As a method of miniaturization, the wavelength of the exposure light source is generally shortened (higher energy).

對於阻劑材料,要求此等對於曝光光源之感度,且可重現微細尺寸之圖型的解像性等光刻特性。 作為滿足如此要求的阻劑材料,過去使用含有藉由酸的作用而對顯影液之溶解性產生變化的基材成分,與藉由曝光而產生酸之酸產生劑成分之化學增幅型阻劑組成物。 Resist materials are required to have such photolithographic properties as sensitivity to exposure light sources and resolution that can reproduce fine-scale patterns. As resist materials that meet such requirements, chemically amplified resist compositions containing a base material component that changes the solubility of a developer by the action of an acid and an acid generator component that generates an acid by exposure have been used in the past.

阻劑圖型之形成中,藉由曝光自酸產生劑成分所產生的酸之舉動成為賦予光刻特性很大影響之一要素。 作為化學增幅型阻劑組成物中所使用的酸產生劑,可提案出至今多種多樣者。例如已知有碘鎓鹽或硫鎓鹽等鎓鹽系酸產生劑、肟磺酸鹽系酸產生劑、重氮甲烷系酸產生劑、硝基苯甲基磺酸鹽系酸產生劑、亞胺磺酸鹽系酸產生劑、二碸系酸產生劑等。 作為鎓鹽系酸產生劑,一般為烷基磺酸離子或該烷基之氫原子的一部分或全部由氟原子進行取代的氟化烷基磺酸離子使用於負離子部。使用於鎓鹽系酸產生劑之陽離子部主要具有三苯基硫鎓等鎓離子者。 例如,專利文獻1中揭示具有含有聯環辛烷骨架之多環結構的負離子與有機陽離子之鹽中作為酸產生劑而含有的阻劑組成物。依據該阻劑組成物,可對曝光光源產生高感度及達成光刻特性提高。 [先前技術文獻] [專利文獻] In the formation of resist patterns, the action of the acid generated by the acid generator component during exposure becomes one of the factors that greatly influences the photolithography characteristics. As the acid generator used in the chemically amplified resist composition, various kinds of acid generators have been proposed so far. For example, onium salt acid generators such as iodonium salts or sulfonium salts, oxime sulfonate acid generators, diazomethane acid generators, nitrobenzene sulfonate acid generators, imide sulfonate acid generators, disulfonate acid generators, etc. are known. As an onium salt acid generator, an alkylsulfonic acid ion or a fluorinated alkylsulfonic acid ion in which a part or all of the hydrogen atoms of the alkyl group are replaced by fluorine atoms is generally used as the negative ion part. The cationic part used in the onium salt acid generator mainly has an onium ion such as triphenylsulfonium. For example, Patent Document 1 discloses a resist composition containing a salt of a negative ion having a polycyclic structure containing a linked octane skeleton and an organic cation as an acid generator. According to the resist composition, high sensitivity to exposure light sources can be generated and improved lithography characteristics can be achieved. [Prior Art Document] [Patent Document]

[專利文獻1] 日本特開2018-92159號公報[Patent Document 1] Japanese Patent Application Publication No. 2018-92159

[發明所解決的問題][Problem solved by the invention]

光刻技術的更進歩,應用領域的擴大等正進行者,且圖型的微型化正急速進展的。然後隨之在製造半導體元件等時,需要具備能夠以良好形狀形成微細圖型之技術。例如,藉由EUV(極端紫外線)或EB(電子線)之光刻以達成數十奈米之微細圖型形成為目標。如此圖型尺寸越小,無須使感度、解像性等光刻特性各權衡下而可越提高作為課題。 然而,如上述過去阻劑組成物中,若要達成高感度化時,有時會有圖型尺寸之面內均勻性(CDU)及微細解像性等不良成為問題之情況產生。 As photolithography technology is further advanced and its application areas are expanded, the miniaturization of patterns is progressing rapidly. As a result, when manufacturing semiconductor components, it is necessary to have a technology that can form fine patterns with good shapes. For example, the goal is to form fine patterns of tens of nanometers by EUV (extreme ultraviolet) or EB (electron beam) lithography. In this way, the smaller the pattern size, the more it can be improved without having to balance the photolithography characteristics such as sensitivity and resolution. However, in the past resist composition mentioned above, when high sensitivity is achieved, sometimes problems such as in-plane uniformity (CDU) of pattern size and fine resolution become problems.

本發明係有鑑於上述事情而成者,係以提供於形成阻劑圖型時可達到高感度化,且提高CDU及微細解像性等光刻特性之阻劑組成物、使用該阻劑組成物的阻劑圖型形成方法,以及作為使用於該阻劑組成物之酸產生劑成分而有用的化合物為課題。 [解決課題的手段] The present invention is made in view of the above-mentioned circumstances, and aims to provide a resist composition that can achieve high sensitivity when forming a resist pattern and improve lithography characteristics such as CDU and fine resolution, a resist pattern forming method using the resist composition, and a compound that is useful as an acid generator component used in the resist composition. [Means for solving the problem]

欲解決上述課題,本發明採用以下構成。 即,本發明之第1態樣為一種阻劑組成物,其特徵為藉由曝光產生酸,且藉由酸的作用對於顯影液的溶解性產生變化之阻劑組成物,其中含有藉由酸的作用對於顯影液的溶解性產生變化的基材成分(A)與下述一般式(b0)所示化合物(B0)者。 In order to solve the above-mentioned problem, the present invention adopts the following structure. That is, the first aspect of the present invention is a resist composition, which is characterized by generating acid by exposure and causing a change in the solubility of the developer by the action of the acid, wherein the resist composition contains a base component (A) causing a change in the solubility of the developer by the action of the acid and a compound (B0) represented by the following general formula (b0).

[式中,R b為鹼分解性基。L 03為2價連結基。Rl 0為可具有取代基的環狀有機基。L 02為2價連結基。I為碘原子。R m1為碘原子以外之取代基。L 01為2價連結基或單鍵。Vb 0為伸烷基、氟化伸烷基或單鍵。但,L 01與Vb 0不會同時成為單鍵。R 0為碳數1~5的氟化烷基、氟原子或氫原子。nb1為1~4的整數,nb2為1~4的整數,nb3為0~3的整數。但,2≦nb1+nb2+nb3≦5。M m+表示m價有機陽離子。m為1以上的整數。] [In the formula, Rb is an alkali-decomposable group. L03 is a divalent linking group. Rl0 is a cyclic organic group which may have a substituent. L02 is a divalent linking group. I is an iodine atom. Rm1 is a substituent other than an iodine atom. L01 is a divalent linking group or a single bond. Vb0 is an alkylene group, a fluorinated alkylene group or a single bond. However, L01 and Vb0 will not simultaneously form a single bond. R0 is a fluorinated alkylene group having 1 to 5 carbon atoms, a fluorine atom or a hydrogen atom. nb1 is an integer from 1 to 4, nb2 is an integer from 1 to 4, and nb3 is an integer from 0 to 3. However, 2≦nb1+nb2+nb3≦5. Mm+ represents an m-valent organic cation. m is an integer greater than 1.]

本發明之第2態樣為一種阻劑圖型形成方法,其特徵為含有在支持體上使用如前述第1態樣的阻劑組成物而形成阻劑膜之步驟、使前述阻劑膜進行曝光之步驟,及將前述曝光後之阻劑膜進行顯影而形成阻劑圖型之步驟。The second aspect of the present invention is a method for forming a resist pattern, which is characterized by comprising the steps of forming a resist film on a support using the resist composition as described in the first aspect, exposing the resist film, and developing the exposed resist film to form a resist pattern.

本發明之第3態樣之一種下述一般式(b0)所示的化合物,其特徵為,A compound represented by the following general formula (b0) in the third aspect of the present invention is characterized in that:

[式中,R b為鹼分解性基。L 03為2價連結基。Rl 0為可具有取代基的環狀有機基。L 02為2價連結基。I為碘原子。R m1為碘原子以外之取代基。L 01為2價連結基或單鍵。Vb 0為伸烷基、氟化伸烷基或單鍵。但,L 01與Vb 0不會同時成為單鍵。R 0為碳數1~5的氟化烷基、氟原子或氫原子。nb1為1~4的整數,nb2為1~4的整數,nb3為0~3的整數。但,2≦nb1+nb2+nb3≦5。M m+表示m價有機陽離子。m為1以上的整數。] [In the formula, Rb is an alkali-decomposable group. L03 is a divalent linking group. Rl0 is a cyclic organic group which may have a substituent. L02 is a divalent linking group. I is an iodine atom. Rm1 is a substituent other than an iodine atom. L01 is a divalent linking group or a single bond. Vb0 is an alkylene group, a fluorinated alkylene group or a single bond. However, L01 and Vb0 will not simultaneously form a single bond. R0 is a fluorinated alkylene group having 1 to 5 carbon atoms, a fluorine atom or a hydrogen atom. nb1 is an integer from 1 to 4, nb2 is an integer from 1 to 4, and nb3 is an integer from 0 to 3. However, 2≦nb1+nb2+nb3≦5. Mm+ represents an m-valent organic cation. m is an integer greater than 1.]

本發明之第4態樣之一種酸產生劑,其特徵為含有如前述第3態樣之化合物。 [發明之效果] An acid generator according to the fourth aspect of the present invention is characterized by containing a compound as described in the third aspect above. [Effect of the invention]

依據本發明,可提供形成阻劑圖型時達成高感度化,且可提高CDU及微細解像性等光刻特性的阻劑組成物、使用該阻劑組成物之阻劑圖型形成方法,以及作為使用於該阻劑組成物的酸產生劑成分而有用化合物。According to the present invention, a resist composition that achieves high sensitivity when forming a resist pattern and improves lithography properties such as CDU and fine resolution, a resist pattern forming method using the resist composition, and a compound useful as an acid generator component used in the resist composition can be provided.

[實施發明的型態][Type of implementation of the invention]

本說明書及本申請專利範圍中,所謂「脂肪族」定義為芳香族之相對概念,不具有芳香族性的基之化合物等者。 「烷基」若無特別說明,包含直鏈狀、分支鏈狀及環狀1價飽和烴基者。烷氧基中之烷基亦相同。 「伸烷基」若無特別說明,包含直鏈狀、分支鏈狀及環狀2價飽和烴基者。 「鹵素原子」可舉出氟原子、氯原子、溴原子、碘原子。 所謂「構成單位」表示構成高分子化合物(樹脂、聚合物、共聚物)之單體單位(單體單位)。 記載為「可具有取代基」之情況時,含有將氫原子 (-H)由1價基進行取代之情況,與將亞甲基(-CH 2-)由2價基進行取代之情況的雙方。 「曝光」包含放射線的整體照射之概念。 In this specification and the scope of this patent application, the so-called "aliphatic" is defined as a relative concept of aromatic, and refers to compounds without aromatic groups. "Alkyl" includes linear, branched and cyclic monovalent saturated hydrocarbon groups unless otherwise specified. The same applies to alkyl groups in alkoxy groups. "Alkylene" includes linear, branched and cyclic divalent saturated hydrocarbon groups unless otherwise specified. "Halogen atom" includes fluorine atom, chlorine atom, bromine atom and iodine atom. The so-called "constituent unit" refers to the monomer unit (monomer unit) constituting a high molecular compound (resin, polymer, copolymer). When it is described as "may have a substituent", it includes both the case where the hydrogen atom (-H) is substituted by a monovalent group and the case where the methylene group (-CH 2 -) is substituted by a divalent group. "Exposure" includes the concept of overall irradiation with radiation.

「酸分解性基」為具有酸分解性的基,該酸分解性為藉由酸的作用而可解開該酸分解性基之結構中的至少一部分鍵者。 作為藉由酸的作用而使極性增大的酸分解性基,例如可舉出藉由酸的作用進行分解而產生極性基之基。 作為極性基,例如可舉出羧基、羥基、胺基、磺酸基(-SO 3H)等。 作為酸分解性基,更具體可舉出前述極性基以酸解離性基進行保護的基(例如將含有OH的極性基之氫原子以酸解離性基進行保護的基)。 "Acid-decomposable group" is a group having acid-decomposability, and the acid-decomposability is that at least a part of the bonds in the structure of the acid-decomposable group can be untied by the action of an acid. Examples of acid-decomposable groups whose polarity is increased by the action of an acid include groups that generate polar groups by decomposition by the action of an acid. Examples of polar groups include carboxyl groups, hydroxyl groups, amino groups, and sulfonic acid groups (-SO 3 H). More specifically, examples of acid-decomposable groups include groups in which the aforementioned polar groups are protected by acid-decomposable groups (e.g., groups in which the hydrogen atom of a polar group containing OH is protected by an acid-decomposable group).

所謂「酸解離性基」表示,(i)具有藉由酸作用,可開裂該酸解離性基與鄰接於該酸解離性基的原子之間的鍵結之酸解離性的基,或(ii)具有藉由酸作用,一部分的鍵結開裂後,進一步藉由脫碳酸反應的產生,可開裂該酸解離性基與鄰接於該酸解離性基的原子之間的鍵結之基的雙方。 構成酸分解性基之酸解離性基必需為,該極性比藉由該酸解離性基之解離所生成的極性基的極性低之基,藉此,在藉由酸作用而解離該酸解離性基時,產生比該酸解離性基的極性高的極性基而使極性增大。該結果,(A1)成分全體之極性增大。藉由極性之增大,相對性地對於顯影液之溶解性產生變化,顯影液在鹼顯影液之情況時溶解性增大,顯影液在有機系顯影液之情況時溶解性減少。 The so-called "acid-dissociable group" means (i) an acid-dissociable group that can cleave the bond between the acid-dissociable group and an atom adjacent to the acid-dissociable group by the action of an acid, or (ii) a group that can cleave the bond between the acid-dissociable group and an atom adjacent to the acid-dissociable group by further generating a decarbonation reaction after a portion of the bonds are cleaved by the action of an acid. The acid-dissociable group constituting the acid-dissociable group must be a group with a lower polarity than the polar group generated by the dissociation of the acid-dissociable group, so that when the acid-dissociable group is dissociated by the action of an acid, a polar group with a higher polarity than the acid-dissociable group is generated to increase the polarity. As a result, the polarity of the (A1) component as a whole increases. The increase in polarity relatively changes the solubility of the developer, and the solubility increases in the case of an alkaline developer, and decreases in the case of an organic developer.

所謂「基材成分」表示具有膜形成能之有機化合物。作為基材成分使用的有機化合物可大概分為非聚合物與聚合物。作為非聚合物,一般使用分子量為500以上且未達4000者(以下稱為「低分子化合物」)。以下所謂「樹脂」、「高分子化合物」或「聚合物」之情況時,其表示分子量為1000以上的聚合物。作為聚合物之分子量,使用經GPC(凝膠滲透層析法)所得之聚苯乙烯換算的重量平均分子量者。The so-called "base component" refers to an organic compound that has the ability to form a film. Organic compounds used as base components can be roughly divided into non-polymers and polymers. As non-polymers, those with a molecular weight of 500 or more and less than 4000 (hereinafter referred to as "low molecular weight compounds") are generally used. In the case of "resin", "high molecular weight compound" or "polymer" below, it means a polymer with a molecular weight of 1000 or more. As the molecular weight of the polymer, the weight average molecular weight converted to polystyrene obtained by GPC (gel permeation chromatography) is used.

所謂「所衍生的構成單位」表示碳原子間之多重鍵結,例如表示乙烯性雙鍵經開裂所構成的構成單位之意思。 「丙烯酸酯」中鍵結於α位碳原子之氫原子可由取代基進行取代。取代鍵結於該α位碳原子之氫原子的取代基(R αx)為氫原子以外之原子或基。又,亦包含取代基(R αx)由含有酯鍵的取代基進行取代之衣康酸二酯,或取代基(R αx)由羥基烷基或將該羥基經修飾的基進行取代的α羥基丙烯酸酯者。且丙烯酸酯之α位碳原子若無特別說明時,其表示丙烯酸的羰基所鍵結的碳原子者。 以下有時將鍵結於α位碳原子的氫原子以取代基進行取代的丙烯酸酯稱為α取代丙烯酸酯。 The so-called "derived constituent unit" means multiple bonds between carbon atoms, for example, it means a constituent unit formed by cleaving an ethylenic double bond. The hydrogen atom bonded to the α-carbon atom in "acrylate" may be substituted by a substituent. The substituent (R αx ) replacing the hydrogen atom bonded to the α-carbon atom is an atom or group other than a hydrogen atom. In addition, it also includes itaconate diesters in which the substituent (R αx ) is substituted by a substituent containing an ester bond, or α-hydroxy acrylates in which the substituent (R αx ) is substituted by a hydroxyalkyl group or a group in which the hydroxy group is modified. Furthermore, unless otherwise specified, the α-carbon atom of the acrylate refers to the carbon atom to which the carbonyl group of acrylic acid is bonded. Hereinafter, an acrylate in which the hydrogen atom bonded to the α-carbon atom is substituted with a substituent may be referred to as an α-substituted acrylate.

所謂「衍生物」表示含有對象化合物之α位氫原子由烷基、鹵化烷基等其他取代基進行取代者,以及此等衍生物之概念。作為此等衍生物,可舉出α位氫原子可由取代基進行取代的對象化合物之羥基的氫原子由有機基進行取代者;對於α位氫原子可由取代基進行取代的對象化合物,羥基以外的取代基進行鍵結者等。且,對α位若無特別說明時,其表示與官能基鄰接的第一個碳原子。 作為取代羥基苯乙烯的α位氫原子之取代基,可舉出與R αx之相同者。 The term "derivative" refers to a compound in which the α-position hydrogen atom of the target compound is replaced by another substituent such as an alkyl group or a halogenated alkyl group, and the concept of such derivatives. Examples of such derivatives include compounds in which the α-position hydrogen atom may be replaced by a substituent, compounds in which the hydroxyl hydrogen atom of the target compound may be replaced by an organic group, compounds in which the α-position hydrogen atom may be replaced by a substituent, compounds in which a substituent other than a hydroxyl group is bonded, and the like. Furthermore, unless otherwise specified, the α-position refers to the first carbon atom adjacent to the functional group. Examples of the substituent for the α-position hydrogen atom of substituted hydroxystyrene include the same as R αx .

本案說明書及本案申請專利範圍中,藉由化學式所示結構,存在著不對稱碳,其中可存在對映異構物(enantiomer)或非對映異構物(diastereomer)者。此情況時,以其中一個化學式代表此等異構物表示。此等異構物可單獨使用,亦可作為混合物使用。In the description and the scope of the patent application of this case, the structure shown by the chemical formula has asymmetric carbon, and enantiomers or diastereomers may exist. In this case, one of the chemical formulas represents these isomers. These isomers can be used alone or as a mixture.

(阻劑組成物) 本實施形態之阻劑組成物為,藉由曝光而產生酸,且藉由酸的作用而對顯影液之溶解性產生變化者。 該阻劑組成物含有藉由酸的作用而對顯影液之溶解性產生變化的基材成分(A)(以下亦稱為「(A)成分」)與藉由曝光而產生酸之酸產生劑成分(B)(以下亦稱為「(B)成分」)。前述(B)成分含有一般式(b0)所示化合物(B0)。 (Resistant composition) The resist composition of this embodiment generates acid by exposure, and changes the solubility of the developer by the action of the acid. The resist composition contains a base component (A) (hereinafter also referred to as "(A) component") that changes the solubility of the developer by the action of the acid and an acid generator component (B) (hereinafter also referred to as "(B) component") that generates acid by exposure. The aforementioned (B) component contains a compound (B0) represented by the general formula (b0).

使用本實施形態之阻劑組成物而形成阻劑膜,對於該阻劑膜進行選擇性曝光時,在該阻劑膜之曝光部,自(B)成分產生酸,藉由該酸的作用,(A)成分對於顯影液之溶解性產生變化,另外在該阻劑膜的未曝光部中,(A)成分對於顯影液之溶解性並無產生變化,故對於顯影液之溶解性在該阻劑膜之曝光部與未曝光部之間產生差異。因此,使該阻劑膜進行顯影時,當該阻劑組成物為正型之情況時,阻劑膜曝光部經溶解除去而形成正型之阻劑圖型,當該阻劑組成物為負型之情況時,阻劑膜未曝光部經溶解除去而形成負型之阻劑圖型。When a resist film is formed using the resist composition of the present embodiment and the resist film is selectively exposed, an acid is generated from the component (B) in the exposed portion of the resist film. Due to the action of the acid, the solubility of the component (A) in the developer changes. Meanwhile, in the unexposed portion of the resist film, the solubility of the component (A) in the developer does not change. Therefore, a difference occurs in the solubility in the developer between the exposed portion and the unexposed portion of the resist film. Therefore, when the resist film is developed, when the resist composition is positive, the exposed portion of the resist film is dissolved and removed to form a positive resist pattern, and when the resist composition is negative, the unexposed portion of the resist film is dissolved and removed to form a negative resist pattern.

本實施形態之阻劑組成物可為正型阻劑組成物,亦可為負型阻劑組成物。又,本實施形態之阻劑組成物可使用於在阻劑圖型形成時的顯影處理上使用鹼顯影液之鹼顯影製程中,亦可使用於對該顯影處理使用含有有機溶劑之顯影液(有機系顯影液)的溶劑顯影製程中。The resist composition of the present embodiment can be a positive resist composition or a negative resist composition. Furthermore, the resist composition of the present embodiment can be used in an alkali development process using an alkali developer in the development process when forming a resist pattern, and can also be used in a solvent development process using a developer containing an organic solvent (organic developer) in the development process.

<基材成分(A)> 本實施形態之阻劑組成物中,(A)成分含有藉由酸的作用而對顯影液之溶解性產生變化的樹脂成分(A1)(以下亦稱為「(A1)成分」)。 藉由使用(A1)成分,在曝光前後因基材成分的極性產生變化,不僅在鹼顯影製程中,亦在溶劑顯影製程中可得到良好顯影對比。 作為(A)成分,使用該(A1)成分之同時,亦可併用其他高分子化合物及/或低分子化合物。 <Base component (A)> In the resist composition of this embodiment, the (A) component contains a resin component (A1) (hereinafter also referred to as "(A1) component") whose solubility in the developer changes due to the action of an acid. By using the (A1) component, the polarity of the base component changes before and after exposure, and good development contrast can be obtained not only in an alkaline development process but also in a solvent development process. As the (A) component, other high molecular weight compounds and/or low molecular weight compounds may be used in combination with the (A1) component.

本實施形態之阻劑組成物中,(A)成分可單獨使用1種,亦可併用2種以上。In the inhibitor composition of this embodiment, the component (A) may be used alone or in combination of two or more.

・對於(A1)成分, (A1)成分為,藉由酸的作用對於顯影液的溶解性產生變化的樹脂成分。 作為(A1)成分,以具有含有藉由酸的作用使極性增大的酸分解性基之構成單位(a1)者為佳。 (A1)成分除具有構成單位(a1)以外,視必要亦可具有其他構成單位。 ・Regarding the component (A1), The component (A1) is a resin component whose solubility in the developer changes due to the action of an acid. As the component (A1), it is preferred to have a constituent unit (a1) containing an acid-degradable group whose polarity increases due to the action of an acid. In addition to the constituent unit (a1), the component (A1) may also have other constituent units as necessary.

≪構成單位(a1)≫ 構成單位(a1)為含有藉由酸的作用使極性增大的酸分解性基之構成單位。 ≪Constituent unit (a1)≫ Constituent unit (a1) is a constituent unit containing an acid-degradable group whose polarity is increased by the action of an acid.

作為酸解離性基,至今可舉出作為化學增幅型阻劑組成物用之基礎樹脂的酸解離性基而被提案者。 作為化學增幅型阻劑組成物用之基礎樹脂的酸解離性基被提案者,具體可舉出以下說明的「縮醛型酸解離性基」、「第3級烷基酯型酸解離性基」、「第3級烷氧基羰基酸解離性基」、「第2級烷氧基羰基酸解離性基」。 As the acid-dissociable group, those proposed as the acid-dissociable group of the base resin for the chemically amplified resistor composition can be cited so far. Specifically, the acid-dissociable group proposed as the base resin for the chemically amplified resistor composition includes the "acetal type acid-dissociable group", "third-level alkyl ester type acid-dissociable group", "third-level alkoxycarbonyl acid-dissociable group", and "second-level alkoxycarbonyl acid-dissociable group" described below.

縮醛型酸解離性基: 作為前述極性基中保護羧基或羥基的酸解離性基,例如可舉出下述一般式(a1-r-1)所示酸解離性基(以下有時稱為「縮醛型酸解離性基」)。 Acetal type acid-dissociable group: Among the aforementioned polar groups, the acid-dissociable group that protects the carboxyl group or the hydroxyl group may be, for example, an acid-dissociable group represented by the following general formula (a1-r-1) (hereinafter sometimes referred to as an "acetal type acid-dissociable group").

[式中,Ra’ 1、Ra’ 2為氫原子或烷基。Ra’ 3為烴基,Ra’ 3可與Ra’ 1、Ra’ 2中任一者鍵結而形成環。] [In the formula, Ra' 1 and Ra' 2 are hydrogen atoms or alkyl groups. Ra' 3 is a alkyl group, and Ra' 3 can be bonded with either Ra' 1 or Ra' 2 to form a ring.]

式(a1-r-1)中,Ra’ 1及Ra’ 2中,至少一方為氫原子者為佳,雙方為氫原子者為較佳。 Ra’ 1或Ra’ 2為烷基之情況時,作為該烷基,可舉出對於上述α取代丙烯酸酯之說明中,作為可鍵結於α位碳原子之取代基而舉出之與烷基之相同者,碳原子數1~5的烷基為佳。具體為較佳可舉出直鏈狀或分支鏈狀烷基。更具體可舉出甲基、乙基、丙基、異丙基、n-丁基、異丁基、tert-丁基、戊基、異戊基、新戊基等,以甲基或乙基為較佳,以甲基為特佳。 In formula (a1-r-1), at least one of Ra'1 and Ra'2 is preferably a hydrogen atom, and both are more preferably hydrogen atoms. When Ra'1 or Ra'2 is an alkyl group, the alkyl group may be the same as the alkyl group listed as a substituent that can be bonded to the α-carbon atom in the description of the α-substituted acrylate, and an alkyl group having 1 to 5 carbon atoms is preferred. Specifically, a straight chain or branched chain alkyl group may be preferably cited. More specifically, a methyl group, an ethyl group, a propyl group, an isopropyl group, an n-butyl group, an isobutyl group, a tert-butyl group, a pentyl group, an isopentyl group, a neopentyl group, etc. may be cited, and a methyl group or an ethyl group may be preferably cited, and a methyl group may be particularly preferred.

式(a1-r-1)中,作為Ra’ 3的烴基,可舉出直鏈狀或者分支鏈狀烷基或環狀烴基。 該直鏈狀烷基以碳原子數1~5者為佳,以碳原子數1~4為較佳,以碳原子數1或2為更佳。具體可舉出甲基、乙基、n-丙基、n-丁基、n-戊基等。此等中亦以甲基、乙基或n-丁基為佳,以甲基或乙基為較佳。 In formula (a1-r-1), as the alkyl group of Ra' 3 , a linear or branched alkyl group or a cyclic alkyl group can be cited. The linear alkyl group preferably has 1 to 5 carbon atoms, more preferably 1 to 4 carbon atoms, and more preferably 1 or 2 carbon atoms. Specifically, methyl, ethyl, n-propyl, n-butyl, n-pentyl and the like can be cited. Among these, methyl, ethyl or n-butyl are also preferred, and methyl or ethyl is more preferred.

該分支鏈狀烷基以碳原子數3~10者為佳,以碳原子數3~5為較佳。具體可舉出異丙基、異丁基、tert-丁基、異戊基、新戊基、1,1-二乙基丙基、2,2-二甲基丁基等,以異丙基者為佳。The branched chain alkyl group preferably has 3 to 10 carbon atoms, more preferably 3 to 5 carbon atoms. Specific examples include isopropyl, isobutyl, tert-butyl, isopentyl, neopentyl, 1,1-diethylpropyl, 2,2-dimethylbutyl, etc., with isopropyl being preferred.

Ra’ 3成為環狀烴基的情況時,該烴基可為脂肪族烴基,亦可為芳香族烴基,又,可為多環式基,亦可為單環式基。 作為單環式基之脂肪族烴基,以自單環烷烴除去1個氫原子的基為佳。作為該單環烷烴,以碳原子數3~6者佳,具體可舉出環戊烷、環己烷等。 作為多環式基之脂肪族烴基,以自聚環烷烴除去1個氫原子的基為佳,作為該聚環烷烴,以碳原子數7~12者為佳,具體可舉出金剛烷、降冰片烷、異冰片、三環癸烷、四環十二烷等。 When Ra'3 is a cyclic alkyl group, the alkyl group may be an aliphatic alkyl group or an aromatic alkyl group, and may be a polycyclic group or a monocyclic group. The aliphatic alkyl group as a monocyclic group is preferably a group obtained by removing one hydrogen atom from a monocyclic alkane. The monocyclic alkane is preferably one having 3 to 6 carbon atoms, and specific examples thereof include cyclopentane and cyclohexane. The aliphatic hydrocarbon group as the polycyclic group is preferably a group obtained by removing one hydrogen atom from a polycycloalkane. The polycycloalkane preferably has 7 to 12 carbon atoms, and specific examples thereof include adamantane, norbornane, isoborneol, tricyclodecane, tetracyclododecane and the like.

Ra’ 3的環狀烴基成為芳香族烴基之情況時,該芳香族烴基具有至少1個芳香環之烴基。 該芳香環若為具有4n+2個π電子之環狀共軛系即可,並無特別限定,可為單環式亦可為多環式。芳香環之碳原子數以5~30者為佳,以碳原子數5~20為較佳,以碳原子數6~15為更佳,以碳原子數6~12為特佳。 作為芳香環,具體可舉出苯、萘、蒽、菲等芳香族烴環;構成前述芳香族烴環之碳原子的一部分由雜原子進行取代的芳香族雜環等。作為芳香族雜環中之雜原子,可舉出氧原子、硫原子、氮原子等。作為芳香族雜環,具體可舉出吡啶環、噻吩環等。 作為Ra’ 3中之芳香族烴基,具體可舉出自前述芳香族烴環或芳香族雜環除去1個氫原子之基(芳基或雜芳基);自含有2個以上芳香環之芳香族化合物(例如聯苯基、芴等)除去1個氫原子之基;前述芳香族烴環或芳香族雜環的1個氫原子由伸烷基進行取代的基(例如苯甲基、苯乙基、1-萘甲基、2-萘甲基、1-萘乙基、2-萘乙基等芳基烷基等)等。鍵結於前述芳香族烴環或芳香族雜環的伸烷基之碳原子數以1~4者為佳,以碳原子數1~2者為較佳,以碳原子數1者為特佳。 When the cyclic alkyl group of Ra' 3 is an aromatic alkyl group, the aromatic alkyl group has at least one aromatic ring. The aromatic ring is not particularly limited as long as it is a cyclic conjugate system having 4n+2 π electrons, and may be a monocyclic or polycyclic ring. The number of carbon atoms in the aromatic ring is preferably 5 to 30, more preferably 5 to 20, more preferably 6 to 15, and particularly preferably 6 to 12. Specific examples of the aromatic ring include aromatic alkyl rings such as benzene, naphthalene, anthracene, and phenanthrene; aromatic heterocyclic rings in which a portion of the carbon atoms constituting the aforementioned aromatic alkyl rings are substituted by heteroatoms, and the like. Examples of the hetero atom in the aromatic heterocyclic ring include oxygen atom, sulfur atom, nitrogen atom, etc. Examples of the aromatic heterocyclic ring include pyridine ring, thiophene ring, etc. Examples of the aromatic hydrocarbon group in Ra' 3 include groups obtained by removing one hydrogen atom from the aforementioned aromatic hydrocarbon ring or aromatic heterocyclic ring (aryl group or heteroaryl group); groups obtained by removing one hydrogen atom from an aromatic compound containing two or more aromatic rings (e.g., biphenyl group, fluorene, etc.); groups obtained by replacing one hydrogen atom of the aforementioned aromatic hydrocarbon ring or aromatic heterocyclic ring with an alkylene group (e.g., arylalkyl groups such as benzyl, phenethyl, 1-naphthylmethyl, 2-naphthylmethyl, 1-naphthylethyl, 2-naphthylethyl, etc.). The alkylene group bonded to the aforementioned aromatic hydrocarbon ring or aromatic heterocyclic ring preferably has 1 to 4 carbon atoms, more preferably 1 to 2 carbon atoms, and particularly preferably 1 carbon atom.

Ra’ 3中之環狀的烴基可具有取代基。作為該取代基,例如可舉出-R P1、-R P2-O-R P1、-R P2-CO-R P1、   -R P2-CO-OR P1、-R P2-O-CO-R P1、-R P2-OH、-R P2-CN或    -R P2-COOH(以下綜合此等取代基稱為「Ra x5」。)等。 其中,R P1為碳原子數1~10的1價鏈狀飽和烴基、碳原子數3~20的1價脂肪族環狀飽和烴基或碳原子數6~30的1價芳香族烴基。又,R P2為單鍵、碳原子數1~10的2價鏈狀飽和烴基、碳原子數3~20的2價脂肪族環狀飽和烴基或碳原子數6~30的2價芳香族烴基。但,R P1及R P2的鏈狀飽和烴基、脂肪族環狀飽和烴基及芳香族烴基所具有氫原子的一部分或全部可由氟原子進行取代。上述脂肪族環狀烴基可具有1種單獨的1個以上的上述取代基,亦可具有各1個以上的上述取代基中之複數種。 作為碳原子數1~10的1價鏈狀飽和烴基,例如可舉出甲基、乙基、丙基、丁基、戊基、己基、庚基、辛基、癸基等。 作為碳原子數3~20的1價脂肪族環狀飽和烴基,例如可舉出環丙基、環丁基、環戊基、環己基、環庚基、環辛基、環癸基、環十二烷基等單環式脂肪族飽和烴基;聯環[2.2.2]辛基、三環[5.2.1.02,6]癸基、三環[3.3.1.13,7]癸基、四環[6.2.1.13,6.02,7]十二烷基、金剛烷基等多環式脂肪族飽和烴基。 作為碳原子數6~30的1價芳香族烴基,例如可舉出自苯、聯苯基、芴、萘、蒽、菲等芳香族烴環除去1個氫原子之基。 The cyclic alkyl group in Ra'3 may have a substituent. Examples of the substituent include -RP1 , -RP2 - ORP1 , -RP2-CO-RP1, -RP2 - CO- ORP1 , -RP2 - O-CO- RP1 , -RP2 - OH , -RP2 -CN or -RP2 - COOH (hereinafter, these substituents are collectively referred to as " Rax5 "). Among them, RP1 is a monovalent chain saturated alkyl group having 1 to 10 carbon atoms, a monovalent aliphatic cyclic saturated alkyl group having 3 to 20 carbon atoms or a monovalent aromatic alkyl group having 6 to 30 carbon atoms. Furthermore, RP2 is a single bond, a divalent chain saturated alkyl group having 1 to 10 carbon atoms, a divalent aliphatic cyclic saturated alkyl group having 3 to 20 carbon atoms, or a divalent aromatic alkyl group having 6 to 30 carbon atoms. However, a part or all of the hydrogen atoms possessed by the chain saturated alkyl group, aliphatic cyclic saturated alkyl group and aromatic alkyl group of RP1 and RP2 may be substituted by fluorine atoms. The above-mentioned aliphatic cyclic alkyl group may have one or more of the above-mentioned substituents alone, or may have more than one of the above-mentioned substituents. Examples of the monovalent chain saturated alkyl group having 1 to 10 carbon atoms include methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, decyl and the like. Examples of the monovalent aliphatic cyclic saturated alkyl group having 3 to 20 carbon atoms include monocyclic aliphatic saturated alkyl groups such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclodecyl and cyclododecyl; and polycyclic aliphatic saturated alkyl groups such as bicyclic [2.2.2]octyl, tricyclo [5.2.1.02,6]decyl, tricyclo [3.3.1.13,7]decyl, tetracyclo [6.2.1.13,6.02,7]dodecyl and adamantyl. Examples of the monovalent aromatic hydrocarbon group having 6 to 30 carbon atoms include groups obtained by removing one hydrogen atom from an aromatic hydrocarbon ring such as benzene, biphenyl, fluorene, naphthalene, anthracene, and phenanthrene.

Ra’ 3為與Ra’ 1、Ra’ 2中任一者鍵結而形成環之情況時,作為該環式基,以4~7員環為佳,以4~6員環為較佳。作為該環式基之具體例子,可舉出四氫吡喃基、四氫呋喃基等。 When Ra'3 is bonded to either Ra'1 or Ra'2 to form a ring, the cyclic group is preferably a 4- to 7-membered ring, more preferably a 4- to 6-membered ring. Specific examples of the cyclic group include tetrahydropyranyl and tetrahydrofuranyl.

第3級烷基酯型酸解離性基: 上述極性基中,作為保護羧基之酸解離性基,例如可舉出下述一般式(a1-r-2)所示酸解離性基。 且,下述式(a1-r-2)所示酸解離性基中,將由烷基所構成者在以下有時簡稱為「第3級烷基酯型酸解離性基」。 Third-level alkyl ester type acid-dissociable group: Among the above polar groups, as an acid-dissociable group for protecting the carboxyl group, for example, an acid-dissociable group represented by the following general formula (a1-r-2) can be cited. In addition, among the acid-dissociable groups represented by the following formula (a1-r-2), those composed of alkyl groups are sometimes referred to as "third-level alkyl ester type acid-dissociable groups" below.

[式中,Ra’ 4~Ra’ 6各為烴基,Ra’ 5、Ra’ 6彼此鍵結而可形成環。] [In the formula, Ra' 4 to Ra' 6 are each a alkyl group, and Ra' 5 and Ra' 6 are bonded to each other to form a ring.]

作為Ra’ 4的烴基,可舉出直鏈狀或者分支鏈狀烷基、鏈狀或者環狀烯基或環狀烴基。 Ra’ 4中之直鏈狀或者分支鏈狀烷基、環狀烴基(單環式基的脂肪族烴基、多環式基的脂肪族烴基、芳香族烴基)可舉出與前述Ra’ 3相同者。 Ra’ 4中之鏈狀或者環狀烯基,以碳原子數2~10的烯基為佳。 作為Ra’ 5、Ra’ 6的烴基,可舉出與前述Ra’ 3之相同者。 As the alkyl group of Ra' 4 , there can be mentioned a linear or branched alkyl group, a linear or cyclic alkenyl group, or a cyclic alkyl group. The linear or branched alkyl group, and the cyclic alkyl group (monocyclic aliphatic alkyl group, polycyclic aliphatic alkyl group, aromatic alkyl group) in Ra' 4 can be the same as those in Ra' 3 above. The linear or cyclic alkenyl group in Ra' 4 is preferably an alkenyl group having 2 to 10 carbon atoms. As the alkyl group of Ra' 5 and Ra' 6 , there can be mentioned the same as those in Ra' 3 above.

Ra’ 5與Ra’ 6彼此鍵結而形成環之情況時,為較佳可舉出下述一般式(a1-r2-1)所示基、下述一般式(a1-r2-2)所示基、下述一般式(a1-r2-3)所示基。 另一方面,Ra’ 4~Ra’ 6彼此未鍵結而獨立為烴基之情況時,為較佳可舉出下述一般式(a1-r2-4)所示基。 When Ra'5 and Ra'6 are bonded to form a ring, preferably, there are groups represented by the following general formula (a1-r2-1), groups represented by the following general formula (a1-r2-2), and groups represented by the following general formula (a1-r2-3). On the other hand, when Ra'4 to Ra'6 are not bonded to each other and are independently alkyl groups, preferably, there are groups represented by the following general formula (a1-r2-4).

[式(a1-r2-1)中,Ra’ 10表示一部分可由鹵素原子或含有雜原子的基進行取代的直鏈狀或分支鏈狀碳原子數1~12的烷基。Ra’ 11表示Ra’ 10與所鍵結的碳原子可共同形成脂肪族環式基的基。式(a1-r2-2)中,Ya為碳原子。Xa為與Ya共同形成環狀烴基的基。該環狀烴基所具有氫原子的一部分或全部可被取代。Ra 101~Ra 103各獨立為氫原子、碳原子數1~10的1價鏈狀飽和烴基或碳原子數3~20的1價脂肪族環狀飽和烴基。該鏈狀飽和烴基及脂肪族環狀飽和烴基所具有氫原子的一部分或全部可被取代。Ra 101~Ra 103的2個以上可彼此鍵結而形成環狀結構。式(a1-r2-3)中,Yaa為碳原子。Xaa為與Yaa共同形成脂肪族環式基的基。Ra 104為可具有取代基的芳香族烴基。式(a1-r2-4)中,Ra’ 12及Ra’ 13各獨立為碳原子數1~10的1價鏈狀飽和烴基。該鏈狀飽和烴基所具有氫原子的一部分或全部可被取代。Ra’ 14可具有取代基之烴基。*表示鍵結位置(以下同樣)。] [In formula (a1-r2-1), Ra' 10 represents a linear or branched alkyl group having 1 to 12 carbon atoms, a portion of which may be substituted by a halogen atom or a group containing a heteroatom. Ra' 11 represents a group that can form an aliphatic cyclic group together with the carbon atom to which Ra' 10 is bound. In formula (a1-r2-2), Ya is a carbon atom. Xa is a group that forms a cyclic hydrocarbon group together with Ya. A part or all of the hydrogen atoms possessed by the cyclic hydrocarbon group may be substituted. Ra 101 to Ra 103 are each independently a hydrogen atom, a monovalent chain saturated hydrocarbon group having 1 to 10 carbon atoms, or a monovalent aliphatic cyclic saturated hydrocarbon group having 3 to 20 carbon atoms. A part or all of the hydrogen atoms possessed by the chain saturated alkyl group and the aliphatic cyclic saturated alkyl group may be substituted. Two or more of Ra 101 to Ra 103 may be bonded to each other to form a ring structure. In formula (a1-r2-3), Yaa is a carbon atom. Xaa is a group that forms an aliphatic cyclic group together with Yaa. Ra 104 is an aromatic alkyl group that may have a substituent. In formula (a1-r2-4), Ra' 12 and Ra' 13 are each independently a monovalent chain saturated alkyl group having 1 to 10 carbon atoms. A part or all of the hydrogen atoms possessed by the chain saturated alkyl group may be substituted. Ra' 14 is a alkyl group that may have a substituent. * indicates a bonding position (the same applies below). ]

上述式(a1-r2-1)中,Ra’ 10為一部分可由鹵素原子或者含有雜原子的基進行取代的直鏈狀或者分支鏈狀碳原子數1~12的烷基。 In the above formula (a1-r2-1), Ra'10 is a linear or branched alkyl group having 1 to 12 carbon atoms which may be partially substituted with a halogen atom or a group containing a heteroatom.

Ra’ 10中之作為直鏈狀烷基,碳原子數為1~12,以碳原子數1~10為佳,以碳原子數1~5為特佳。 Ra’ 10中之作為分支鏈狀烷基,可舉出前述Ra’ 3之相同者。 As the linear alkyl group in Ra'10 , the carbon number is 1 to 12, preferably 1 to 10, and particularly preferably 1 to 5. As the branched alkyl group in Ra'10 , the same as those mentioned above for Ra'3 can be cited.

Ra’ 10中之烷基的一部分可由鹵素原子或者含有雜原子的基進行取代。例如構成烷基之氫原子的一部分亦可由鹵素原子或含有雜原子的基進行取代。又,構成烷基的碳原子(亞甲基等)之一部分可由含有雜原子的基進行取代。 作為在此的雜原子,可舉出氧原子、硫原子、氮原子。作為含有雜原子的基,可舉出(-O-)、-C(=O)-O-、   -O-C(=O)-、-C(=O)-、-O-C(=O)-O-、-C(=O)-NH-、     -NH-、-S-、-S(=O) 2-、-S(=O) 2-O-等。 A part of the alkyl group in Ra' 10 may be substituted by a halogen atom or a group containing a heteroatom. For example, a part of the hydrogen atoms constituting the alkyl group may be substituted by a halogen atom or a group containing a heteroatom. In addition, a part of the carbon atoms (methylene group, etc.) constituting the alkyl group may be substituted by a group containing a heteroatom. As the heteroatom here, an oxygen atom, a sulfur atom, and a nitrogen atom may be cited. As the group containing a heteroatom, (-O-), -C(=O)-O-, -OC(=O)-, -C(=O)-, -OC(=O)-O-, -C(=O)-NH-, -NH-, -S-, -S(=O) 2 -, -S(=O) 2 -O-, etc. may be cited.

式(a1-r2-1)中,Ra’ 11(Ra’ 10與所鍵結的碳原子共同形成的脂肪族環式基)以作為式(a1-r-1)中之Ra’ 3的單環式基或多環式基之脂肪族烴基(脂環式烴基)所舉出的基為佳。其中亦以單環式之脂環式烴基為佳,具體以環戊基、環己基為較佳。 In formula (a1-r2-1), Ra' 11 (the aliphatic cyclic group formed by Ra' 10 and the carbon atom to which it is bonded) is preferably a group listed as the aliphatic hydrocarbon group (alicyclic hydrocarbon group) of the monocyclic group or polycyclic group of Ra' 3 in formula (a1-r-1). Among them, the monocyclic alicyclic hydrocarbon group is also preferred, and specifically, cyclopentyl and cyclohexyl are preferred.

式(a1-r2-2)中,作為Xa與Ya共同所形成的環狀烴基,可舉出前述式(a1-r-1)中自Ra’ 3中之環狀1價烴基(脂肪族烴基)進一步除去1個以上氫原子之基。 Xa與Ya共同所形成的環狀烴基可具有取代基。作為該取代基,可舉出上述Ra’ 3中環狀烴基可具有的取代基之相同者。 式(a1-r2-2)中,Ra 101~Ra 103中,作為碳原子數1~10的1價鏈狀飽和烴基,例如可舉出甲基、乙基、丙基、丁基、戊基、己基、庚基、辛基、癸基等。 Ra 101~Ra 103中,作為碳原子數3~20的1價脂肪族環狀飽和烴基,例如可舉出環丙基、環丁基、環戊基、環己基、環庚基、環辛基、環癸基、環十二烷基等單環式脂肪族飽和烴基;聯環[2.2.2]辛基、三環[5.2.1.02,6]癸基、三環[3.3.1.13,7]癸基、四環[6.2.1.13,6.02,7]十二烷基、金剛烷基等多環式脂肪族飽和烴基等。 Ra 101~Ra 103在其中由合成容易性之觀點來看,以氫原子、碳原子數1~10的1價鏈狀飽和烴基為佳,其中亦以氫原子、甲基、乙基為較佳,以氫原子為特佳。 In the formula (a1-r2-2), as the cyclic hydrocarbon group formed by Xa and Ya together, there can be mentioned the group obtained by further removing one or more hydrogen atoms from the cyclic monovalent hydrocarbon group (aliphatic hydrocarbon group) in Ra' 3 in the aforementioned formula (a1-r-1). The cyclic hydrocarbon group formed by Xa and Ya together may have a substituent. As the substituent, there can be mentioned the same substituents that the cyclic hydrocarbon group in the aforementioned Ra' 3 may have. In the formula (a1-r2-2), in Ra 101 to Ra 103 , as the monovalent chain-like saturated hydrocarbon group having 1 to 10 carbon atoms, there can be mentioned, for example, a methyl group, an ethyl group, a propyl group, a butyl group, a pentyl group, a hexyl group, a heptyl group, an octyl group, a decyl group, and the like. In Ra 101 to Ra 103 , examples of the monovalent aliphatic cyclic saturated alkyl group having 3 to 20 carbon atoms include monocyclic aliphatic saturated alkyl groups such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclodecyl and cyclododecyl; and polycyclic aliphatic saturated alkyl groups such as bicyclic [2.2.2]octyl, tricyclo [5.2.1.02,6]decyl, tricyclo [3.3.1.13,7]decyl, tetracyclo [6.2.1.13,6.02,7]dodecyl and adamantyl. Among them, Ra 101 to Ra 103 are preferably a hydrogen atom or a monovalent chain saturated hydrocarbon group having 1 to 10 carbon atoms from the viewpoint of ease of synthesis, and among them, a hydrogen atom, a methyl group, and an ethyl group are more preferred, and a hydrogen atom is particularly preferred.

作為上述Ra 101~Ra 103所示鏈狀飽和烴基或脂肪族環狀飽和烴基所具有取代基,例如可舉出與上述Ra x5之相同基。 Examples of the substituent possessed by the chain saturated hydrocarbon group or aliphatic cyclic saturated hydrocarbon group represented by Ra 101 to Ra 103 include the same substituents as those for Ra x5 above.

作為藉由Ra 101~Ra 103的2個以上彼此鍵結而形成環狀結構所產生的含有碳-碳雙鍵之基,例如可舉出環戊烯基、環己烯基、甲基環戊烯基、甲基環己烯基、環亞戊基乙烯基、環亞己基乙烯基等。此等中,亦由合成容易性之觀點來看,以環戊烯基、環己烯基、環亞戊基乙烯基為佳。 Examples of the group containing a carbon-carbon double bond formed by two or more of Ra 101 to Ra 103 being bonded to each other to form a cyclic structure include cyclopentenyl, cyclohexenyl, methylcyclopentenyl, methylcyclohexenyl, cyclopentylidenevinyl, cyclohexylidenevinyl, etc. Among these, cyclopentenyl, cyclohexenyl, and cyclopentylidenevinyl are preferred from the viewpoint of ease of synthesis.

式(a1-r2-3)中,Xaa與Yaa共同所形成的脂肪族環式基以作為式(a1-r-1)中之Ra’ 3的單環式基或多環式基之脂肪族烴基而舉出者為佳。 式(a1-r2-3)中,作為Ra 104中之芳香族烴基,可舉出自碳原子數5~30的芳香族烴環除去1個以上氫原子之基。其中亦以Ra 104表示自碳原子數6~15的芳香族烴環除去1個以上氫原子的基為佳,以自苯、萘、蒽或菲除去1個以上氫原子的基為較佳,以自苯、萘或蒽除去1個以上的氫原子的基為更佳,以自苯或萘除去1個以上的氫原子的基為特佳,以自苯除去1個以上的氫原子的基為最佳。 In the formula (a1-r2-3), the aliphatic cyclic group formed by Xaa and Yaa is preferably an aliphatic hydrocarbon group of a monocyclic group or a polycyclic group of Ra' 3 in the formula (a1-r-1). In the formula (a1-r2-3), the aromatic hydrocarbon group in Ra 104 may be a group obtained by removing one or more hydrogen atoms from an aromatic hydrocarbon ring having 5 to 30 carbon atoms. Among them, Ra 104 represents a group obtained by removing one or more hydrogen atoms from an aromatic hydrocarbon ring having 6 to 15 carbon atoms, more preferably a group obtained by removing one or more hydrogen atoms from benzene, naphthalene, anthracene or phenanthrene, even more preferably a group obtained by removing one or more hydrogen atoms from benzene, naphthalene or anthracene, particularly preferably a group obtained by removing one or more hydrogen atoms from benzene or naphthalene, and most preferably a group obtained by removing one or more hydrogen atoms from benzene.

作為式(a1-r2-3)中之Ra 104可具有的取代基,例如可舉出甲基、乙基、丙基、羥基、羧基、鹵素原子、烷氧基(甲氧基、乙氧基、丙氧基、丁氧基等)、烷氧基羰基等。 Examples of the substituent that Ra 104 in the formula (a1-r2-3) may have include a methyl group, an ethyl group, a propyl group, a hydroxyl group, a carboxyl group, a halogen atom, an alkoxy group (methoxy, ethoxy, propoxy, butoxy, etc.), and an alkoxycarbonyl group.

式(a1-r2-4)中,Ra’ 12及Ra’ 13各獨立為碳原子數1~10的1價鏈狀飽和烴基。Ra’ 12及Ra’ 13中,作為碳原子數1~10的1價鏈狀飽和烴基,可舉出與上述Ra 101~Ra 103中之碳原子數1~10的1價鏈狀飽和烴基之相同者。該鏈狀飽和烴基所具有氫原子的一部分或全部可被取代。 Ra’ 12及Ra’ 13中以碳原子數1~5的烷基為佳,以碳原子數1~5的烷基為較佳,以甲基、乙基為更佳,以甲基為特佳。 上述Ra’ 12及Ra’ 13所示鏈狀飽和烴基被取代之情況時,作為該取代基,例如可舉出與上述Ra x5的相同基。 In formula (a1-r2-4), Ra' 12 and Ra' 13 are each independently a monovalent chain saturated alkyl group having 1 to 10 carbon atoms. In Ra' 12 and Ra' 13 , the monovalent chain saturated alkyl group having 1 to 10 carbon atoms includes the same as the monovalent chain saturated alkyl group having 1 to 10 carbon atoms in Ra 101 to Ra 103. A part or all of the hydrogen atoms possessed by the chain saturated alkyl group may be substituted. In Ra' 12 and Ra' 13 , an alkyl group having 1 to 5 carbon atoms is preferred, an alkyl group having 1 to 5 carbon atoms is more preferred, a methyl group and an ethyl group are more preferred, and a methyl group is particularly preferred. When the chain saturated alkyl group represented by Ra'12 and Ra'13 is substituted, examples of the substituent include the same groups as those exemplified for Rax5 .

式(a1-r2-4)中,Ra’ 14為可具有取代基的烴基。作為Ra’ 14中之烴基,可舉出直鏈狀或者分支鏈狀烷基或環狀烴基。 In formula (a1-r2-4), Ra' 14 is a alkyl group which may have a substituent. Examples of the alkyl group in Ra' 14 include a linear or branched alkyl group or a cyclic alkyl group.

Ra’ 14中之直鏈狀烷基,以碳原子數1~5者為佳,以1~4為較佳,以1或2為更佳。具體可舉出甲基、乙基、n-丙基、n-丁基、n-戊基等。此等中亦以甲基、乙基或n-丁基為佳,以甲基或乙基為較佳。 The linear alkyl group in Ra' 14 preferably has 1 to 5 carbon atoms, more preferably 1 to 4 carbon atoms, and more preferably 1 or 2 carbon atoms. Specific examples include methyl, ethyl, n-propyl, n-butyl, n-pentyl, etc. Among them, methyl, ethyl or n-butyl is preferred, and methyl or ethyl is more preferred.

Ra’ 14中之分支鏈狀烷基以碳原子數3~10者為佳,以3~5為較佳。具體可舉出異丙基、異丁基、tert-丁基、異戊基、新戊基、1,1-二乙基丙基、2,2-二甲基丁基等,以異丙基者為佳。 The branched chain alkyl group in Ra' 14 preferably has 3 to 10 carbon atoms, more preferably 3 to 5 carbon atoms. Specific examples include isopropyl, isobutyl, tert-butyl, isopentyl, neopentyl, 1,1-diethylpropyl, 2,2-dimethylbutyl, etc., with isopropyl being preferred.

Ra’ 14成為環狀烴基的情況時,該烴基可為脂肪族烴基,亦可為芳香族烴基,又可為多環式基,亦可為單環式基。 作為單環式基之脂肪族烴基,以自單環烷烴除去1個氫原子的基為佳。作為該單環烷烴,以碳原子數3~6者為佳,具體可舉出環戊烷、環己烷等。 作為多環式基之脂肪族烴基,以自聚環烷烴除去1個氫原子的基為佳,作為該聚環烷烴,以碳原子數7~12者為佳,具體可舉出金剛烷、降冰片烷、異冰片、三環癸烷、四環十二烷等。 When Ra' 14 is a cyclic alkyl group, the alkyl group may be an aliphatic alkyl group, an aromatic alkyl group, a polycyclic group, or a monocyclic group. The aliphatic alkyl group as a monocyclic group is preferably a group obtained by removing one hydrogen atom from a monocyclic alkane. The monocyclic alkane is preferably one having 3 to 6 carbon atoms, and specific examples thereof include cyclopentane and cyclohexane. The aliphatic hydrocarbon group as the polycyclic group is preferably a group obtained by removing one hydrogen atom from a polycycloalkane. The polycycloalkane preferably has 7 to 12 carbon atoms, and specific examples thereof include adamantane, norbornane, isoborneol, tricyclodecane, tetracyclododecane and the like.

作為Ra’ 14中之芳香族烴基,可舉出Ra 104中之芳香族烴基的相同者。其中Ra’ 14亦以自碳原子數6~15的芳香族烴環除去1個以上氫原子的基為佳,以自苯、萘、蒽或菲除去1個以上氫原子的基為較佳,以自苯、萘或蒽除去1個以上氫原子的基為更佳,以自萘或蒽除去1個以上氫原子的基為特佳,以自萘除去1個以上氫原子的基為最佳。 作為Ra’ 14可具有的取代基,可舉出Ra 104可具有的取代基之相同者。 As the aromatic hydrocarbon group in Ra' 14 , the same ones as the aromatic hydrocarbon group in Ra 104 can be cited. Among them, Ra' 14 is preferably a group obtained by removing one or more hydrogen atoms from an aromatic hydrocarbon ring having 6 to 15 carbon atoms, more preferably a group obtained by removing one or more hydrogen atoms from benzene, naphthalene, anthracene or phenanthrene, more preferably a group obtained by removing one or more hydrogen atoms from benzene, naphthalene or anthracene, particularly preferably a group obtained by removing one or more hydrogen atoms from naphthalene or anthracene, and most preferably a group obtained by removing one or more hydrogen atoms from naphthalene. As the substituent that Ra' 14 may have, the same ones as the substituent that Ra 104 may have can be cited.

式(a1-r2-4)中之Ra’ 14為萘基之情況下,與前述式(a1-r2-4)中之第3級碳原子鍵結的位置可為萘基之第1位或第2位中任一者。 式(a1-r2-4)中之Ra’ 14為蒽基之情況時,與前述式(a1-r2-4)中之第3級碳原子鍵結的位置可為蒽基之第1位、第2位或第9位中任一者。 When Ra' 14 in formula (a1-r2-4) is a naphthyl group, the bonding position to the third carbon atom in the aforementioned formula (a1-r2-4) may be either the 1st position or the 2nd position of the naphthyl group. When Ra' 14 in formula (a1-r2-4) is an anthracene group, the bonding position to the third carbon atom in the aforementioned formula (a1-r2-4) may be either the 1st position, the 2nd position or the 9th position of the anthracene group.

前述式(a1-r2-1)所示基的具體例子舉出如以下者。Specific examples of the group represented by the above formula (a1-r2-1) are listed below.

前述式(a1-r2-2)所示基的具體例子可舉出以下者。Specific examples of the group represented by the above formula (a1-r2-2) include the following.

前述式(a1-r2-3)所示基的具體例子可舉出以下者。Specific examples of the group represented by the above formula (a1-r2-3) include the following.

前述式(a1-r2-4)所示基的具體例子可舉出以下者。Specific examples of the group represented by the above formula (a1-r2-4) include the following.

第3級烷氧基羰基酸解離性基: 作為前述極性基中保護羥基的酸解離性基,例如可舉出下述一般式(a1-r-3)所示酸解離性基(以下有時簡稱為「第3級烷氧基羰基酸解離性基」)。 Third-level alkoxycarbonyl acid-dissociable group: As the acid-dissociable group for protecting the hydroxyl group in the aforementioned polar group, for example, there can be cited the acid-dissociable group represented by the following general formula (a1-r-3) (hereinafter sometimes referred to as "third-level alkoxycarbonyl acid-dissociable group").

[式中,Ra’ 7~Ra’ 9各為烷基。] [In the formula, Ra' 7 to Ra' 9 are each an alkyl group.]

式(a1-r-3)中,Ra’ 7~Ra’ 9各以碳原子數1~5的烷基為佳,以碳原子數1~3的烷基為較佳。 又,各烷基之合計碳原子數以3~7者為佳,以碳原子數3~5者為較佳,以碳原子數3~4者為最佳。 In formula (a1-r-3), Ra'7 to Ra'9 are each preferably an alkyl group having 1 to 5 carbon atoms, more preferably an alkyl group having 1 to 3 carbon atoms. Furthermore, the total number of carbon atoms of each alkyl group is preferably 3 to 7, more preferably 3 to 5, and most preferably 3 to 4.

第2級烷基酯型酸解離性基: 上述極性基中,作為保護羧基之酸解離性基,例如可舉出下述一般式(a1-r-4)所示酸解離性基。 Secondary alkyl ester type acid-dissociable group: Among the above polar groups, the acid-dissociable group for protecting the carboxyl group may be, for example, an acid-dissociable group represented by the following general formula (a1-r-4).

[式中,Ra’ 10為烴基。Ra’ 11a及Ra’ 11b各獨立為氫原子、鹵素原子或烷基。Ra’ 12為氫原子或烴基。Ra’ 10與Ra’ 11a或與Ra’ 11b彼此鍵結可形成環。Ra’ 11a或Ra’ 11b與Ra’ 12彼此鍵結而可形成環。] [In the formula, Ra'10 is a alkyl group. Ra'11a and Ra'11b are each independently a hydrogen atom, a halogen atom or an alkyl group. Ra'12 is a hydrogen atom or a alkyl group. Ra'10 and Ra'11a or Ra'11b may bond to each other to form a ring. Ra'11a or Ra'11b and Ra'12 may bond to each other to form a ring.]

式中,作為Ra’ 10及Ra’ 12中之烴基,可舉出與前述Ra’ 3之相同者。 式中,作為Ra’ 11a及Ra’ 11b中之烷基,可舉出前述Ra’ 1中之烷基的相同者。 式中,Ra’ 10及Ra’ 12中之烴基,以及Ra’ 11a及Ra’ 11b中之烷基可具有取代基。作為該取代基,例如可舉出上述Ra x5等。 In the formula, as the alkyl group in Ra'10 and Ra'12 , the same as the aforementioned Ra'3 can be cited. In the formula, as the alkyl group in Ra'11a and Ra'11b , the same as the aforementioned alkyl group in Ra'1 can be cited. In the formula, the alkyl group in Ra'10 and Ra'12 , and the alkyl group in Ra'11a and Ra'11b may have a substituent. As the substituent, for example, the aforementioned Rax5 can be cited.

Ra’ 10與Ra’ 11a或與Ra’ 11b彼此鍵結可形成環。該環可為多環,亦可為單環,亦可為脂環,亦可為芳香環。 該脂環及芳香環亦可為含有雜原子者。 Ra'10 and Ra'11a or Ra'11b may bond to each other to form a ring. The ring may be polycyclic, monocyclic, alicyclic, or aromatic. The alicyclic and aromatic rings may contain heteroatoms.

作為Ra’ 10與Ra’ 11a或與Ra’ 11b彼此鍵結所形成的環,上述中,亦以單環鏈烯、單環鏈烯之碳原子的一部分由雜原子(氧原子、硫原子等)進行取代的環、單環二烯為佳,以碳數3~6的環鏈烯為佳,以環戊烯或環己烯為佳。 As the ring formed by the mutual bonding of Ra'10 and Ra'11a or Ra'11b , among the above, monocyclic olefins, cyclic olefins in which part of the carbon atoms are substituted by heteroatoms (oxygen atoms, sulfur atoms, etc.), and monocyclic dienes are preferred. Cycloolefins having 3 to 6 carbon atoms are preferred, and cyclopentene or cyclohexene is preferred.

Ra’ 10與Ra’ 11a或與Ra’ 11b彼此鍵結所形成的環可為縮合環。作為該縮合環,具體可舉出茚滿等。 The ring formed by the mutual bonding of Ra'10 and Ra'11a or Ra'11b may be a condensed ring. Specific examples of the condensed ring include indane and the like.

Ra’ 10與Ra’ 11a或與Ra’ 11b彼此鍵結所形成的環可具有取代基。作為該取代基,例如可舉出上述Ra x5等。 The ring formed by the mutual bonding of Ra'10 and Ra'11a or Ra'11b may have a substituent. Examples of the substituent include the above-mentioned Ra x5 .

Ra’ 11a或Ra’ 11b與Ra’ 12彼此鍵結可形成環,作為該環,可舉出與Ra’ 10與Ra’ 11a或與Ra’ 11b彼此鍵結所形成的環之相同者。 Ra' 11a or Ra' 11b and Ra' 12 may bond to each other to form a ring, and examples of the ring include the same ring as the ring formed by bonding Ra' 10 and Ra' 11a or Ra' 11b .

前述式(a1-r-4)所示基的具體例子可舉出以下者。Specific examples of the group represented by the above formula (a1-r-4) include the following.

作為構成單位(a1),可舉出自鍵結於α位碳原子的氫原子可由取代基進行取代的丙烯酸酯所衍生的構成單位、自丙烯醯胺衍生的構成單位、自羥基苯乙烯或者羥基苯乙烯衍生物所衍生的構成單位之羥基中的氫原子的至少一部分藉由含有前述酸分解性基之取代基進行保護的構成單位、由乙烯基安息香酸或者乙烯基安息香酸衍生物所衍生的構成單位之-C(=O)-OH中的氫原子之至少一部分藉由含有前述酸分解性基之取代基進行保護的構成單位等。Examples of the constituent unit (a1) include a constituent unit derived from an acrylic ester in which the hydrogen atom bonded to the carbon atom at the α-position may be substituted with a substituent, a constituent unit derived from an acrylamide, a constituent unit derived from hydroxystyrene or a hydroxystyrene derivative in which at least a portion of the hydrogen atoms in the hydroxyl group are protected by a substituent containing the aforementioned acid-decomposable group, a constituent unit derived from vinyl benzoic acid or a vinyl benzoic acid derivative in which at least a portion of the hydrogen atoms in -C(=O)-OH are protected by a substituent containing the aforementioned acid-decomposable group, and the like.

作為構成單位(a1),上述中,亦以自鍵結於α位碳原子的氫原子可由取代基進行取代的丙烯酸酯所衍生的構成單位為佳。 作為該構成單位(a1)之為較佳具體例子,可舉出下述一般式(a1-1)、(a1-2)或(a1-3)所示構成單位。 As the constituent unit (a1), among the above, a constituent unit derived from an acrylic acid ester in which the hydrogen atom bonded to the α-carbon atom may be substituted by a substituent is also preferred. As a preferred specific example of the constituent unit (a1), the constituent units represented by the following general formula (a1-1), (a1-2) or (a1-3) can be cited.

[式中,R為氫原子、碳原子數1~5的烷基或碳原子數1~5的鹵化烷基。Va 1為可具有醚鍵之2價烴基。n a1為0~2的整數。Ra 1為上述一般式(a1-r-1)、(a1-r-2)或(a1-r-4)所示酸解離性基。Wa 1為n a2+1價烴基,n a2為1~3的整數,Ra 2為上述一般式(a1-r-1)或(a1-r-3)所示酸解離性基。Ya 001為單鍵或2價連結基。Ya 01為單鍵或2價連結基。Rax 01為上述一般式(a1-r-1)、(a1-r-2)或(a1-r-4)所示酸解離性基。Rz 01為烷基、鹵素原子、鹵化烷基、羥基或烷氧基。q為0~3的整數。n為0以上的整數。但,n≦q×2+4。] [In the formula, R is a hydrogen atom, an alkyl group having 1 to 5 carbon atoms, or a halogenated alkyl group having 1 to 5 carbon atoms. Va 1 is a divalent hydrocarbon group which may have an ether bond. n a1 is an integer from 0 to 2. Ra 1 is an acid-dissociable group represented by the above-mentioned general formula (a1-r-1), (a1-r-2) or (a1-r-4). Wa 1 is a n a2 +1-valent hydrocarbon group, n a2 is an integer from 1 to 3, and Ra 2 is an acid-dissociable group represented by the above-mentioned general formula (a1-r-1) or (a1-r-3). Ya 001 is a single bond or a divalent linking group. Ya 01 is a single bond or a divalent linking group. Rax 01 is an acid-dissociable group represented by the above-mentioned general formula (a1-r-1), (a1-r-2) or (a1-r-4). Rz 01 is an alkyl group, a halogen atom, a halogenated alkyl group, a hydroxyl group or an alkoxy group. q is an integer from 0 to 3. n is an integer greater than 0. However, n ≤ q × 2 + 4.]

前述式(a1-1)中,R為氫原子、碳原子數1~5的烷基或碳原子數1~5的鹵化烷基。R中之碳原子數1~5的烷基以碳原子數1~5的直鏈狀或分支鏈狀烷基為佳,具體可舉出甲基、乙基、丙基、異丙基、n-丁基、異丁基、tert-丁基、戊基、異戊基、新戊基等。碳原子數1~5的鹵化烷基為前述碳原子數1~5的烷基之氫原子的一部分或全部由鹵素原子進行取代之基。作為該鹵素原子,特別以氟原子為佳。 作為R,以氫原子、碳原子數1~5的烷基或碳原子數1~5的氟化烷基為佳,由工業上獲得之容易度來看,以氫原子或甲基最佳。 In the above formula (a1-1), R is a hydrogen atom, an alkyl group having 1 to 5 carbon atoms, or a halogenated alkyl group having 1 to 5 carbon atoms. The alkyl group having 1 to 5 carbon atoms in R is preferably a linear or branched alkyl group having 1 to 5 carbon atoms, and specific examples thereof include methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, tert-butyl, pentyl, isopentyl, neopentyl, etc. The halogenated alkyl group having 1 to 5 carbon atoms is a group in which a part or all of the hydrogen atoms of the above alkyl group having 1 to 5 carbon atoms are substituted by halogen atoms. As the halogen atom, a fluorine atom is particularly preferred. As R, a hydrogen atom, an alkyl group having 1 to 5 carbon atoms, or a fluorinated alkyl group having 1 to 5 carbon atoms is preferred, and a hydrogen atom or a methyl group is the best in terms of ease of industrial availability.

前述式(a1-1)中,Va 1中之2價烴基可為脂肪族烴基,亦可為芳香族烴基。 In the aforementioned formula (a1-1), the divalent hydrocarbon group in Va1 may be an aliphatic hydrocarbon group or an aromatic hydrocarbon group.

作為Va 1中之2價烴基的脂肪族烴基可為飽和,亦可為不飽和,通常以飽和者為佳。 作為該脂肪族烴基,更具體可舉出直鏈狀或者分支鏈狀脂肪族烴基或於結構中含有環之脂肪族烴基等。 The aliphatic hydrocarbon group as the divalent hydrocarbon group in Va 1 may be saturated or unsaturated, but a saturated hydrocarbon group is generally preferred. More specifically, the aliphatic hydrocarbon group may be a linear or branched chain aliphatic hydrocarbon group or an aliphatic hydrocarbon group containing a ring in its structure.

前述直鏈狀脂肪族烴基以碳原子數1~10者為佳,以碳原子數1~6為較佳,以碳原子數1~4為更佳,以碳原子數1~3為最佳。 作為直鏈狀脂肪族烴基,以直鏈狀伸烷基為佳,具體可舉出亞甲基[-CH 2-]、伸乙基[-(CH 2) 2-]、三亞甲基    [-(CH 2) 3-]、四亞甲基[-(CH 2) 4-]、五亞甲基[-(CH 2) 5-]等。 前述分支鏈狀脂肪族烴基,以碳原子數2~10者為佳,以碳原子數3~6為較佳,以碳原子數3或4為更佳,以碳原子數3為最佳。 作為分支鏈狀脂肪族烴基,以分支鏈狀伸烷基為佳,具體可舉出-CH(CH 3)-、-CH(CH 2CH 3)-、-C(CH 3) 2-、    -C(CH 3)(CH 2CH 3)-、-C(CH 3)(CH 2CH 2CH 3)-、-C(CH 2CH 3) 2-等烷基亞甲基;-CH(CH 3)CH 2-、-CH(CH 3)CH(CH 3)-、    -C(CH 3) 2CH 2-、-CH(CH 2CH 3)CH 2-、-C(CH 2CH 3) 2-CH 2-等烷基伸乙基;-CH(CH 3)CH 2CH 2-、-CH 2CH(CH 3)CH 2-等烷基三亞甲基;-CH(CH 3)CH 2CH 2CH 2-、-CH 2CH(CH 3)CH 2CH 2-等烷基四亞甲基等之烷基伸烷基等。作為烷基伸烷基中之烷基,以碳原子數1~5的直鏈狀烷基為佳。 The aforementioned linear aliphatic alkyl group preferably has 1 to 10 carbon atoms, more preferably 1 to 6 carbon atoms, more preferably 1 to 4 carbon atoms, and most preferably 1 to 3 carbon atoms. As the linear aliphatic alkyl group, a linear alkylene group is preferred, and specific examples thereof include methylene [-CH 2 -], ethylene [-(CH 2 ) 2 -], trimethylene [-(CH 2 ) 3 -], tetramethylene [-(CH 2 ) 4 -], and pentamethylene [-(CH 2 ) 5 -]. The aforementioned branched aliphatic alkyl group preferably has 2 to 10 carbon atoms, more preferably 3 to 6 carbon atoms, more preferably 3 or 4 carbon atoms, and most preferably 3 carbon atoms. The branched chain aliphatic hydrocarbon group is preferably a branched chain alkylene group, and specific examples thereof include -CH(CH 3 )-, -CH(CH 2 CH 3 )-, -C(CH 3 ) 2 -, -C(CH 3 )(CH 2 CH 3 )-, -C(CH 3 )(CH 2 CH 2 CH 3 )-, -C(CH 2 CH 3 ) 2 - and the like alkylmethylene groups; -CH(CH 3 )CH 2 -, -CH(CH 3 )CH(CH 3 )-, -C(CH 3 ) 2 CH 2 -, -CH(CH 2 CH 3 )CH 2 -, -C(CH 2 CH 3 ) 2 - and the like alkylethylene groups; -CH(CH 3 )CH 2 -, -CH(CH 3 )CH(CH 3 )-, -C(CH 3 ) 2 CH 2 -, -CH(CH 2 CH 3 )CH 2 -, -C(CH 2 CH 3 ) 2 -CH 2 - and the like alkylethylene groups; -CH(CH 3 )CH 2 CH 2 -, -CH 2 CH(CH 3 )CH 2 -, alkyl trimethylene, -CH(CH 3 )CH 2 CH 2 - , -CH 2 CH(CH 3 )CH 2 CH 2 -, etc.; alkyl alkylene groups such as -CH(CH 3 )CH 2 CH 2 -, etc. The alkyl group in the alkyl alkylene group is preferably a linear alkyl group having 1 to 5 carbon atoms.

作為於前述結構中含有環之脂肪族烴基,可舉出脂環式烴基(自脂肪族烴環除去2個氫原子之基)、脂環式烴基鍵結於直鏈狀或分支鏈狀脂肪族烴基之末端的基、脂環式烴基隔在直鏈狀或分支鏈狀脂肪族烴基之途中的基等。作為前述直鏈狀或分支鏈狀脂肪族烴基,可舉出與前述直鏈狀脂肪族烴基或前述分支鏈狀脂肪族烴基之相同者。 前述脂環式烴基,以碳原子數3~20者為佳,以碳原子數3~12者為較佳。 前述脂環式烴基可為多環式,亦可為單環式。作為單環式之脂環式烴基,以自單環烷烴除去2個氫原子的基為佳。作為該單環烷烴,以碳原子數3~6者為佳,具體可舉出環戊烷、環己烷等。作為多環式之脂環式烴基,以自聚環烷烴除去2個氫原子的基為佳,作為該聚環烷烴,以碳原子數7~12者為佳,具體可舉出金剛烷、降冰片烷、異冰片、三環癸烷、四環十二烷等。 As the aliphatic hydrocarbon group containing a ring in the above structure, there can be cited an alicyclic hydrocarbon group (a group obtained by removing two hydrogen atoms from an aliphatic hydrocarbon ring), a group in which an alicyclic hydrocarbon group is bonded to the end of a straight chain or branched chain aliphatic hydrocarbon group, a group in which an alicyclic hydrocarbon group is separated in the middle of a straight chain or branched chain aliphatic hydrocarbon group, etc. As the above-mentioned straight chain or branched chain aliphatic hydrocarbon group, there can be cited the same ones as the above-mentioned straight chain aliphatic hydrocarbon group or the above-mentioned branched chain aliphatic hydrocarbon group. The above-mentioned alicyclic hydrocarbon group preferably has 3 to 20 carbon atoms, and more preferably has 3 to 12 carbon atoms. The aforementioned alicyclic hydrocarbon group may be polycyclic or monocyclic. As a monocyclic alicyclic hydrocarbon group, a group obtained by removing two hydrogen atoms from a monocyclic alkane is preferred. As the monocyclic alkane, a group having 3 to 6 carbon atoms is preferred, and specific examples thereof include cyclopentane and cyclohexane. As a polycyclic alicyclic hydrocarbon group, a group obtained by removing two hydrogen atoms from a polycycloalkane is preferred, and the polycycloalkane has 7 to 12 carbon atoms, and specific examples thereof include adamantane, norbornane, isoborneol, tricyclodecane, tetracyclododecane, and the like.

作為Va 1中之2價烴基的芳香族烴基為具有芳香環的烴基。 該芳香族烴基的碳原子數以3~30者為佳,以5~30者為較佳,以5~20為更佳,以6~15為特佳,以6~12為最佳。但,該碳原子數為未含有取代基中之碳原子數者。 作為芳香族烴基所具有芳香環,具體可舉出苯、聯苯基、芴、萘、蒽、菲等芳香族烴環;構成前述芳香族烴環之碳原子的一部分由雜原子進行取代的芳香族雜環等。作為芳香族雜環中之雜原子,可舉出氧原子、硫原子、氮原子等。 作為該芳香族烴基,具體可舉出自前述芳香族烴環除去2個氫原子之基(伸芳基);自前述芳香族烴環除去1個氫原子之基(芳基)的1個氫原子由伸烷基進行取代的基(例如自苯甲基、苯乙基、1-萘甲基、2-萘甲基、1-萘乙基、2-萘乙基等芳基烷基中之芳基進一步除去1個氫原子之基)等。前述伸烷基(芳基烷基中之烷基鏈)的碳原子數以1~4者為佳,以1~2者為較佳,以1者為特佳。 The aromatic hydrocarbon group as the divalent hydrocarbon group in Va1 is a hydrocarbon group having an aromatic ring. The number of carbon atoms in the aromatic hydrocarbon group is preferably 3 to 30, more preferably 5 to 30, more preferably 5 to 20, particularly preferably 6 to 15, and most preferably 6 to 12. However, the number of carbon atoms does not include the number of carbon atoms in the substituent. Specific examples of the aromatic ring possessed by the aromatic hydrocarbon group include aromatic hydrocarbon rings such as benzene, biphenyl, fluorene, naphthalene, anthracene, and phenanthrene; and aromatic heterocyclic rings in which a part of the carbon atoms constituting the aforementioned aromatic hydrocarbon rings are substituted by heteroatoms. Examples of the heteroatoms in the aromatic heterocyclic ring include oxygen atoms, sulfur atoms, nitrogen atoms, and the like. Specific examples of the aromatic hydrocarbon group include a group obtained by removing two hydrogen atoms from the aforementioned aromatic hydrocarbon ring (arylene group); a group obtained by removing one hydrogen atom from the aforementioned aromatic hydrocarbon ring (aryl group) in which one hydrogen atom is substituted by an alkylene group (for example, a group obtained by further removing one hydrogen atom from an aryl group in an arylalkyl group such as benzyl, phenethyl, 1-naphthylmethyl, 2-naphthylmethyl, 1-naphthylethyl, 2-naphthylethyl, etc.). The number of carbon atoms in the aforementioned alkylene group (alkyl chain in the arylalkyl group) is preferably 1 to 4, more preferably 1 to 2, and particularly preferably 1.

前述式(a1-1)中,Ra 1為上述式(a1-r-1)、(a1-r-2)或(a1-r-4)所示酸解離性基。 In the aforementioned formula (a1-1), Ra1 is an acid-lysable group represented by the aforementioned formula (a1-r-1), (a1-r-2) or (a1-r-4).

前述式(a1-2)中,Wa 1中之n a2+1價烴基可為脂肪族烴基,亦可為芳香族烴基。該脂肪族烴基表示未具有芳香族性的烴基,可為飽和,亦可為不飽和,通常以飽和者為佳。作為前述脂肪族烴基,可舉出直鏈狀或分支鏈狀脂肪族烴基、於結構中含有環的脂肪族烴基,或直鏈狀或分支鏈狀脂肪族烴基與於結構中含有環的脂肪族烴基之組合的基。 前述n a2+1價以2~4價為佳,以2或3價為較佳。 In the aforementioned formula (a1-2), the na2 +1 valence alkyl group in Wa1 may be an aliphatic alkyl group or an aromatic alkyl group. The aliphatic alkyl group means a alkyl group which does not have aromaticity and may be saturated or unsaturated, but saturated alkyl groups are generally preferred. Examples of the aforementioned aliphatic alkyl group include a linear or branched aliphatic alkyl group, an aliphatic alkyl group containing a ring in its structure, or a combination of a linear or branched aliphatic alkyl group and an aliphatic alkyl group containing a ring in its structure. The aforementioned na2 +1 valence is preferably 2 to 4, and more preferably 2 or 3.

前述式(a1-2)中,Ra 2為上述一般式(a1-r-1)或(a1-r-3)所示酸解離性基。 In the aforementioned formula (a1-2), Ra 2 is an acid-liquidable group represented by the aforementioned general formula (a1-r-1) or (a1-r-3).

前述式(a1-3)中,作為Ya 001中之2價連結基,雖無特別限定,但可舉出作為可具有取代基之2價烴基及含有雜原子之2價連結基等為較佳者。 作為Ya 001,以酯鍵[-C(=O)-O-、-O-C(=O)-]、醚鍵  (-O-)、直鏈狀或者分支鏈狀伸烷基、芳香族烴基或此等組合或者單鍵者為佳。伸烷基之碳原子數以1~10者為佳,以碳原子數1~6為較佳,以碳原子數1~4為更佳,以碳原子數1~3特佳。 此等中,作為Ya 001,亦以酯鍵[-C(=O)-O-、-O-C(=O)-]與直鏈狀伸烷基之組合,或單鍵者為較佳,以單鍵者為更佳。 In the above formula (a1-3), the divalent linking group in Ya001 is not particularly limited, but preferably includes a divalent alkyl group which may have a substituent and a divalent linking group containing a heteroatom. Ya001 is preferably an ester bond [-C(=O)-O-, -OC(=O)-], an ether bond (-O-), a linear or branched alkylene group, an aromatic alkylene group, or a combination thereof or a single bond. The alkylene group preferably has 1 to 10 carbon atoms, more preferably 1 to 6 carbon atoms, more preferably 1 to 4 carbon atoms, and particularly preferably 1 to 3 carbon atoms. Among these, as Ya 001 , a combination of an ester bond [—C(═O)—O—, —OC(═O)—] and a linear alkylene group, or a single bond is preferred, and a single bond is more preferred.

前述式(a1-3)中,作為Ya 01中之2價連結基,雖無特別限定,可舉出作為可具有取代基的2價烴基、含有雜原子的2價連結基等為較佳者。 Ya 01在上述中亦以酯鍵[-C(=O)-O-、-O-C(=O)-]、醚鍵(-O-)、直鏈狀或者分支鏈狀伸烷基、芳香族烴基或此等組合或者單鍵者為佳。此等中,作為Ya 01,亦以酯鍵   [-C(=O)-O-、-O-C(=O)-]與直鏈狀伸烷基之組合,或單鍵者為較佳,以單鍵者為更佳。 In the above formula (a1-3), the divalent linking group in Ya 01 is not particularly limited, and preferably includes a divalent hydrocarbon group which may have a substituent, a divalent linking group containing a heteroatom, and the like. Among the above, Ya 01 is preferably an ester bond [-C(=O)-O-, -OC(=O)-], an ether bond (-O-), a linear or branched alkylene group, an aromatic hydrocarbon group, or a combination thereof or a single bond. Among these, Ya 01 is preferably a combination of an ester bond [-C(=O)-O-, -OC(=O)-] and a linear alkylene group, or a single bond, and more preferably a single bond.

前述式(a1-3)中,Rax 01以上述一般式(a1-r-2)或(a1-r-4)所示酸解離性基為佳,此等中,亦以一般式(a1-r-2)所示酸解離性基為較佳,以一般式(a1-r2-1)所示基為更佳。 In the aforementioned formula (a1-3), Rax 01 is preferably an acid-lysable group represented by the aforementioned general formula (a1-r-2) or (a1-r-4). Among them, the acid-lysable group represented by the general formula (a1-r-2) is also preferred, and the group represented by the general formula (a1-r2-1) is even more preferred.

前述式(a1-3)中,Rz 01中之烷基、鹵化烷基及烷氧基以碳原子數1~10為佳,以碳原子數1~5為較佳,以碳原子數1~3為更佳,以碳原子數1或2特佳。前述烷基、鹵化烷基及烷氧基亦可為直鏈狀,亦可為分支鏈狀。 作為Rz 01中之鹵素原子,以碘原子或溴原子為佳。作為Rz 01中之鹵化烷基的鹵素原子,以氟原子、碘原子或溴原子為佳,以氟原子為較佳。 作為Rz 01,以烷氧基或羥基為佳,以羥基為較佳。 In the aforementioned formula (a1-3), the alkyl group, halogenated alkyl group and alkoxy group in Rz 01 preferably have 1 to 10 carbon atoms, preferably 1 to 5 carbon atoms, more preferably 1 to 3 carbon atoms, and particularly preferably 1 or 2 carbon atoms. The aforementioned alkyl group, halogenated alkyl group and alkoxy group may be in the form of a straight chain or a branched chain. The halogen atom in Rz 01 is preferably an iodine atom or a bromine atom. The halogen atom of the halogenated alkyl group in Rz 01 is preferably a fluorine atom, an iodine atom or a bromine atom, and preferably a fluorine atom. Rz 01 is preferably an alkoxy group or a hydroxyl group, and preferably a hydroxyl group.

前述式(a1-3)中,q為0~3的整數。q為0之情況時成為苯結構,q為1之情況時成為萘結構,q為2之情況時成為蒽結構,q為3之情況時成為並四苯結構。 前述式(a1-3)中,n為0以上的整數,以0~5的整數為佳,為較佳為0~3的整數,為更佳為1或2。n為2以上的整數時,2個以上之Rz 01彼此可相同或相異。 前述式(a1-3)中,n≦q×2+4。例如,q為1之萘結構的情況時,該萘的6個全部氫原子可由Rz 01進行取代。又,該萘中,Ya 001、-Ya 01-C(=O)-O-Ra 01基及Rz 01之取代位置並無特別限定。 In the aforementioned formula (a1-3), q is an integer of 0 to 3. When q is 0, a benzene structure is obtained, when q is 1, a naphthalene structure is obtained, when q is 2, an anthracene structure is obtained, and when q is 3, a tetracene structure is obtained. In the aforementioned formula (a1-3), n is an integer greater than or equal to 0, preferably an integer of 0 to 5, more preferably an integer of 0 to 3, and more preferably 1 or 2. When n is an integer greater than or equal to 2, two or more Rz 01 may be the same or different from each other. In the aforementioned formula (a1-3), n≦q×2+4. For example, when q is 1 in the case of a naphthalene structure, all six hydrogen atoms of the naphthalene may be substituted by Rz 01 . In the naphthalene, the substitution positions of Ya 001 , -Ya 01 -C(=O)-O-Ra 01 group and Rz 01 are not particularly limited.

以下表示構成單位(a1)之具體例子。 以下各式中,R α表示氫原子、甲基或三氟甲基。 Specific examples of the constituent unit (a1) are shown below. In the following formulae, R α represents a hydrogen atom, a methyl group or a trifluoromethyl group.

以下各式中,R α表示氫原子、甲基或三氟甲基。Rz各獨立表示氫原子、烷基、鹵素原子、鹵化烷基、羥基或烷氧基。 In the following formulae, R α represents a hydrogen atom, a methyl group or a trifluoromethyl group. R z each independently represents a hydrogen atom, an alkyl group, a halogen atom, a halogenated alkyl group, a hydroxyl group or an alkoxy group.

(A1)成分所具有構成單位(a1)可為1種亦可為2種以上。 作為構成單位(a1),因可容易提高在藉由電子線或EUV之光刻時的特性(感度、形狀等),故以前述式(a1-1)所示構成單位或前述式(a1-3)所示構成單位為較佳。 其中亦由可為較佳提高EB用或EUV用中之反應性的觀點來看,酸解離性基(Ra 1、Rax 01)各以上述一般式(a1-r2-1)、(a1-r2-3)、(a1-r2-4)或(a1-r-4)所示酸解離性基者為佳,其中亦以選自環式基者為特佳。 The constituent unit (a1) of the component (A1) may be one or more. As the constituent unit (a1), the constituent unit represented by the above formula (a1-1) or the constituent unit represented by the above formula (a1-3) is preferred because it can easily improve the characteristics (sensitivity, shape, etc.) during photolithography by electron beam or EUV. Among them, from the viewpoint of preferably improving the reactivity for EB or EUV, the acid-dissociable groups (Ra 1 , Rax 01 ) are preferably acid-dissociable groups represented by the above general formula (a1-r2-1), (a1-r2-3), (a1-r2-4) or (a1-r-4), and those selected from cyclic groups are particularly preferred.

(A1)成分中之構成單位(a1)的比例,相對於構成該(A1)成分之全構成單位的合計(100莫耳%)而言,以5~80莫耳%為佳,以10~75莫耳%為較佳,以30~70莫耳%為更佳,以40~70莫耳%特佳。 藉由將構成單位(a1)之比例設定在前述為較佳範圍之下限值以上時,感度、圖型尺寸之面內均勻性(CDU)及微細解像性等光刻特性提高。另一方面,若在前述為較佳範圍之上限值以下時,可取得與其他構成單位之平衡,種種光刻特性成為良好。 The ratio of the constituent unit (a1) in the component (A1) is preferably 5 to 80 mol%, more preferably 10 to 75 mol%, more preferably 30 to 70 mol%, and particularly preferably 40 to 70 mol% relative to the total of all constituent units constituting the component (A1) (100 mol%). By setting the ratio of the constituent unit (a1) to above the lower limit of the aforementioned preferred range, the photolithography characteristics such as sensitivity, in-plane uniformity of pattern size (CDU), and fine resolution are improved. On the other hand, if it is below the upper limit of the aforementioned preferred range, a balance with other constituent units can be achieved, and various photolithography characteristics become good.

≪其他構成單位≫ (A1)成分除具有上述構成單位(a1)以外,視必要亦可具有其他構成單位者。 作為其他構成單位,例如可舉出下述一般式(a10-1)所示構成單位、具有含有內酯的環式基之構成單位(a2)、由下述一般式(a8-1)所示化合物衍生的構成單位等。 ≪Other constituent units≫ Component (A1) may have other constituent units as necessary in addition to the above-mentioned constituent unit (a1). As other constituent units, for example, there can be cited constituent units represented by the following general formula (a10-1), constituent units (a2) having a cyclic group containing lactone, constituent units derived from compounds represented by the following general formula (a8-1), etc.

構成單位(a10): 構成單位(a10)為下述一般式(a10-1)所示構成單位。 Constituent unit (a10): Constituent unit (a10) is a constituent unit represented by the following general formula (a10-1).

[式中,R為氫原子、碳原子數1~5的烷基或碳原子數1~5的鹵化烷基。Ya x1為單鍵或2價連結基。Wa x1為可具有取代基的芳香族烴基。n ax1為1以上的整數。] [In the formula, R is a hydrogen atom, an alkyl group having 1 to 5 carbon atoms, or a halogenated alkyl group having 1 to 5 carbon atoms. Yax1 is a single bond or a divalent linking group. Wax1 is an aromatic hydrocarbon group which may have a substituent. Nax1 is an integer greater than or equal to 1.]

前述式(a10-1)中,R與前述一般式(a1-1)中之R相同。作為R,以氫原子、碳原子數1~5的烷基或碳原子數1~5的氟化烷基為佳,由工業上獲得之容易度來看,以氫原子或甲基特佳。In the aforementioned formula (a10-1), R is the same as R in the aforementioned general formula (a1-1). As R, a hydrogen atom, an alkyl group having 1 to 5 carbon atoms, or a fluorinated alkyl group having 1 to 5 carbon atoms is preferred, and a hydrogen atom or a methyl group is particularly preferred in view of ease of industrial availability.

前述式(a10-1)中,Ya x1為單鍵或2價連結基。 前述化學式中,作為Ya x1中之2價連結基,雖無特別限定,可為較佳舉出作為可具有取代基的2價烴基、含有雜原子的2價連結基等者。 In the above formula (a10-1), Yax1 is a single bond or a divalent linking group. In the above chemical formula, the divalent linking group in Yax1 is not particularly limited, and preferably includes a divalent hydrocarbon group which may have a substituent, a divalent linking group containing a heteroatom, and the like.

・可具有取代基之2價烴基: 可具有取代基的2價烴基,可為脂肪族烴基,亦可為芳香族烴基。 ・Divalent hydrocarbon groups that may have a substituent: Divalent hydrocarbon groups that may have a substituent may be aliphatic hydrocarbon groups or aromatic hydrocarbon groups.

・・脂肪族烴基 脂肪族烴基表示不具有芳香族性之烴基。該脂肪族烴基可為飽和,亦可為不飽和,通常以飽和者為佳。 作為前述脂肪族烴基,可舉出直鏈狀或者分支鏈狀脂肪族烴基、或於結構中含有環之脂肪族烴基等。 ・・Aliphatic alkyl Aliphatic alkyl refers to a alkyl group that does not have aromaticity. The aliphatic alkyl group may be saturated or unsaturated, and saturated alkyl groups are generally preferred. Examples of the aliphatic alkyl group include a linear or branched aliphatic alkyl group, or an aliphatic alkyl group containing a ring in the structure.

・・・直鏈狀或者分支鏈狀脂肪族烴基 該直鏈狀脂肪族烴基以碳原子數1~10為佳,以碳原子數1~6為較佳,以碳原子數1~4為更佳,以碳原子數1~3為最佳。 作為直鏈狀脂肪族烴基,以直鏈狀伸烷基為佳,具體可舉出亞甲基[-CH 2-]、伸乙基[-(CH 2) 2-]、三亞甲基    [-(CH 2) 3-]、四亞甲基[-(CH 2) 4-]、五亞甲基[-(CH 2) 5-]等。 該分支鏈狀脂肪族烴基以碳原子數2~10為佳,以碳原子數3~6為較佳,以碳原子數3或4為更佳,以碳原子數3為最佳。 作為分支鏈狀脂肪族烴基,以分支鏈狀伸烷基為佳,具體可舉出-CH(CH 3)-、-CH(CH 2CH 3)-、-C(CH 3) 2-、    -C(CH 3)(CH 2CH 3)-、-C(CH 3)(CH 2CH 2CH 3)-、-C(CH 2CH 3) 2-等烷基亞甲基;-CH(CH 3)CH 2-、-CH(CH 3)CH(CH 3)-、    -C(CH 3) 2CH 2-、-CH(CH 2CH 3)CH 2-、-C(CH 2CH 3) 2-CH 2-等烷基伸乙基;-CH(CH 3)CH 2CH 2-、-CH 2CH(CH 3)CH 2-等烷基三亞甲基;-CH(CH 3)CH 2CH 2CH 2-、-CH 2CH(CH 3)CH 2CH 2-等烷基四亞甲基等烷基伸烷基等。作為烷基伸烷基中之烷基,以碳原子數1~5的直鏈狀烷基為佳。 ・・・Linear or branched aliphatic alkyl group The linear aliphatic alkyl group preferably has 1 to 10 carbon atoms, more preferably 1 to 6 carbon atoms, more preferably 1 to 4 carbon atoms, and most preferably 1 to 3 carbon atoms. The linear aliphatic alkyl group is preferably a linear alkylene group, and specific examples thereof include methylene [-CH 2 -], ethylene [-(CH 2 ) 2 -], trimethylene [-(CH 2 ) 3 -], tetramethylene [-(CH 2 ) 4 -], and pentamethylene [-(CH 2 ) 5 -]. The branched aliphatic alkyl group preferably has 2 to 10 carbon atoms, more preferably 3 to 6 carbon atoms, more preferably 3 or 4 carbon atoms, and most preferably 3 carbon atoms. The branched chain aliphatic hydrocarbon group is preferably a branched chain alkylene group, and specific examples thereof include -CH(CH 3 )-, -CH(CH 2 CH 3 )-, -C(CH 3 ) 2 -, -C(CH 3 )(CH 2 CH 3 )-, -C(CH 3 )(CH 2 CH 2 CH 3 )-, -C(CH 2 CH 3 ) 2 - and the like alkylmethylene groups; -CH(CH 3 )CH 2 -, -CH(CH 3 )CH(CH 3 )-, -C(CH 3 ) 2 CH 2 -, -CH(CH 2 CH 3 )CH 2 -, -C(CH 2 CH 3 ) 2 - and the like alkylethylene groups; -CH(CH 3 )CH 2 -, -CH(CH 3 )CH(CH 3 )-, -C(CH 3 ) 2 CH 2 -, -CH(CH 2 CH 3 )CH 2 -, -C(CH 2 CH 3 ) 2 -CH 2 - and the like alkylethylene groups; -CH(CH 3 )CH 2 CH 2 -, -CH 2 CH(CH 3 )CH 2 -, alkyltrimethylene, -CH(CH 3 )CH 2 CH 2 -, -CH 2 CH(CH 3 )CH 2 CH 2 -, alkyltetramethylene, etc. , alkylalkylene, etc. The alkyl in the alkylalkylene is preferably a linear alkyl having 1 to 5 carbon atoms.

前述直鏈狀或分支鏈狀脂肪族烴基可具有取代基亦可不具有取代基。作為該取代基,可舉出氟原子、由氟原子取代的碳原子數1~5的氟化烷基、羰基等。The linear or branched aliphatic hydrocarbon group may or may not have a substituent. Examples of the substituent include a fluorine atom, a fluorinated alkyl group having 1 to 5 carbon atoms substituted with a fluorine atom, and a carbonyl group.

・・・於結構中含有環之脂肪族烴基 作為於該結構中含有環之脂肪族烴基,可舉出亦可含有於環結構中含有雜原子之取代基的環狀脂肪族烴基(自脂肪族烴環除去2個氫原子之基)、前述環狀脂肪族烴基鍵結於直鏈狀或分支鏈狀脂肪族烴基之末端的基、前述環狀脂肪族烴基隔在直鏈狀或分支鏈狀脂肪族烴基之途中的基等。作為前述直鏈狀或分支鏈狀脂肪族烴基,可舉出與前述相同者。 環狀脂肪族烴基以碳原子數3~20為佳,以碳原子數3~12為較佳。 環狀脂肪族烴基可為多環式基,亦可為單環式基。作為單環式之脂環式烴基,以自單環烷烴除去2個氫原子的基為佳。作為該單環烷烴,以碳原子數3~6者為佳,具體可舉出環戊烷、環己烷等。作為多環式之脂環式烴基,以自聚環烷烴除去2個氫原子的基為佳,作為該聚環烷烴,以碳原子數7~12者為佳,具體可舉出金剛烷、降冰片烷、異冰片、三環癸烷、四環十二烷等。 ・・・Aliphatic alkyl group containing a ring in the structure As the aliphatic alkyl group containing a ring in the structure, there can be mentioned a cyclic aliphatic alkyl group (a group obtained by removing two hydrogen atoms from an aliphatic alkyl ring) which may also contain a substituent containing a heteroatom in the ring structure, a group in which the aforementioned cyclic aliphatic alkyl group is bonded to the end of a linear or branched aliphatic alkyl group, a group in which the aforementioned cyclic aliphatic alkyl group is separated in the middle of a linear or branched aliphatic alkyl group, etc. As the aforementioned linear or branched aliphatic alkyl group, the same as mentioned above can be mentioned. The cyclic aliphatic alkyl group preferably has 3 to 20 carbon atoms, more preferably 3 to 12 carbon atoms. The cyclic aliphatic hydrocarbon group may be a polycyclic group or a monocyclic group. As a monocyclic alicyclic hydrocarbon group, a group obtained by removing two hydrogen atoms from a monocyclic alkane is preferred. As the monocyclic alkane, a group having 3 to 6 carbon atoms is preferred, and specific examples thereof include cyclopentane and cyclohexane. As a polycyclic alicyclic hydrocarbon group, a group obtained by removing two hydrogen atoms from a polycycloalkane is preferred, and the polycycloalkane has 7 to 12 carbon atoms, and specific examples thereof include adamantane, norbornane, isoborneol, tricyclodecane, tetracyclododecane, and the like.

環狀脂肪族烴基可具有取代基亦可不具有取代基。作為該取代基,可舉出烷基、烷氧基、鹵素原子、鹵化烷基、羥基、羰基等。 作為前述取代基之烷基,以碳原子數1~5的烷基為佳,以甲基、乙基、丙基、n-丁基、tert-丁基者為較佳。 作為前述取代基之烷氧基,以碳原子數1~5的烷氧基為佳,以甲氧基、乙氧基、n-丙氧基、iso-丙氧基、n-丁氧基、tert-丁氧基為較佳,以甲氧基、乙氧基為更佳。 作為前述取代基之鹵素原子,以氟原子為佳。 作為前述取代基之鹵化烷基,可舉出前述烷基之氫原子的一部分或全部由前述鹵素原子進行取代的基。 環狀脂肪族烴基中構成該環結構之碳原子的一部分亦可由含有雜原子之取代基進行取代。作為含有該雜原子之取代基,以-O-、-C(=O)-O-、-S-、-S(=O) 2-、-S(=O) 2-O-為佳。 The cyclic aliphatic alkyl group may or may not have a substituent. Examples of the substituent include an alkyl group, an alkoxy group, a halogen atom, a halogenated alkyl group, a hydroxyl group, a carbonyl group, and the like. As the alkyl group as the substituent, an alkyl group having 1 to 5 carbon atoms is preferred, and a methyl group, an ethyl group, a propyl group, an n-butyl group, and a tert-butyl group are more preferred. As the alkoxy group as the substituent, an alkoxy group having 1 to 5 carbon atoms is preferred, and a methoxy group, an ethoxy group, an n-propoxy group, an iso-propoxy group, an n-butoxy group, and a tert-butoxy group are more preferred, and a methoxy group and an ethoxy group are more preferred. As the halogen atom as the substituent, a fluorine atom is preferred. As the halogenated alkyl group as the substituent, examples include a group in which a part or all of the hydrogen atoms of the alkyl group are substituted by the halogen atom. A portion of the carbon atoms constituting the ring structure of the cyclic aliphatic hydrocarbon group may be substituted by a substituent containing a heteroatom. Preferred substituents containing a heteroatom are -O-, -C(=O)-O-, -S-, -S(=O) 2 -, and -S(=O) 2 -O-.

・・芳香族烴基 該芳香族烴基為具有至少1個芳香環之烴基。 該芳香環若為具有4n+2個π電子之環狀共軛系即可,並無特別限定,可為單環式,亦可為多環式。芳香環之碳原子數以5~30者為佳,以碳原子數5~20為較佳,以碳原子數6~15為更佳,以碳原子數6~12特佳。但,於該碳原子數中未含有取代基中之碳原子數者。 作為芳香環,具體可舉出苯、萘、蒽、菲等芳香族烴環;構成前述芳香族烴環之碳原子的一部分由雜原子進行取代的芳香族雜環等。作為芳香族雜環中之雜原子,可舉出氧原子、硫原子、氮原子等。作為芳香族雜環,具體可舉出吡啶環、噻吩環等。 作為芳香族烴基,具體可舉出自前述芳香族烴環或芳香族雜環除去2個氫原子之基(伸芳基或雜伸芳基);自含有2個以上芳香環之芳香族化合物(例如聯苯基、芴等)除去2個氫原子的基;自前述芳香族烴環或芳香族雜環除去1個氫原子之基(芳基或雜芳基)的1個氫原子由伸烷基進行取代之基(例如自苯甲基、苯乙基、1-萘甲基、2-萘甲基、1-萘乙基、2-萘乙基等芳基烷基中之芳基進一步除去1個氫原子之基)等。鍵結於前述芳基或雜芳基的伸烷基之碳原子數以1~4者為佳,以碳原子數1~2者為較佳,以碳原子數1者為特佳。 ・・Aromatic alkyl The aromatic alkyl group is a alkyl group having at least one aromatic ring. The aromatic ring is not particularly limited as long as it is a cyclic conjugate system having 4n+2 π electrons, and may be monocyclic or polycyclic. The number of carbon atoms in the aromatic ring is preferably 5 to 30, more preferably 5 to 20, more preferably 6 to 15, and particularly preferably 6 to 12. However, the number of carbon atoms does not include the number of carbon atoms in the substituent. As the aromatic ring, there are specifically mentioned aromatic alkyl rings such as benzene, naphthalene, anthracene, and phenanthrene; aromatic heterocyclic rings in which a part of the carbon atoms constituting the aforementioned aromatic alkyl rings are substituted by heteroatoms, and the like. As the heteroatom in the aromatic heterocyclic ring, oxygen atom, sulfur atom, nitrogen atom, etc. can be cited. As the aromatic heterocyclic ring, specifically, pyridine ring, thiophene ring, etc. can be cited. Specific examples of the aromatic hydrocarbon group include a group obtained by removing two hydrogen atoms from the aforementioned aromatic hydrocarbon ring or aromatic heterocyclic ring (arylene group or heteroarylene group); a group obtained by removing two hydrogen atoms from an aromatic compound having two or more aromatic rings (e.g., biphenyl group, fluorene, etc.); a group obtained by removing one hydrogen atom from the aforementioned aromatic hydrocarbon ring or aromatic heterocyclic ring (aryl group or heteroaryl group) in which one hydrogen atom is substituted by an alkylene group (e.g., a group obtained by further removing one hydrogen atom from the aryl group in an arylalkyl group such as benzyl, phenethyl, 1-naphthylmethyl, 2-naphthylmethyl, 1-naphthylethyl, 2-naphthylethyl, etc.). The alkylene group bonded to the aforementioned aryl or heteroaryl group preferably has 1 to 4 carbon atoms, more preferably 1 to 2 carbon atoms, and particularly preferably 1 carbon atom.

前述芳香族烴基中,該芳香族烴基所具有氫原子亦可由取代基進行取代。例如鍵結於該芳香族烴基中之芳香環的氫原子可由取代基進行取代。作為該取代基,例如可舉出烷基、烷氧基、鹵素原子、鹵化烷基、羥基等。 作為前述取代基之烷基,以碳原子數1~5的烷基為佳,以甲基、乙基、丙基、n-丁基、tert-丁基者為較佳。 作為前述取代基之烷氧基、鹵素原子及鹵化烷基,可舉出作為取代前述環狀脂肪族烴基所具有氫原子的取代基而例示者。 In the aforementioned aromatic alkyl group, the hydrogen atom possessed by the aromatic alkyl group may also be substituted by a substituent. For example, the hydrogen atom bonded to the aromatic ring in the aromatic alkyl group may be substituted by a substituent. Examples of the substituent include alkyl groups, alkoxy groups, halogen atoms, halogenated alkyl groups, hydroxyl groups, etc. As the aforementioned substituent, the alkyl group having 1 to 5 carbon atoms is preferred, and methyl, ethyl, propyl, n-butyl, and tert-butyl are preferred. As the aforementioned substituent, the alkoxy group, halogen atom, and halogenated alkyl group may be exemplified as the substituent for replacing the hydrogen atom possessed by the aforementioned cyclic aliphatic alkyl group.

・含有雜原子的2價連結基: 作為含有雜原子的2價連結基,可舉出-O-、-C(=O)-O-、-O-C(=O)-、-C(=O)-、-O-C(=O)-O-、-C(=O)-NH-、 -NH-、-NH-C(=NH)-(H可由烷基、醯基等取代基進行取代。)、-S-、-S(=O) 2-、-S(=O) 2-O-、一般式-Y 21-O-Y 22-、  -Y 21-O-、-Y 21-C(=O)-O-、-C(=O)-O-Y 21-、 -[Y 21-C(=O)-O] m”-Y 22-、-Y 21-O-C(=O)-Y 22-或 -Y 21-S(=O) 2-O-Y 22-所示基[式中,Y 21及Y 22各獨立為可具有取代基的2價烴基,O為氧原子,m”為1~3的整數。]等。 含有前述雜原子之2價連結基為-C(=O)-NH-、 -C(=O)-NH-C(=O)-、-NH-、-NH-C(=NH)-之情況時,該H可由烷基、醯基等取代基進行取代。該取代基(烷基、醯基等)以碳原子數1~10者為佳,以1~8者為更佳,以1~5者特佳。 一般式-Y 21-O-Y 22-、-Y 21-O-、-Y 21-C(=O)-O-、     -C(=O)-O-Y 21-、-[Y 21-C(=O)-O] m”-Y 22-、 -Y 21-O-C(=O)-Y 22-或-Y 21-S(=O) 2-O-Y 22-中,Y 21及Y 22各獨立為可具有取代基之2價烴基。作為該2價烴基,可舉出與前述相同者。 作為Y 21,以直鏈狀脂肪族烴基為佳,以直鏈狀伸烷基為較佳,以碳原子數1~5的直鏈狀伸烷基為更佳,以亞甲基或伸乙基特佳。 作為Y 22,以直鏈狀或分支鏈狀脂肪族烴基為佳,以亞甲基、伸乙基或烷基亞甲基為較佳。該烷基亞甲基中之烷基以碳原子數1~5的直鏈狀烷基為佳,以碳原子數1~3的直鏈狀烷基為較佳,以甲基為最佳。 式-[Y 21-C(=O)-O] m”-Y 22-所示基中,m”為1~3的整數,以1或2為較佳,以1特佳。換言之,作為式 -[Y 21-C(=O)-O] m”-Y 22-所示基,以式-Y 21-C(=O)-O-Y 22-所示基特佳。其中亦以式-(CH 2) a -C(=O)-O-(CH 2) b -所示基為佳。該式中,a’為1~10的整數,以1~8的整數為佳,以1~5的整數為較佳,以1或2為更佳,以1為最佳。b’為1~10的整數,以1~8的整數為佳,以1~5的整數為較佳,以1或2為更佳,以1為最佳。 ・Divalent linking group containing a heteroatom: As the divalent linking group containing a heteroatom, there can be mentioned -O-, -C(=O)-O-, -OC(=O)-, -C(=O)-, -OC(=O)-O-, -C(=O)-NH-, -NH-, -NH-C(=NH)- (H may be substituted by a substituent such as an alkyl group or an acyl group), -S-, -S(=O) 2 -, -S(=O) 2 -O-, general formula -Y 21 -OY 22 -, -Y 21 -O-, -Y 21 -C(=O)-O-, -C(=O)-OY 21 -, -[Y 21 -C(=O)-O] m" -Y 22 -, -Y 21 -OC(=O)-Y 22 - or -Y 21 -S(=O) 2 -OY 22 - [wherein Y 21 and Y 22 are each independently a divalent hydrocarbon group which may have a substituent, O is an oxygen atom, and m" is an integer of 1 to 3.], etc. When the divalent linking group containing the aforementioned heteroatom is -C(=O)-NH-, -C(=O)-NH-C(=O)-, -NH-, -NH-C(=NH)-, the H may be substituted by a substituent such as an alkyl group or an acyl group. The substituent (alkyl group, acyl group, etc.) preferably has 1 to 10 carbon atoms, more preferably 1 to 8 carbon atoms, and particularly preferably 1 to 5 carbon atoms. In the general formula -Y 21 -OY 22 -, -Y 21 -O-, -Y 21 -C(=O)-O-, -C(=O)-OY 21 -, -[Y 21 -C(=O)-O] m" -Y 22 -, -Y 21 -OC(=O)-Y 22 - or -Y 21 -S(=O) 2 -OY 22 -, Y 21 and Y 22 are each independently a divalent hydrocarbon group which may have a substituent. Examples of the divalent hydrocarbon group include the same as those mentioned above. Y 21 is preferably a linear aliphatic hydrocarbon group, more preferably a linear alkylene group, more preferably a linear alkylene group having 1 to 5 carbon atoms, and particularly preferably a methylene group or an ethylene group. Y 22 is , preferably a straight-chain or branched-chain aliphatic alkyl group, more preferably a methylene group, an ethylene group or an alkylmethylene group. The alkyl group in the alkylmethylene group is preferably a straight-chain alkyl group having 1 to 5 carbon atoms, more preferably a straight-chain alkyl group having 1 to 3 carbon atoms, and most preferably a methyl group. In the group represented by the formula -[Y 21 -C(=O)-O] m" -Y 22 -, m" is an integer of 1 to 3, preferably 1 or 2, and particularly preferably 1. In other words, as the group represented by the formula -[Y 21 -C(=O)-O] m" -Y 22 -, the group represented by the formula -Y 21 -C(=O)-OY 22 - is particularly preferred. Among them, the group represented by the formula -(CH 2 ) a ' -C(=O)-O-(CH 2 ) b ' - is also preferred. In the formula, a' is an integer of 1 to 10, preferably an integer of 1 to 8, more preferably an integer of 1 to 5, more preferably 1 or 2, and most preferably 1. b' is an integer of 1 to 10, preferably an integer of 1 to 8, more preferably an integer of 1 to 5, more preferably 1 or 2, and most preferably 1.

作為Ya x1,以單鍵、酯鍵[-C(=O)-O-、    -O-C(=O)-]、醚鍵(-O-)、直鏈狀或者分支鏈狀伸烷基或此等組合為佳,以單鍵、酯鍵[-C(=O)-O-、-O-C(=O)-]為較佳。 As Ya x1 , a single bond, an ester bond [-C(=O)-O-, -OC(=O)-], an ether bond (-O-), a linear or branched alkylene group or a combination thereof is preferred, and a single bond, an ester bond [-C(=O)-O-, -OC(=O)-] is more preferred.

前述式(a10-1)中,Wa x1為可具有取代基之芳香族烴基。 作為Wa x1中之芳香族烴基,可舉出自可具有取代基之芳香環除去(n ax1+1)個氫原子之基。此等芳香環若為具有4n+2個π電子的環狀共軛系即可並無特別限定。芳香環之碳原子數以5~30者為佳,以碳原子數5~20為較佳,以碳原子數6~15為更佳,以碳原子數6~12為特佳。作為該芳香環,具體可舉出苯、萘、蒽、菲等芳香族烴環;構成前述芳香族烴環之碳原子的一部分由雜原子進行取代的芳香族雜環等。作為芳香族雜環中之雜原子,可舉出氧原子、硫原子、氮原子等。作為芳香族雜環,具體可舉出吡啶環、噻吩環等。 又,作為Wa x1中之芳香族烴基,亦可舉出自含有可具有2個以上取代基之芳香環的芳香族化合物(例如聯苯基、芴等)除去(n ax1+1)個氫原子之基。 上述中,作為Wa x1,亦以自苯、萘、蒽或聯苯基除去(n ax1+1)個氫原子的基為佳,以自苯或萘除去(n ax1+1)個氫原子的基為較佳,以自苯除去(n ax1+1)個氫原子的基為更佳。 In the aforementioned formula (a10-1), Wax1 is an aromatic hydrocarbon group which may have a substituent. As the aromatic hydrocarbon group in Wax1 , there can be mentioned a group obtained by removing ( nax1 +1) hydrogen atoms from an aromatic ring which may have a substituent. Such aromatic rings are not particularly limited as long as they are cyclic conjugated systems having 4n+2 π electrons. The number of carbon atoms in the aromatic ring is preferably 5 to 30, more preferably 5 to 20, more preferably 6 to 15, and particularly preferably 6 to 12. Specific examples of the aromatic ring include aromatic hydrocarbon rings such as benzene, naphthalene, anthracene, and phenanthrene; and aromatic heterocyclic rings in which a part of the carbon atoms constituting the aforementioned aromatic hydrocarbon rings are substituted by heteroatoms. As the hetero atom in the aromatic heterocyclic ring, an oxygen atom, a sulfur atom, a nitrogen atom, etc. can be cited. As the aromatic heterocyclic ring, specifically, a pyridine ring, a thiophene ring, etc. can be cited. Furthermore, as the aromatic alkyl group in Wa x1 , a group obtained by removing (n ax1 +1) hydrogen atoms from an aromatic compound containing an aromatic ring which may have two or more substituents (e.g., biphenyl group, fluorene, etc.) can be cited. Among the above, as Wa x1 , a group obtained by removing (n ax1 +1) hydrogen atoms from benzene, naphthalene, anthracene, or biphenyl group is preferred, a group obtained by removing (n ax1 +1) hydrogen atoms from benzene or naphthalene is more preferred, and a group obtained by removing (n ax1 +1) hydrogen atoms from benzene is even more preferred.

Wa x1中之芳香族烴基可具有取代基,亦可不具有取代基。作為前述取代基,例如可舉出烷基、烷氧基、鹵素原子、鹵化烷基等。作為前述取代基之烷基、烷氧基、鹵素原子、鹵化烷基,可舉出與作為Ya x1中之環狀脂肪族烴基的取代基而舉出的相同者。前述取代基以碳原子數1~5的直鏈狀或者分支鏈狀烷基為佳,以碳原子數1~3的直鏈狀或者分支鏈狀烷基為較佳,以乙基或甲基為更佳,以甲基為特佳。Wa x1中之芳香族烴基以不具有取代基者為佳。 The aromatic hydrocarbon group in Wa x1 may or may not have a substituent. Examples of the aforementioned substituent include an alkyl group, an alkoxy group, a halogen atom, a halogenated alkyl group, and the like. Examples of the aforementioned substituent include the same ones as those listed as the substituent for the cyclic aliphatic hydrocarbon group in Ya x1 . The aforementioned substituent is preferably a linear or branched alkyl group having 1 to 5 carbon atoms, more preferably a linear or branched alkyl group having 1 to 3 carbon atoms, more preferably an ethyl group or a methyl group, and particularly preferably a methyl group. The aromatic hydrocarbon group in Wa x1 preferably has no substituent.

前述式(a10-1)中,n ax1為1以上的整數,以1~10的整數為佳,以1~5的整數為較佳,以1、2或3為更佳,以1或2為特佳。 In the above formula (a10-1), n ax1 is an integer greater than or equal to 1, preferably an integer from 1 to 10, more preferably an integer from 1 to 5, more preferably 1, 2 or 3, and particularly preferably 1 or 2.

以下表示前述式(a10-1)所示構成單位(a10)之具體例子。 以下各式中,R α表示氫原子、甲基或三氟甲基。 Specific examples of the constituent unit (a10) represented by the above formula (a10-1) are shown below. In the following formulae, R α represents a hydrogen atom, a methyl group or a trifluoromethyl group.

(A1)成分所具有構成單位(a10)可1種亦可為2種以上。(A1)成分可具有或可不具有構成單位(a10),但以具有構成單位(a10)者為佳。 (A1)成分具有構成單位(a10)之情況時,(A1)成分中之構成單位(a10)的比例相對於構成(A1)成分之全構成單位的合計(100莫耳%),以20~80莫耳%為佳,以25~70莫耳%為較佳,以30~60莫耳%為更佳,以40~60莫耳%特佳。 藉由構成單位(a10)的比例設定在下限值以上時,更提高感度變得容易。另一方面,藉由設定在上限值以下時,可容易得到與其他構成單位之平衡。 The constituent unit (a10) of the component (A1) may be one or more. The component (A1) may or may not have the constituent unit (a10), but it is preferred to have the constituent unit (a10). When the component (A1) has the constituent unit (a10), the ratio of the constituent unit (a10) in the component (A1) is preferably 20 to 80 mol%, more preferably 25 to 70 mol%, more preferably 30 to 60 mol%, and particularly preferably 40 to 60 mol% relative to the total of all constituent units constituting the component (A1) (100 mol%). When the ratio of the constituent unit (a10) is set to a value above the lower limit, it becomes easier to increase the sensitivity. On the other hand, when it is set to a value below the upper limit, it is easier to achieve a balance with other constituent units.

對於構成單位(a2): (A1)成分可為具有構成單位(a2)(但,除去相當於構成單位(a1)者)者,該構成單位(a2)為具有含有內酯的環式基者。 構成單位(a2)之含有內酯的環式基在將(A1)成分使用於阻劑膜的形成之情況時,於提高阻劑膜對基板之密著性上為有效者。又,藉由具有構成單位(a2)時,例如可適當地調整酸擴散長,提高阻劑膜對基板之密著性,藉由將顯影時之溶解性進行適當的調整等效果,可使光刻特性等變得良好。 Regarding constituent unit (a2): The component (A1) may have a constituent unit (a2) (but excluding constituent units equivalent to the constituent unit (a1)), and the constituent unit (a2) has a lactone-containing cyclic group. The lactone-containing cyclic group of the constituent unit (a2) is effective in improving the adhesion of the resist film to the substrate when the component (A1) is used to form a resist film. In addition, by having the constituent unit (a2), for example, the acid diffusion length can be appropriately adjusted to improve the adhesion of the resist film to the substrate, and the solubility during development can be appropriately adjusted, so that the photolithography characteristics can be improved.

所謂「含有內酯的環式基」表示,於該環骨架中具有含有-O-C(=O)-的環(內酯環)之環式基。將內酯環作為第一個環而開始數,僅為內酯環之情況時稱為單環式基,進一步具有其他環結構之情況時,與該結構無關而稱為多環式基。含有內酯的環式基可為單環式基,亦可為多環式基。 作為構成單位(a2)中之含有內酯的環式基,無需特別限定下,可使用任意者。具體可舉出下述一般式(a2-r-1)~(a2-r-8)各表示的基。 The so-called "lactone-containing cyclic group" means a cyclic group having a ring (lactone ring) containing -O-C(=O)- in the cyclic skeleton. When the lactone ring is counted as the first ring, it is called a monocyclic group when it is only a lactone ring, and when it has other ring structures, it is called a polycyclic group regardless of the structure. The lactone-containing cyclic group may be a monocyclic group or a polycyclic group. As the lactone-containing cyclic group in the constituent unit (a2), any one can be used without particular limitation. Specifically, the groups represented by the following general formulas (a2-r-1) to (a2-r-8) can be cited.

作為構成單位(a2),其中亦以自鍵結於α位碳原子的氫原子可由取代基進行取代的丙烯酸酯所衍生的構成單位為佳。 該構成單位(a2)係以下述一般式(a2-1)所示構成單位者為佳。 As the constituent unit (a2), a constituent unit derived from an acrylic acid ester in which the hydrogen atom bonded to the α-carbon atom can be substituted by a substituent is preferred. The constituent unit (a2) is preferably a constituent unit represented by the following general formula (a2-1).

[式中,R為氫原子、碳原子數1~5的烷基或碳原子數1~5的鹵化烷基。Ya 21為單鍵或2價連結基。La 21表示-O-、   -COO-、-CON(R’)-、-OCO-、-CONHCO-或-CONHCS-,R’表示氫原子或甲基。但,La 21為-O-之情況時,Ya 21不會成為-CO-。Ra 21為含有內酯的環式基。] [In the formula, R is a hydrogen atom, an alkyl group having 1 to 5 carbon atoms, or a halogenated alkyl group having 1 to 5 carbon atoms. Ya 21 is a single bond or a divalent linking group. La 21 represents -O-, -COO-, -CON(R')-, -OCO-, -CONHCO-, or -CONHCS-, and R' represents a hydrogen atom or a methyl group. However, when La 21 is -O-, Ya 21 will not become -CO-. Ra 21 is a cyclic group containing a lactone.]

前述式(a2-1)中,R與前述相同。作為R,以氫原子、碳原子數1~5的烷基或碳原子數1~5的氟化烷基為佳,由工業上獲得容易度來看,以氫原子或甲基為特佳。In the above formula (a2-1), R is the same as above. R is preferably a hydrogen atom, an alkyl group having 1 to 5 carbon atoms, or a fluorinated alkyl group having 1 to 5 carbon atoms, and is particularly preferably a hydrogen atom or a methyl group in view of industrial availability.

前述式(a2-1)中,作為Ya 21中之2價連結基,雖無特別限定,為較佳可舉出可具有取代基的2價烴基、含有雜原子的2價連結基等。作為Ya 21中之2價連結基,可舉出與上述一般式(a10-1)中Ya x1中之2價連結基相同者。 In the above formula (a2-1), the divalent linking group in Ya21 is not particularly limited, and preferably includes a divalent alkyl group which may have a substituent, a divalent linking group containing a heteroatom, etc. As the divalent linking group in Ya21 , the same as the divalent linking group in Yax1 in the above general formula (a10-1) can be mentioned.

作為Ya 21,以單鍵、酯鍵[-C(=O)-O-]、醚鍵(-O-)、直鏈狀或者分支鏈狀伸烷基,或此等組合者為佳。 Ya 21 is preferably a single bond, an ester bond [—C(═O)—O—], an ether bond (—O—), a linear or branched alkylene group, or a combination thereof.

前述式(a2-1)中,以Ya 21為單鍵,La 21為   -COO-或-OCO-者為佳。 In the above formula (a2-1), it is preferred that Ya 21 is a single bond and La 21 is -COO- or -OCO-.

前述式(a2-1)中,Ra 21為含有內酯的環式基。 作為Ra 21中之含有內酯的環式基,為較佳可舉出後述一般式(a2-r-1)~(a2-r-8)分別表示的基。 In the above formula (a2-1), Ra 21 is a lactone-containing cyclic group. Preferred examples of the lactone-containing cyclic group in Ra 21 include groups represented by general formulae (a2-r-1) to (a2-r-8) described below.

(A1)成分所具有構成單位(a2)可為1種亦可為2種以上。(A1)成分可具有亦可不具有構成單位(a2)。 (A1)成分具有構成單位(a2)之情況時,構成單位(a2)之比例相對於構成該(A1)成分之全構成單位的合計(100莫耳%),以1~20莫耳%者為佳,以1~15莫耳%者為較佳,以1~10莫耳%者為更佳。 若將構成單位(a2)的比例設定在為較佳下限值以上時,可藉由前述效果,可充分得到藉由含有構成單位(a2)之效果,若為上限值以下時,可取得與其他構成單位之平衡,種種光刻特性變得良好。 The constituent unit (a2) of the component (A1) may be one or more. The component (A1) may or may not have the constituent unit (a2). When the component (A1) has the constituent unit (a2), the ratio of the constituent unit (a2) relative to the total of all constituent units constituting the component (A1) (100 mol%) is preferably 1 to 20 mol%, more preferably 1 to 15 mol%, and even more preferably 1 to 10 mol%. If the ratio of the constituent unit (a2) is set to be above the preferred lower limit, the effect of containing the constituent unit (a2) can be fully obtained by the above-mentioned effect. If it is below the upper limit, a balance with other constituent units can be achieved, and various lithography characteristics become good.

對於構成單位(a8): 構成單位(a8)為自下述一般式(a8-1)所示化合物所衍生的構成單位。 Regarding constituent unit (a8): Constituent unit (a8) is a constituent unit derived from a compound represented by the following general formula (a8-1).

[式中,W 2為含有聚合性基的基。Ya x2為單鍵或(n ax2+1)價連結基。Ya x2與W 2可形成縮合環。R 1為碳數1~12的氟化烷基。R 2為可具有氟原子的碳數1~12的有機基或氫原子。R 2及Ya x2彼此鍵結可形成環結構。n ax2為1~3的整數。] [ W2 is a group containing a polymerizable group. Yax2 is a single bond or a ( nax2 +1)-valent linking group. Yax2 and W2 can form a condensed ring. R1 is a fluorinated alkyl group having 1 to 12 carbon atoms. R2 is an organic group having 1 to 12 carbon atoms which may have a fluorine atom or a hydrogen atom. R2 and Yax2 can form a ring structure by bonding to each other. Nax2 is an integer of 1 to 3.]

所謂W 2的含有聚合性基的基中之「聚合性基」表示具有聚合性基之化合物藉由自由基聚合等而可進行聚合的基,例如乙烯性雙鍵等碳原子間含有多重鍵的基。 The "polymerizable group" in the group containing a polymerizable group of W2 refers to a group in which a compound having a polymerizable group can be polymerized by free radical polymerization, for example, a group containing multiple bonds between carbon atoms such as an ethylenic double bond.

作為含有聚合性基的基,可為僅由聚合性基所構成的基,亦可為由聚合性基與該聚合性基以外的其他基所構成的基。作為該聚合性基以外的其他基,可舉出可具有取代基的2價烴基、含有雜原子的2價連結基等。 作為含有聚合性基的基,例如為較佳可舉出化學式:C(R X11)(R X12)=C(R X13)-Ya x0-所示基。 該化學式中,R X11、R X12及R X13各為氫原子、碳數1~5的烷基或碳數1~5的鹵化烷基,Ya x0為單鍵或2價連結基。 The group containing a polymerizable group may be a group consisting of only a polymerizable group or a group consisting of a polymerizable group and other groups other than the polymerizable group. As other groups other than the polymerizable group, a divalent hydrocarbon group which may have a substituent, a divalent linking group containing a heteroatom, etc. may be cited. As the group containing a polymerizable group, for example, a group represented by the chemical formula: C( RX11 )( RX12 )=C( RX13 ) -Yax0- may be preferably cited. In the chemical formula, RX11 , RX12 and RX13 are each a hydrogen atom, an alkyl group having 1 to 5 carbon atoms or a halogenated alkyl group having 1 to 5 carbon atoms, and Yax0 is a single bond or a divalent linking group.

作為Ya x2與W 2所形成的縮合環,可舉出W 2部位的聚合性基與Ya x2所形成的縮合環、W 2部位之聚合性基以外的其他基與Ya x2所形成的縮合環。 Ya x2與W 2所形成的縮合環亦可具有取代基。 Examples of the condensed ring formed by Yax2 and W2 include a condensed ring formed by a polymerizable group at W2 and Yax2 , and a condensed ring formed by a group other than the polymerizable group at W2 and Yax2 . The condensed ring formed by Yax2 and W2 may have a substituent.

以下表示構成單位(a8)之具體例子。 下述式中,R α表示氫原子、甲基或三氟甲基。 Specific examples of the constituent unit (a8) are shown below. In the following formula, R α represents a hydrogen atom, a methyl group or a trifluoromethyl group.

上述例示中,構成單位(a8)亦以選自由化學式(a8-1-01)~(a8-1-04)、(a8-1-06)、(a8-1-08)、(a8-1-09)及(a8-1-10)各表示的構成單位所成群的至少1種為佳,以選自由化學式(a8-1-01)~(a8-1-04)、(a8-1-09)各表示的構成單位所成群的至少1種為較佳。In the above examples, the constituent unit (a8) is preferably at least one selected from the group consisting of constituent units represented by chemical formulas (a8-1-01) to (a8-1-04), (a8-1-06), (a8-1-08), (a8-1-09) and (a8-1-10), and is more preferably at least one selected from the group consisting of constituent units represented by chemical formulas (a8-1-01) to (a8-1-04), (a8-1-09).

(A1)成分所具有構成單位(a8)可1種亦可為2種以上。(A1)成分可具有亦可不具有構成單位(a8)。 (A1)成分中之構成單位(a8)的比例相對於構成(A1)成分之全構成單位的合計(100莫耳%),以0~50莫耳%者為佳,以0~30莫耳%者為較佳。 The constituent unit (a8) of component (A1) may be one or more. Component (A1) may or may not have constituent unit (a8). The ratio of constituent unit (a8) in component (A1) relative to the total of all constituent units constituting component (A1) (100 mol%) is preferably 0 to 50 mol%, more preferably 0 to 30 mol%.

阻劑組成物所含有的(A1)成分可單獨使用1種,亦可併用2種以上。The component (A1) contained in the inhibitor composition may be used alone or in combination of two or more.

作為(A1)成分,例如可舉出含有構成單位(a1)與構成單位(a10)之重複結構的高分子化合物。 作為較佳(A1)成分,可舉出由構成單位(a1)與構成單位(a10)之重複結構所成的高分子化合物,構成單位(a1)之比例相對於構成該(A1)成分之全構成單位的合計(100莫耳%),以20~80莫耳%為佳,以25~70莫耳%為較佳,以30~60莫耳%為更佳,以40~60莫耳%為特佳,構成單位(a10)之比例相對於構成該(A1)成分之全構成單位合計(100莫耳%)而言,以20~80莫耳%為佳,以30~75莫耳%為較佳,以40~70莫耳%為更佳,以40~60莫耳%特佳。 As component (A1), for example, a polymer compound having a repeated structure of constituent units (a1) and constituent units (a10) can be cited. As a preferred component (A1), a polymer compound composed of a repeated structure of a constituent unit (a1) and a constituent unit (a10) can be cited. The proportion of the constituent unit (a1) relative to the total (100 mol%) of all constituent units constituting the component (A1) is preferably 20 to 80 mol%, preferably 25 to 70 mol%, more preferably 30 to 60 mol%, and particularly preferably 40 to 60 mol%. The proportion of the constituent unit (a10) relative to the total (100 mol%) of all constituent units constituting the component (A1) is preferably 20 to 80 mol%, preferably 30 to 75 mol%, more preferably 40 to 70 mol%, and particularly preferably 40 to 60 mol%.

該(A1)成分係可藉由,將衍生為各構成單位的單體溶解於聚合溶劑,於此例如加入偶氮二異丁腈(AIBN)、偶氮二異丁酸二甲酯(例如V-601等)等自由基聚合起始劑進行聚合而可製造。 或者該(A1)成分可藉由,將衍生構成單位(a1)的單體與任意之構成單位(例如構成單位(a10))的單體溶解於聚合溶劑中,於此加入如上述自由基聚合起始劑使其聚合後,經脫保護反應而可製造。 且,在聚合時,例如藉由併用如 HS-CH 2-CH 2-CH 2-C(CF 3) 2-OH之鏈轉移劑,可於末端導入 -C(CF 3) 2-OH基。導入如此烷基的氫原子之一部分由氟原子所取代的羥基烷基之共聚物對於顯影缺陷之減低或LER(線邊緣粗糙度:線側壁之不均勻凹凸)之減低上為有效。 The component (A1) can be produced by dissolving the monomers derived from the constituent units in a polymerization solvent, adding a radical polymerization initiator such as azobisisobutyronitrile (AIBN) or dimethyl azobisisobutyrate (e.g., V-601) to the solvent for polymerization. Alternatively, the component (A1) can be produced by dissolving the monomers derived from the constituent unit (a1) and the monomers of any constituent unit (e.g., constituent unit (a10)) in a polymerization solvent, adding the above-mentioned radical polymerization initiator to the solvent for polymerization, and then subjecting the mixture to a deprotection reaction. Furthermore, during the polymerization, a chain transfer agent such as HS- CH2 - CH2 - CH2 -C( CF3 ) 2 -OH can be used in combination to introduce a -C( CF3 ) 2 -OH group at the terminal. The copolymer into which a part of the hydrogen atoms of the alkyl group is introduced is replaced by fluorine atoms, and is effective in reducing development defects or LER (line edge roughness: unevenness of the line sidewall).

(A1)成分之重量平均分子量(Mw)(依據藉由凝膠滲透層析法(GPC)之聚苯乙烯換算基準)並非特別限定者,以1000~50000為佳,以2000~40000為較佳,以4000~30000為更佳,5000~10000為特佳。 (A1)成分的Mw設定在該範圍之為較佳上限值以下時,作為阻劑使用時,對於阻劑溶劑具有充分的溶解性,若設定在該範圍之為較佳下限值以上時,耐乾蝕刻性或阻劑圖型截面形狀為良好。 (A1)成分之分散度(Mw/Mn)並無特別限定,以1.0~4.0為佳,以1.0~3.0為較佳,以1.0~2.0為特佳。且Mn表示數平均分子量。 The weight average molecular weight (Mw) of the component (A1) (based on the polystyrene conversion standard by gel permeation chromatography (GPC)) is not particularly limited, and is preferably 1,000 to 50,000, more preferably 2,000 to 40,000, more preferably 4,000 to 30,000, and particularly preferably 5,000 to 10,000. When the Mw of the component (A1) is set below the preferred upper limit of the range, it has sufficient solubility in the resist solvent when used as a resist, and when it is set above the preferred lower limit of the range, the etching resistance or the cross-sectional shape of the resist pattern is good. The dispersion degree (Mw/Mn) of the (A1) component is not particularly limited, but is preferably 1.0 to 4.0, more preferably 1.0 to 3.0, and particularly preferably 1.0 to 2.0. Mn represents the number average molecular weight.

・對於(A2)成分 本實施形態之阻劑組成物中,作為(A)成分亦可併用非相當於前述(A1)成分之藉由酸的作用而對顯影液之溶解性產生變化的基材成分(以下稱為「(A2)成分」。)。 作為(A2)成分,並無特別限定,僅使用任意選自作為化學增幅型阻劑組成物用之基材成分的自過去已知的多數者即可。 (A2)成分可單獨使用一種高分子化合物或低分子化合物,亦可組合此等2種以上而使用。 ・Regarding component (A2) In the resist composition of this embodiment, a base component (hereinafter referred to as "component (A2)") which is not equivalent to the aforementioned component (A1) and changes the solubility in the developer by the action of an acid may be used as component (A). Component (A2) is not particularly limited, and any one selected from a plurality of conventionally known base components for chemically amplified resist compositions may be used. Component (A2) may be a single polymer compound or a low molecular weight compound, or may be used in combination of two or more thereof.

(A)成分中之(A1)成分的比例,相對於(A)成分之總質量而言,以25質量%以上為佳,以50質量%以上為較佳,以75質量%以上為更佳,亦可為100質量%。該比例若設定在25質量%以上時,高感度化或圖型尺寸之面內均勻性(CDU)及微細解像性等光刻特性優異的阻劑圖型變得更容易形成。The ratio of the component (A1) in the component (A) is preferably 25% by mass or more, more preferably 50% by mass or more, more preferably 75% by mass or more, and may be 100% by mass, relative to the total mass of the component (A). When the ratio is set at 25% by mass or more, it becomes easier to form a resist pattern having excellent lithography characteristics such as high sensitivity or in-plane uniformity of pattern size (CDU) and fine resolution.

本實施形態之阻劑組成物中,(A)成分之含有量可配合所要形成的阻劑膜厚等而調整即可。In the resist composition of this embodiment, the content of the component (A) can be adjusted according to the thickness of the resist film to be formed.

<酸產生劑成分(B)> 本實施形態之阻劑組成物中除(A)成分以外,進一步可含有藉由曝光產生酸之酸產生劑成分((B)成分)。(B)成分含有下述一般式(b0)所示化合物(B0)(以下亦稱為「(B0)成分」)。 <Acid generator component (B)> The resist composition of this embodiment may contain, in addition to component (A), an acid generator component (component (B)) that generates acid by exposure. Component (B) contains a compound (B0) represented by the following general formula (b0) (hereinafter also referred to as "component (B0)").

・對於(B0)成分 (B0)成分為下述一般式(b0)所示化合物。 ・ Regarding the component (B0) The component (B0) is a compound represented by the following general formula (b0).

[式中,R b為鹼分解性基。L 03為2價連結基。Rl 0為可具有取代基的環狀有機基。L 02為2價連結基。I為碘原子。R m1為碘原子以外之取代基。L 01為2價連結基或單鍵。Vb 0為伸烷基、氟化伸烷基或單鍵。但,L 01與Vb 0不會同時成為單鍵。R 0為碳數1~5的氟化烷基、氟原子或氫原子。nb1為1~4的整數,nb2為1~4的整數,nb3為0~3的整數。但,2≦nb1+nb2+nb3≦5。M m+表示m價有機陽離子。m為1以上的整數。] [In the formula, Rb is an alkali-decomposable group. L03 is a divalent linking group. Rl0 is a cyclic organic group which may have a substituent. L02 is a divalent linking group. I is an iodine atom. Rm1 is a substituent other than an iodine atom. L01 is a divalent linking group or a single bond. Vb0 is an alkylene group, a fluorinated alkylene group or a single bond. However, L01 and Vb0 will not simultaneously form a single bond. R0 is a fluorinated alkylene group having 1 to 5 carbon atoms, a fluorine atom or a hydrogen atom. nb1 is an integer from 1 to 4, nb2 is an integer from 1 to 4, and nb3 is an integer from 0 to 3. However, 2≦nb1+nb2+nb3≦5. Mm+ represents an m-valent organic cation. m is an integer greater than 1.]

{(B0)成分之負離子部} 前述式(b0)中,R b為鹼分解性基。 其中所謂「鹼分解性基」表示具有,藉由鹼顯影液之作用可使該鹼分解性基的結構中之至少一部分的鍵結被開裂之分解性的基。 「藉由鹼顯影液之作用可使前述鍵結開裂之分解性」表示,藉由0.1~30質量%之鹼顯影液的作用進行分解(為較佳為在23℃,且藉由2.38質量%之四甲基銨氫氧化物水溶液的作用進行分解),對於鹼顯影液的溶解性增大之意思。此為例如藉由鹼顯影液(鹼)之作用使酯鍵分解(水解)後,產生親水基而造成。作為該親水基可舉出羧基、羥基等。 {Negative ion portion of component (B0)} In the aforementioned formula (b0), R b is an alkali-degradable group. The so-called "alkali-degradable group" refers to a group having a degradability that can cleave at least a portion of the bonds in the structure of the alkali-degradable group by the action of an alkali developer. "Degradability that can cleave the aforementioned bonds by the action of an alkali developer" means that the solubility in the alkali developer is increased by decomposition by the action of a 0.1 to 30 mass % alkali developer (preferably at 23°C and by the action of a 2.38 mass % tetramethylammonium hydroxide aqueous solution). This is caused, for example, by the decomposition (hydrolysis) of the ester bond by the action of an alkali developer (alkali) to generate a hydrophilic group. Examples of the hydrophilic group include a carboxyl group and a hydroxyl group.

作為R b中之鹼分解性基,藉由鹼進行分解,可使(B0)成分對於鹼顯影液的可溶性產生變化之基者即可,並無特別限定,至今可使用作為添加於化學增幅型阻劑組成物之成分中之鹼分解性基而被提案者,例如可舉出含有酯鍵之結構。 其中亦以前述式(b0)中之R b為具有含有內酯的環式基之基者為佳。 The alkali-decomposable group in Rb is not particularly limited to any group that can change the solubility of the component (B0) in the alkali developer by decomposing it with an alkali. Alkali-decomposable groups that have been proposed as components added to chemically amplified resist compositions can be used, for example, structures containing an ester bond. Among them, Rb in the aforementioned formula (b0) is preferably a group having a cyclic group containing a lactone.

所謂「含有內酯的環式基」表示於該環骨架中具有含有-O-C(=O)-之環(內酯環)的環式基。將內酯環作為第一個環開始數,僅為內酯環之情況時稱為單環式基,具有其他環結構之情況時,與該結構無關皆稱為多環式基。含有內酯的環式基可為單環式基亦可為多環式基。 作為該含有內酯的環式基,無特別限定下,可使用任意者。具體可舉出下述一般式(a2-r-1)~(a2-r-8)各表示的基。 The so-called "lactone-containing cyclic group" means a cyclic group having a ring (lactone ring) containing -O-C(=O)- in the cyclic skeleton. When the lactone ring is counted as the first ring, it is called a monocyclic group when it is only a lactone ring, and when it has other ring structures, it is called a polycyclic group regardless of the structure. The lactone-containing cyclic group may be a monocyclic group or a polycyclic group. As the lactone-containing cyclic group, any one can be used without particular limitation. Specifically, the groups represented by the following general formulas (a2-r-1) to (a2-r-8) can be cited.

[式中,Ra’ 21各獨立為氫原子、烷基、烷氧基、鹵素原子、鹵化烷基、羥基、-COOR”、-OC(=O)R”、羥基烷基或氰基;R”為氫原子、烷基或含有內酯的環式基;A”為亦可含有氧原子(-O-)或者硫原子(-S-)之碳原子數1~5的伸烷基、氧原子或硫原子,n’為0~2的整數,m’為0或1。*表示鍵結位置。] [In the formula, Ra' 21 are each independently a hydrogen atom, an alkyl group, an alkoxy group, a halogen atom, a halogenated alkyl group, a hydroxyl group, -COOR", -OC(=O)R", a hydroxyl alkyl group or a cyano group; R" is a hydrogen atom, an alkyl group or a cyclic group containing a lactone; A" is an alkylene group having 1 to 5 carbon atoms, an oxygen atom or a sulfur atom which may also contain an oxygen atom (-O-) or a sulfur atom (-S-); n' is an integer of 0 to 2; and m' is 0 or 1. * indicates a bonding position.]

前述式(a2-r-1)~(a2-r-8)中,作為Ra’ 21中之烷基,以碳原子數1~6的烷基為佳。該烷基以直鏈狀或分支鏈狀者為佳。具體可舉出甲基、乙基、丙基、異丙基、n-丁基、異丁基、tert-丁基、戊基、異戊基、新戊基、己基等。此等中亦以甲基或乙基為佳,以甲基特佳。 作為Ra’ 21中之烷氧基,以碳原子數1~6的烷氧基為佳。該烷氧基以直鏈狀或分支鏈狀者為佳。具體可舉出作為前述Ra’ 21中之烷基所舉出的烷基與氧原子(-O-)連結的基。 作為Ra’ 21中之鹵素原子,以氟原子為佳。 作為Ra’ 21中之鹵化烷基,可舉出前述Ra’ 21中之烷基的氫原子的一部分或全部由前述鹵素原子所取代的基。作為該鹵化烷基,以氟化烷基為佳,特佳為全氟烷基。 In the aforementioned formulas (a2-r-1) to (a2-r-8), the alkyl group in Ra' 21 is preferably an alkyl group having 1 to 6 carbon atoms. The alkyl group is preferably a straight chain or a branched chain. Specifically, methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, tert-butyl, pentyl, isopentyl, neopentyl, hexyl, etc. are mentioned. Among them, methyl or ethyl is also preferred, and methyl is particularly preferred. As the alkoxy group in Ra' 21 , an alkoxy group having 1 to 6 carbon atoms is preferably an alkoxy group. The alkoxy group is preferably a straight chain or a branched chain. Specifically, a group in which the alkyl group listed as the aforementioned alkyl group in Ra' 21 is linked to an oxygen atom (-O-) is mentioned. As the halogen atom in Ra' 21 , a fluorine atom is preferred. As the halogenated alkyl group in Ra' 21 , there can be mentioned a group in which a part or all of the hydrogen atoms of the alkyl group in Ra' 21 are substituted by the halogen atom. As the halogenated alkyl group, a fluorinated alkyl group is preferred, and a perfluoroalkyl group is particularly preferred.

對於Ra’ 21中之-COOR”、-OC(=O)R”,R”皆為氫原子、烷基或含有內酯的環式基。 作為R”中之烷基,可為直鏈狀、分支鏈狀、環狀中任一者,以碳原子數1~15為佳。 R”為直鏈狀或者分支鏈狀烷基之情況時,以碳原子數1~10者為佳,以碳原子數1~5者為更佳,以甲基或乙基者為特佳。 R”為環狀烷基之情況時,以碳原子數3~15者為佳,以碳原子數4~12者為更佳,以碳原子數5~10為最佳。具體可例示出自可由氟原子或氟化烷基進行取代或亦可不被取代的單環烷烴除去1個以上氫原子之基;自聯環烷烴、三環烷烴、四環烷烴等聚環烷烴除去1個以上氫原子之基等。更具體可舉出自環戊烷、環己烷等單環烷烴除去1個以上氫原子之基;自金剛烷、降冰片烷、異冰片、三環癸烷、四環十二烷等聚環烷烴除去1個以上氫原子之基等。 作為R”中之含有內酯的環式基,可舉出與前述一般式(a2-r-1)~(a2-r-8)各表示基之相同者。 作為Ra’ 21中之羥基烷基,以碳原子數1~6者為佳,具體可舉出前述Ra’ 21中之烷基的氫原子之至少1個由羥基進行取代的基。 For -COOR", -OC(=O)R", in Ra' 21 , R" is a hydrogen atom, an alkyl group or a cyclic group containing lactone. The alkyl group in R" may be any of a linear, branched or cyclic group, and preferably has 1 to 15 carbon atoms. When R" is a linear or branched alkyl group, preferably has 1 to 10 carbon atoms, more preferably has 1 to 5 carbon atoms, and particularly preferably is a methyl or ethyl group. When R" is a cyclic alkyl group, preferably has 3 to 15 carbon atoms, more preferably has 4 to 12 carbon atoms, and most preferably has 5 to 10 carbon atoms. Specifically, there can be exemplified a group obtained by removing one or more hydrogen atoms from a monocyclic alkane which may or may not be substituted with a fluorine atom or a fluorinated alkyl group; a group obtained by removing one or more hydrogen atoms from a polycyclic alkane such as a bicyclic alkane, a tricyclic alkane, or a tetracyclic alkane; and the like. More specifically, there can be exemplified a group obtained by removing one or more hydrogen atoms from a monocyclic alkane such as cyclopentane or cyclohexane; and a group obtained by removing one or more hydrogen atoms from a polycyclic alkane such as adamantane, norbornane, isoborneol, tricyclodecane, or tetracyclododecane. As the lactone-containing cyclic group in R", the same ones as those represented by the aforementioned general formulas (a2-r-1) to (a2-r-8) can be cited. As the hydroxyalkyl group in Ra' 21 , those having 1 to 6 carbon atoms are preferred, and specifically, groups in which at least one of the hydrogen atoms of the alkyl group in Ra' 21 is substituted by a hydroxyl group can be cited.

作為Ra’ 21,上述中亦以各獨立為氫原子或氰基者為佳。 As Ra' 21 , it is also preferred that each of the above independently represents a hydrogen atom or a cyano group.

前述一般式(a2-r-2)、(a2-r-3)、(a2-r-5)中,作為A”中之碳原子數1~5的伸烷基,以直鏈狀或分支鏈狀伸烷基為佳,可舉出亞甲基、伸乙基、n-伸丙基、異伸丙基等。該伸烷基含有氧原子或硫原子之情況時,作為該具體例子,可舉出於前述伸烷基之末端或碳原子間隔著-O-或-S-之基,例如可舉出-O-CH 2-、-CH 2-O-CH 2-、-S-CH 2-、-CH 2-S-CH 2-等。作為A”,以碳原子數1~5的伸烷基或-O-為佳,以碳原子數1~5的伸烷基為較佳,以亞甲基為最佳。 In the aforementioned general formulas (a2-r-2), (a2-r-3) and (a2-r-5), the alkylene group having 1 to 5 carbon atoms in A" is preferably a linear or branched alkylene group, and examples thereof include methylene, ethylene, n-propylene, isopropylene and the like. When the alkylene group contains an oxygen atom or a sulfur atom, specific examples thereof include groups in which -O- or -S- is separated from the terminal of the aforementioned alkylene group or between carbon atoms, such as -O- CH2- , -CH2 -O- CH2- , -S- CH2- , -CH2 -S-CH2- and the like. A" is preferably an alkylene group having 1 to 5 carbon atoms or -O-, more preferably an alkylene group having 1 to 5 carbon atoms, and most preferably a methylene group.

以下舉出以一般式(a2-r-1)~(a2-r-8)各表示的基之具體例子。Specific examples of the groups represented by general formulae (a2-r-1) to (a2-r-8) are given below.

前述式(b0)中,R b以具有含有內酯的環式基之基者為佳,以上述一般式(a2-r-1)~(a2-r-8)各表示基為較佳,以上述一般式(a2-r-1)~(a2-r-2)各表示基為更佳,以上述一般式(a2-r-1)所示基為特佳。 In the aforementioned formula (b0), R b is preferably a group having a cyclic group containing a lactone, and the groups represented by the aforementioned general formulas (a2-r-1) to (a2-r-8) are preferred, the groups represented by the aforementioned general formulas (a2-r-1) to (a2-r-2) are further preferred, and the group represented by the aforementioned general formula (a2-r-1) is particularly preferred.

前述式(b0)中,Rl 0中之環狀有機基可為脂肪族烴基,亦可為芳香族烴基,又可為多環式基亦可為單環式基。 In the aforementioned formula (b0), the cyclic organic group in R10 may be an aliphatic hydrocarbon group or an aromatic hydrocarbon group, and may be a polycyclic group or a monocyclic group.

作為Rl 0中之單環式基的脂肪族烴基,以自單環烷烴或單環鏈烯除去2個以上氫原子的基為佳。作為該單環烷烴,以碳原子數3~6者為佳,具體可舉出環戊烷、環己烷等。作為該單環鏈烯,以碳原子數3~6者為佳,具體可舉出環戊烯、環己烯等。 作為Rl 0中之多環式基的脂肪族烴基,以自聚環烷烴或聚環鏈烯除去2個以上氫原子之基為佳,作為該聚環烷烴,以碳原子數7~12者為佳,具體可舉出金剛烷、降冰片烷、異冰片、三環癸烷、四環十二烷等。又,作為該聚環鏈烯,以碳原子數7~12者為佳,具體可舉出金剛烷、降冰片烯、異硼烷、三環癸烯、四環十二烯等。 The aliphatic hydrocarbon group as the monocyclic group in R10 is preferably a group obtained by removing two or more hydrogen atoms from a monocyclic alkane or a monocyclic alkene. The monocyclic alkane is preferably a group having 3 to 6 carbon atoms, and specific examples thereof include cyclopentane and cyclohexane. The monocyclic alkene is preferably a group having 3 to 6 carbon atoms, and specific examples thereof include cyclopentene and cyclohexene. The aliphatic hydrocarbon group of the polycyclic group in R10 is preferably a group obtained by removing two or more hydrogen atoms from a polycycloalkane or a polycycloalkene. The polycycloalkane is preferably a group having 7 to 12 carbon atoms, and specifically includes adamantane, norbornene, isobornene, tricyclodecane, tetracyclododecane, etc. Furthermore, the polycycloalkene is preferably a group having 7 to 12 carbon atoms, and specifically includes adamantane, norbornene, isoborane, tricyclodecene, tetracyclododecene, etc.

作為Rl 0中之芳香族烴基,以自苯、萘、蒽或菲除去2個以上氫原子的基為佳,以自苯、萘或蒽除去2個以上氫原子的基為較佳,以自苯除去2個以上氫原子之基為更佳。 The aromatic hydrocarbon group in R10 is preferably a group obtained by removing two or more hydrogen atoms from benzene, naphthalene, anthracene or phenanthrene, more preferably a group obtained by removing two or more hydrogen atoms from benzene, naphthalene or anthracene, and even more preferably a group obtained by removing two or more hydrogen atoms from benzene.

作為Rl 0中之可具有環狀有機基之取代基,例如可舉出與上述Ra x5之相同基。 又,該有機基中構成該有機基之碳原子(亞甲基等)的一部分亦可由含有雜原子的基進行取代。 作為在此所謂的雜原子,可舉出氧原子、硫原子、氮原子。作為含有雜原子的基,可舉出(-O-)、-C(=O)-O-、 -O-C(=O)-、-C(=O)-、-O-C(=O)-O-、-C(=O)-NH-、-NH-、-S-、-S(=O) 2-、-S(=O) 2-O-等。 即,Rl 0中之可具有取代基的環狀有機基,可為自吡啶環、噻吩環等芳香族雜環除去2個以上氫原子之基;自四氫呋喃、四氫吡喃、四氫噻吩等脂肪族雜環除去2個以上氫原子之基。 As the substituent group which may have a cyclic organic group in R10 , for example, the same groups as those for Ra x5 mentioned above can be cited. In addition, a part of the carbon atoms (methylene etc.) constituting the organic group can also be substituted by a group containing a heteroatom. As the heteroatom mentioned here, an oxygen atom, a sulfur atom and a nitrogen atom can be cited. As the group containing a heteroatom, (-O-), -C(=O)-O-, -OC(=O)-, -C(=O)-, -OC(=O)-O-, -C(=O)-NH-, -NH-, -S-, -S(=O) 2 -, -S(=O) 2 -O- and the like can be cited. That is, the cyclic organic group which may have a substituent in R10 may be a group obtained by removing two or more hydrogen atoms from an aromatic heterocyclic ring such as a pyridine ring and a thiophene ring; or a group obtained by removing two or more hydrogen atoms from an aliphatic heterocyclic ring such as tetrahydrofuran, tetrahydropyran, and tetrahydrothiophene.

Rl 0中之環狀有機基可為含有脂肪族烴環與芳香環經縮合的縮合環之縮合環式基。作為前述縮合環,例如可舉出具有交聯環系多環式骨架之聚環烷烴上縮合1個以上之芳香環者等。作為前述交聯環系聚環烷烴之具體例子,可舉出聯環[2.2.1]庚烷(降冰片烷)、聯環[2.2.2]辛烷等聯環烷烴。作為前述縮合環式,以於聯環烷烴含有縮合2個或3個芳香環之縮合環的基為佳。 The cyclic organic group in R10 may be a condensed ring group containing a condensed ring in which an aliphatic hydrocarbon ring and an aromatic ring are condensed. Examples of the aforementioned condensed ring include a polycycloalkane having a cross-linked ring system polycyclic skeleton in which one or more aromatic rings are condensed. Specific examples of the aforementioned cross-linked ring system polycycloalkane include bicycloalkanes such as bicyclo[2.2.1]heptane (norbornane) and bicyclo[2.2.2]octane. As the aforementioned condensed ring group, a group containing a condensed ring in which two or three aromatic rings are condensed in a bicycloalkane is preferred.

上述一般式(b0)中,Rl 0在上述中,亦由提高阻劑膜內中之(B0)成分的分散均勻性之觀點來看,以可具有取代基之芳香族烴基或可具有取代基之多環脂環式烴基者為佳,以自芳香族烴基、聚環烷烴或者聚環鏈烯除去2個氫原子之基,或含有脂肪族烴環與芳香環經縮合的縮合環之縮合環式基者為較佳。 In the above general formula (b0), R10 is preferably an aromatic hydrocarbon group which may have a substituent or a polycyclic alicyclic hydrocarbon group which may have a substituent, from the viewpoint of improving the dispersion uniformity of the (B0) component in the resist film. It is preferably a group obtained by removing two hydrogen atoms from an aromatic hydrocarbon group, a polycycloalkane or a polycycloalkene, or a condensed cyclic group containing a condensed ring of an aliphatic hydrocarbon ring and an aromatic ring.

作為Rl 0,具體以下述化學式(Rl0-1)~(Rl0-4)中任一所示基者為佳,以下述化學式(Rl0-1)、(Rl0-2)或(Rl0-4)所示基者為較佳,以下述化學式(Rl0-4)所示基者為更佳。 又,以下述化學式(Rl0-1)~(Rl0-4)各表示的基所具有氫原子各獨立可被取代基進行取代。作為該取代基,可舉出與上述Ra x5相同者。 Specifically, R10 is preferably a group represented by any one of the following chemical formulas (R10-1) to (R10-4), more preferably a group represented by the following chemical formula (R10-1), (R10-2) or (R10-4), and even more preferably a group represented by the following chemical formula (R10-4). In addition, the hydrogen atoms in the groups represented by the following chemical formulas (R10-1) to (R10-4) may be substituted by a substituent. Examples of the substituent include the same as those for Ra x5 above.

前述式(b0)中,L 01為2價連結基或單鍵。L 02為2價連結基。L 03為2價連結基。 作為L 01、L 02及L 03中之2價連結基,可舉出含有氧原子的2價連結基之為較佳者。 L 01、L 02及L 03為含有氧原子的2價連結基之情況時,L 01、L 02及L 03亦可含有除氧原子以外之原子。作為氧原子以外之原子,例如可舉出碳原子、氫原子、硫原子、氮原子等。 作為含有氧原子的2價連結基,例如可舉出氧原子(醚鍵:-O-)、酯鍵(-C(=O)-O-)、氧羰基(-O-C(=O)-)、醯胺鍵(-C(=O)-NH-)、羰基(-C(=O)-)、碳酸酯鍵(-O-C(=O)-O-)等非烴系含有氧原子的連結基;該非烴系含有氧原子之連結基與伸烷基之組合等。該組合可進一步連結磺醯基     (-SO 2-)。 In the above formula (b0), L 01 is a divalent linking group or a single bond. L 02 is a divalent linking group. L 03 is a divalent linking group. As the divalent linking group among L 01 , L 02 and L 03 , a divalent linking group containing an oxygen atom can be cited as a preferred one. When L 01 , L 02 and L 03 are divalent linking groups containing an oxygen atom, L 01 , L 02 and L 03 may also contain an atom other than an oxygen atom. As the atom other than an oxygen atom, for example, a carbon atom, a hydrogen atom, a sulfur atom, a nitrogen atom, etc. can be cited. Examples of the divalent linking group containing an oxygen atom include an oxygen atom (ether bond: -O-), an ester bond (-C(=O)-O-), an oxycarbonyl group (-OC(=O)-), an amide bond (-C(=O)-NH-), a carbonyl group (-C(=O)-), a carbonate bond (-OC(=O)-O-), and the like; a combination of the linking group containing an oxygen atom and an alkylene group, etc. The combination may further be linked to a sulfonyl group (-SO 2 -).

作為L 01、L 02及L 03中之2價連結基,更具體可舉出-O-、-CO-、-OCO-、-COO-、-SO 2-、-N(R a)-C(=O)-、-N(R a)-、-C(R a)(R a)-N(R a)-、-C(R a)(N(R a)(R a))-或者   -C(=O)-N(R a)-,或前述非烴系含有氧原子的連結基與伸烷基之組合等。R a各獨立為氫原子或烷基。 More specifically, the divalent linking group in L01 , L02 and L03 includes -O-, -CO-, -OCO-, -COO-, -SO2- , -N( Ra )-C(= O )-, -N(Ra)-, -C(Ra)(Ra)-N( Ra )-, -C(Ra)(N( Ra )( Ra ))- or -C(=O)-N( Ra )-, or a combination of the above non- hydrocarbon oxygen-containing linking groups and an alkylene group. Each Ra is independently a hydrogen atom or an alkyl group.

前述式(b0)中,L 01在上述中,亦以2價連結基者為佳,以含有氧原子的2價連結基者為較佳,以    -OCO-、-COO-或者-C(=O)-N(R a)-,或前述非烴系含有氧原子之連結基與伸烷基之組合者為更佳,以-OCO-、    -COO-或前述非烴系含有氧原子之連結基與伸烷基之組合者特佳。 In the aforementioned formula (b0), L01 is preferably a divalent linking group, more preferably a divalent linking group containing an oxygen atom, more preferably -OCO-, -COO- or -C(=O)-N( Ra )-, or a combination of the aforementioned non-hydrocarbon linking group containing an oxygen atom and an alkylene group, and particularly preferably -OCO-, -COO- or a combination of the aforementioned non-hydrocarbon linking group containing an oxygen atom and an alkylene group.

前述式(b0)中,L 02在上述中,亦以含有氧原子之2價連結基者為佳,以-OCO-、-COO-或-C(=O)-N(R a)-者為較佳,以-OCO-、-COO-或-C(=O)-NH-者為特佳。 In the aforementioned formula (b0), L02 is preferably a divalent linking group containing an oxygen atom, preferably -OCO-, -COO- or -C(=O)-N( Ra )-, and particularly preferably -OCO-, -COO- or -C(=O)-NH-.

前述式(b0)中,L 03在上述中,亦已含有氧原子的2價連結基者為佳,以-OCO-、-COO-或-C(=O)-N(R a)-者為較佳,以-OCO-或-COO-者為特佳。 In the above formula (b0), L03 is preferably a divalent linking group containing an oxygen atom, more preferably -OCO-, -COO- or -C(=O)-N(R a )-, and particularly preferably -OCO- or -COO-.

前述式(b0)中,作為R m1中之碘原子以外的取代基,可舉出羥基、烷基、氟化烷基、氟原子、氯原子等。 作為該烷基及該氟化烷基中之烷基,以碳原子數1~5的烷基為佳,以甲基或乙基為較佳。 In the above formula (b0), as the substituent other than the iodine atom in Rm1 , there can be mentioned a hydroxyl group, an alkyl group, a fluorinated alkyl group, a fluorine atom, a chlorine atom, etc. As the alkyl group and the fluorinated alkyl group, an alkyl group having 1 to 5 carbon atoms is preferred, and a methyl group or an ethyl group is more preferred.

前述式(b0)中,Vb 0中之伸烷基、氟化伸烷基各以碳原子數1~4者為佳,以碳原子數1~3者為較佳。 作為Vb 0中之氟化伸烷基,可舉出伸烷基之氫原子的一部分或全部由氟原子進行取代的基。 Vb 0在上述中,亦以伸烷基或氟化伸烷基者為佳,以碳原子數1~4的伸烷基或碳原子數1~4的氟化伸烷基者為較佳,以亞甲基(-CH 2-)、-CH(CF 3)-、-CH 2CH 2CF 2-或   -CH 2CH 2CHF-者為更佳。 In the above formula (b0), the alkylene group and the fluorinated alkylene group in Vb0 are each preferably those having 1 to 4 carbon atoms, more preferably those having 1 to 3 carbon atoms. Examples of the fluorinated alkylene group in Vb0 include those in which a part or all of the hydrogen atoms of the alkylene group are substituted with fluorine atoms. Among the above, Vb0 is also preferably an alkylene group or a fluorinated alkylene group, more preferably an alkylene group having 1 to 4 carbon atoms or a fluorinated alkylene group having 1 to 4 carbon atoms, and more preferably a methylene group ( -CH2- ) , -CH( CF3 )-, -CH2CH2CF2- or -CH2CH2CHF- .

例如作為前述一般式(b0)中之-L 01-Vb 0-,可舉出下述一般式(b0-r-1)~(b0-r-7)中任一所示連結基。 For example, as -L 01 -Vb 0 - in the general formula (b0) above, there can be mentioned any one of the linking groups represented by the following general formulas (b0-r-1) to (b0-r-7).

[式中,L 011為碳原子數1~5的伸烷基或單鍵。L 012為碳原子數1~30的2價飽和烴基或單鍵。Vb 01為碳原子數1~4的氟化伸烷基或單鍵。但,L 012與Vb 01不會同時成為單鍵。] [In the formula, L 011 is an alkylene group having 1 to 5 carbon atoms or a single bond. L 012 is a divalent saturated alkyl group having 1 to 30 carbon atoms or a single bond. Vb 01 is a fluorinated alkylene group having 1 to 4 carbon atoms or a single bond. However, L 012 and Vb 01 cannot be single bonds at the same time.]

前述式(b0-r-1)、(b0-r-2)及(b0-r-5)~(b0-r-7)中,L 012中之2價飽和烴基以碳原子數1~30的伸烷基者為佳,以碳原子數1~10的伸烷基者為較佳,以碳原子數1~5的伸烷基者為更佳。 作為前述一般式(b0)中之-L 01-Vb 0-,其中亦以一般式(b0-r-1)~(b0-r-2)中任一所示連結基特佳。 In the aforementioned formulae (b0-r-1), (b0-r-2) and (b0-r-5) to (b0-r-7), the divalent saturated alkyl group in L 012 is preferably an alkylene group having 1 to 30 carbon atoms, more preferably an alkylene group having 1 to 10 carbon atoms, and even more preferably an alkylene group having 1 to 5 carbon atoms. As -L 01 -Vb 0 - in the aforementioned general formula (b0), the linking group represented by any of the general formulae (b0-r-1) to (b0-r-2) is particularly preferred.

前述式(b0)中,R 0為碳數1~5的氟化烷基、氟原子或氫原子。 R 0以碳數1~5的氟化烷基、氟原子為佳,以碳原子數1~5的全氟烷基、氟原子為較佳,以氟原子者為更佳。 In the above formula (b0), R0 is a fluorinated alkyl group having 1 to 5 carbon atoms, a fluorine atom or a hydrogen atom. R0 is preferably a fluorinated alkyl group having 1 to 5 carbon atoms or a fluorine atom, more preferably a perfluoroalkyl group having 1 to 5 carbon atoms or a fluorine atom, and more preferably a fluorine atom.

前述式(b0)中,nb1表示碘原子(I)的數,其為1~4的整數,以1~3的整數者為佳,以2或3者為較佳。 nb2為1~4的整數,以1或2者為佳,以1者為較佳。 nb3表示碘原子以外的取代基(R m1)之數,其為0~3的整數,以0或1者為佳,以0者為較佳。 In the above formula (b0), nb1 represents the number of iodine atoms (I), which is an integer of 1 to 4, preferably 1 to 3, and more preferably 2 or 3. nb2 represents the number of 1 to 4, preferably 1 or 2, and more preferably 1. nb3 represents the number of substituents (R m1 ) other than iodine atoms, which is an integer of 0 to 3, preferably 0 or 1, and more preferably 0.

以下表示(B0)成分的負離子部之為較佳具體例子。 以下所示的化學式(b0-an-101)~(b0-an-129)各表示的負離子為前述式(b0)中之Rl 0為苯環的情況時的負離子部之例子。 以下所示的化學式(b0-an-201)~(b0-an-223)各表示的負離子為前述式(b0)中之Rl 0為降冰片烯環的情況時的負離子部之例子。 以下所示的化學式(b0-an-301)~(b0-an-322)各所表示的負離子為前述式(b0)中之Rl 0為聯環辛烷環的情況時之負離子部的例子。 The following are preferred specific examples of the negative ion part of the component (B0). The negative ions represented by the chemical formulas (b0-an-101) to (b0-an-129) shown below are examples of the negative ion part when R10 in the aforementioned formula (b0) is a benzene ring. The negative ions represented by the chemical formulas (b0-an-201) to (b0-an-223) shown below are examples of the negative ion part when R10 in the aforementioned formula (b0) is a norbornene ring. The negative ions represented by the chemical formulas (b0-an-301) to (b0-an-322) shown below are examples of the negative ion part when R10 in the above formula (b0) is a bicyclic octane ring.

作為(B0)成分之負離子部,以選自由上述化學式(b0-an-101)~(b0-an-129)各表示的負離子所成群者、選自由上述化學式(b0-an-201)~(b0-an-223)各表示的負離子所成群者,或選自由上述化學式(b0-an-301)~(b0-an-322)各表示的負離子所成群者為佳。 此等中,(B0)成分的負離子部由可更容易得到本發明之效果的觀點來看,亦以選自由上述化學式(b0-an-301)~(b0-an-322)各表示的負離子所成群者為較佳。 As the negative ion part of the component (B0), it is preferably selected from the group consisting of negative ions represented by the above chemical formulas (b0-an-101) to (b0-an-129), the group consisting of negative ions represented by the above chemical formulas (b0-an-201) to (b0-an-223), or the group consisting of negative ions represented by the above chemical formulas (b0-an-301) to (b0-an-322). Among these, the negative ion part of the component (B0) is preferably selected from the group consisting of negative ions represented by the above chemical formulas (b0-an-301) to (b0-an-322) from the viewpoint of more easily obtaining the effect of the present invention.

{(B0)成分之陽離子部} 前述式(b0)中,M m+為m價有機陽離子。m為1以上的整數。 作為M m+中之有機陽離子,以鎓陽離子為佳,其中亦以硫鎓陽離子、碘鎓陽離子為較佳。 {Cation part of component (B0)} In the above formula (b0), M m+ is an m-valent organic cation. m is an integer greater than 1. The organic cation in M m+ is preferably an onium cation, and among them, a sulfonium cation and an iodonium cation are more preferred.

作為M m+中之有機陽離子,可舉出下述一般式(ca-1)~(ca-3)各表示的有機陽離子。 As the organic cation in M m+ , there can be cited organic cations represented by the following general formulas (ca-1) to (ca-3).

[式中,R 201~R 207各獨立表示可具有取代基之芳基、烷基或烯基。R 201~R 203、R 206~R 207彼此鍵結與式中之硫原子可共同形成環。R 208~R 209各獨立表示氫原子或碳原子數1~5的烷基。R 210為可具有取代基之芳基、可具有取代基之烷基、可具有取代基之烯基或可具有取代基之含有   -SO 2-的環式基。L 201表示-C(=O)-或-C(=O)-O-。] [In the formula, R 201 to R 207 each independently represents an aryl group, an alkyl group or an alkenyl group which may have a substituent. R 201 to R 203 and R 206 to R 207 may form a ring together with the sulfur atom in the formula. R 208 to R 209 each independently represents a hydrogen atom or an alkyl group having 1 to 5 carbon atoms. R 210 is an aryl group which may have a substituent, an alkyl group which may have a substituent, an alkenyl group which may have a substituent, or a cyclic group containing -SO 2 - which may have a substituent. L 201 represents -C(=O)- or -C(=O)-O-.]

上述式(ca-1)~(ca-3)中,作為R 201~R 207中之芳基,可舉出碳原子數6~20的無取代之芳基,以苯基、萘基為佳。 作為R 201~R 207中之烷基,其為鏈狀或環狀烷基,以碳原子數1~30者為佳。 作為R 201~R 207中之烯基,以碳原子數2~10者為佳。 作為R 201~R 207及R 210可具有的取代基,例如可舉出烷基、鹵素原子、鹵化烷基、羰基、氰基、胺基、芳基、下述一般式(ca-r-1)~(ca-r-7)各表示的基等。 In the above formulae (ca-1) to (ca-3), the aryl group in R 201 to R 207 includes unsubstituted aryl groups having 6 to 20 carbon atoms, preferably phenyl and naphthyl. The alkyl group in R 201 to R 207 is a chain or cyclic alkyl group having 1 to 30 carbon atoms. The alkenyl group in R 201 to R 207 is preferably an alkenyl group having 2 to 10 carbon atoms. Examples of the substituents that R 201 to R 207 and R 210 may have include alkyl groups, halogen atoms, halogenated alkyl groups, carbonyl groups, cyano groups, amino groups, aryl groups, and groups represented by the following general formulae (ca-r-1) to (ca-r-7).

[式中,R’ 201各獨立為氫原子、可具有取代基的環式基、可具有取代基的鏈狀烷基,或可具有取代基的鏈狀烯基。] [In the formula, R'201 is independently a hydrogen atom, a cyclic group which may have a substituent, a chain alkyl group which may have a substituent, or a chain alkenyl group which may have a substituent.]

可具有取代基的環式基: 該環式基以環狀烴基者為佳,該環狀烴基可為芳香族烴基,亦可為脂肪族烴基。脂肪族烴基表示不具有芳香族性之烴基。又,脂肪族烴基可為飽和,亦可為不飽和,通常以飽和者為佳。 Cyclic group which may have a substituent: The cyclic group is preferably a cyclic hydrocarbon group, which may be an aromatic hydrocarbon group or an aliphatic hydrocarbon group. An aliphatic hydrocarbon group refers to a hydrocarbon group which is not aromatic. Moreover, an aliphatic hydrocarbon group may be saturated or unsaturated, and a saturated hydrocarbon group is generally preferred.

R’ 201中之芳香族烴基為具有芳香環之烴基。該芳香族烴基之碳原子數以3~30者為佳,以碳原子數5~30為較佳,以碳原子數5~20為更佳,以碳原子數6~15為特佳,以碳原子數6~10為最佳。但,該碳原子數係為未含有取代基中之碳原子數者。 作為R’ 201中之芳香族烴基所具有芳香環,具體可舉出苯、芴、萘、蒽、菲、聯苯基或構成此等芳香環之碳原子的一部分以雜原子進行取代之芳香族雜環等。作為芳香族雜環中之雜原子,可舉出氧原子、硫原子、氮原子等。 作為R’ 201中之芳香族烴基,具體可舉出自前述芳香環除去1個氫原子之基(芳基:例如苯基、萘基等)、前述芳香環之1個氫原子由伸烷基進行取代之基(例如苯甲基、苯乙基、1-萘甲基、2-萘甲基、1-萘乙基、2-萘乙基等芳基烷基等)等。前述伸烷基(芳基烷基中之烷基鏈)之碳原子數以1~4者為佳,以碳原子數1~2為較佳,以碳原子數1為特佳。 The aromatic alkyl group in R'201 is an alkyl group having an aromatic ring. The number of carbon atoms of the aromatic alkyl group is preferably 3 to 30, more preferably 5 to 30, more preferably 5 to 20, particularly preferably 6 to 15, and most preferably 6 to 10. However, the number of carbon atoms does not include the number of carbon atoms in the substituent. Specific examples of the aromatic ring possessed by the aromatic alkyl group in R'201 include benzene, fluorene, naphthalene, anthracene, phenanthrene, biphenyl, or aromatic heterocyclic rings in which a portion of the carbon atoms constituting these aromatic rings are substituted with heteroatoms. Examples of the heteroatoms in the aromatic heterocyclic ring include oxygen atoms, sulfur atoms, nitrogen atoms, and the like. Specific examples of the aromatic alkyl group in R'201 include a group obtained by removing one hydrogen atom from the aforementioned aromatic ring (aryl group: for example, phenyl, naphthyl, etc.), a group obtained by replacing one hydrogen atom of the aforementioned aromatic ring with an alkylene group (for example, benzyl, phenethyl, 1-naphthylmethyl, 2-naphthylmethyl, 1-naphthylethyl, 2-naphthylethyl and other arylalkyl groups), etc. The aforementioned alkylene group (alkyl chain in the arylalkyl group) preferably has 1 to 4 carbon atoms, more preferably 1 to 2 carbon atoms, and particularly preferably 1 carbon atom.

R’ 201中之環狀脂肪族烴基可舉出於結構中含有環之脂肪族烴基。 作為於該結構中含有環之脂肪族烴基,可舉出脂環式烴基(自脂肪族烴環除去1個氫原子之基)、脂環式烴基鍵結於直鏈狀或分支鏈狀脂肪族烴基之末端的基、脂環式烴基隔在直鏈狀或分支鏈狀脂肪族烴基之途中的基等。 前述脂環式烴基以碳原子數3~20者為佳,以3~12者為較佳。 前述脂環式烴基可為多環式基,亦可為單環式基。作為單環式之脂環式烴基,以自單環烷烴除去1個以上氫原子之基為佳。作為該單環烷烴,以碳原子數3~6者為佳,具體可舉出環戊烷、環己烷等。作為多環式脂環式烴基,以自聚環烷烴除去1個以上氫原子之基為佳,作為該聚環烷烴,以碳原子數7~30者為佳。其中作為該聚環烷烴,亦以金剛烷、降冰片烷、異冰片、三環癸烷、四環十二烷等交聯環系之具有多環式骨架的聚環烷烴;具有類固醇骨架之環式基等縮合環系具有多環式骨架之聚環烷烴為較佳。 The cyclic aliphatic hydrocarbon group in R'201 can be an aliphatic hydrocarbon group containing a ring in the structure. As the aliphatic hydrocarbon group containing a ring in the structure, there can be mentioned an alicyclic hydrocarbon group (a group obtained by removing one hydrogen atom from an aliphatic hydrocarbon ring), a group in which an alicyclic hydrocarbon group is bonded to the end of a straight chain or branched chain aliphatic hydrocarbon group, a group in which an alicyclic hydrocarbon group is separated in the middle of a straight chain or branched chain aliphatic hydrocarbon group, etc. The aforementioned alicyclic hydrocarbon group preferably has 3 to 20 carbon atoms, more preferably 3 to 12 carbon atoms. The aforementioned alicyclic hydrocarbon group may be a polycyclic group or a monocyclic group. As a monocyclic alicyclic alkyl group, a group obtained by removing one or more hydrogen atoms from a monocyclic alkane is preferred. The monocyclic alkane is preferably one having 3 to 6 carbon atoms, and specific examples thereof include cyclopentane and cyclohexane. As a polycyclic alicyclic alkyl group, a group obtained by removing one or more hydrogen atoms from a polycycloalkane is preferred, and the polycycloalkane is preferably one having 7 to 30 carbon atoms. The polycycloalkane is preferably a polycycloalkane having a cross-linked ring system with a polycyclic skeleton such as adamantane, norbornane, isoborneol, tricyclodecane, tetracyclododecane, etc.; a polycycloalkane having a polycyclic skeleton such as a condensed ring system with a steroid skeleton.

其中,作為R’ 201中之環狀脂肪族烴基,係以自單環烷烴或聚環烷烴除去1個以上的氫原子之基為佳,以自聚環烷烴除去1個氫原子之基為較佳,以金剛烷基、降冰片基為特佳,以金剛烷基為最佳。 Among them, the cyclic aliphatic hydrocarbon group in R'201 is preferably a group obtained by removing one or more hydrogen atoms from a monocyclic alkane or a polycyclic alkane, more preferably a group obtained by removing one hydrogen atom from a polycyclic alkane, particularly preferably an adamantyl group and a norbornyl group, and most preferably an adamantyl group.

可鍵結於脂環式烴基之直鏈狀或分支鏈狀脂肪族烴基,以碳原子數1~10者為佳,以碳原子數1~6為較佳,以碳原子數1~4為更佳,以碳原子數1~3為特佳。 作為直鏈狀脂肪族烴基,以直鏈狀伸烷基為佳,具體可舉出亞甲基[-CH 2-]、伸乙基[-(CH 2) 2-]、三亞甲基    [-(CH 2) 3-]、四亞甲基[-(CH 2) 4-]、五亞甲基[-(CH 2) 5-]等。 作為分支鏈狀脂肪族烴基,以分支鏈狀伸烷基為佳,具體可舉出-CH(CH 3)-、-CH(CH 2CH 3)-、-C(CH 3) 2-、    -C(CH 3)(CH 2CH 3)-、-C(CH 3)(CH 2CH 2CH 3)-、-C(CH 2CH 3) 2-等烷基亞甲基;-CH(CH 3)CH 2-、-CH(CH 3)CH(CH 3)-、   -C(CH 3) 2CH 2-、-CH(CH 2CH 3)CH 2-、-C(CH 2CH 3) 2-CH 2-等烷基伸乙基;-CH(CH 3)CH 2CH 2-、-CH 2CH(CH 3)CH 2-等烷基三亞甲基;-CH(CH 3)CH 2CH 2CH 2-、-CH 2CH(CH 3)CH 2CH 2-等烷基四亞甲基等烷基伸烷基等。作為烷基伸烷基中之烷基,以碳原子數1~5的直鏈狀烷基為佳。 The linear or branched aliphatic alkyl group which can be bonded to the alicyclic alkyl group preferably has 1 to 10 carbon atoms, more preferably 1 to 6 carbon atoms, more preferably 1 to 4 carbon atoms, and particularly preferably 1 to 3 carbon atoms. The linear aliphatic alkyl group is preferably a linear alkylene group, and specific examples thereof include methylene [-CH 2 -], ethylene [-(CH 2 ) 2 -], trimethylene [-(CH 2 ) 3 -], tetramethylene [-(CH 2 ) 4 -], and pentamethylene [-(CH 2 ) 5 -]. The branched chain aliphatic hydrocarbon group is preferably a branched chain alkylene group, and specific examples thereof include -CH(CH 3 )-, -CH(CH 2 CH 3 )-, -C(CH 3 ) 2 -, -C(CH 3 )(CH 2 CH 3 )-, -C(CH 3 )(CH 2 CH 2 CH 3 )-, -C(CH 2 CH 3 ) 2 - and the like alkylmethylene groups; -CH(CH 3 )CH 2 -, -CH(CH 3 )CH(CH 3 )-, -C(CH 3 ) 2 CH 2 -, -CH(CH 2 CH 3 )CH 2 -, -C(CH 2 CH 3 ) 2 - and the like alkylethylene groups; -CH(CH 3 )CH 2 -, -CH(CH 3 )CH(CH 3 )-, -C(CH 3 ) 2 CH 2 -, -CH(CH 2 CH 3 )CH 2 -, -C(CH 2 CH 3 ) 2 -CH 2 - and the like alkylethylene groups; -CH(CH 3 )CH 2 CH 2 -, -CH 2 CH(CH 3 )CH 2 -, alkyltrimethylene, -CH(CH 3 )CH 2 CH 2 -, -CH 2 CH(CH 3 )CH 2 CH 2 -, alkyltetramethylene, etc. , alkylalkylene, etc. The alkyl in the alkylalkylene is preferably a linear alkyl having 1 to 5 carbon atoms.

又,R’ 201中之環狀烴基亦可含有如雜環等之雜原子。具體可舉出前述一般式(a2-r-1)~(a2-r-8)各表示的含有內酯的環式基、後述一般式(b5-r-1)~(b5-r-4)各表示的含有-SO 2-的環式基、其他後述化學式(r-hr-1)~(r-hr-16)各表示的雜環式基。 Furthermore, the cyclic hydrocarbon group in R'201 may also contain heteroatoms such as heterocyclic atoms. Specific examples include lactone-containing cyclic groups represented by the aforementioned general formulas (a2-r-1) to (a2-r-8), -SO 2 -containing cyclic groups represented by the following general formulas (b5-r-1) to (b5-r-4), and heterocyclic groups represented by the following chemical formulas (r-hr-1) to (r-hr-16).

作為R’ 201的環式基中之取代基,例如可舉出烷基、烷氧基、鹵素原子、鹵化烷基、羥基、羰基、硝基等。 作為取代基的烷基,以碳原子數1~5的烷基為佳,以甲基、乙基、丙基、n-丁基、tert-丁基為最佳。 作為取代基的烷氧基,以碳原子數1~5的烷氧基為佳,以甲氧基、乙氧基、n-丙氧基、iso-丙氧基、n-丁氧基、tert-丁氧基為較佳,以甲氧基、乙氧基為最佳。 作為取代基的鹵素原子,以氟原子為佳。 作為取代基的鹵化烷基,可舉出碳原子數1~5的烷基,例如可舉出甲基、乙基、丙基、n-丁基、tert-丁基等氫原子的一部分或全部由前述鹵素原子所取代的基。 作為取代基的羰基為取代構成環狀烴基之亞甲基   (-CH 2-)的基。 As the substituent in the cyclic group of R'201 , for example, there can be mentioned an alkyl group, an alkoxy group, a halogen atom, a halogenated alkyl group, a hydroxyl group, a carbonyl group, a nitro group, etc. As the alkyl group as the substituent, an alkyl group having 1 to 5 carbon atoms is preferred, and a methyl group, an ethyl group, a propyl group, an n-butyl group, and a tert-butyl group are the most preferred. As the alkoxy group as the substituent, an alkoxy group having 1 to 5 carbon atoms is preferred, and a methoxy group, an ethoxy group, an n-propoxy group, an iso-propoxy group, an n-butoxy group, and a tert-butoxy group are more preferred, and a methoxy group and an ethoxy group are the most preferred. As the halogen atom as the substituent, a fluorine atom is preferred. Examples of the halogenated alkyl group as a substituent include alkyl groups having 1 to 5 carbon atoms, such as methyl, ethyl, propyl, n-butyl, tert-butyl, etc., in which a part or all of the hydrogen atoms are replaced by the above-mentioned halogen atoms. The carbonyl group as a substituent is a group replacing the methylene group ( -CH2- ) constituting the cyclic hydrocarbon group.

可具有取代基的鏈狀烷基: 作為R’ 201的鏈狀烷基,亦可為直鏈狀或分支鏈狀中任一者。 作為直鏈狀烷基,以碳原子數1~20者為佳,以碳原子數1~15者為較佳,以碳原子數1~10為最佳。 作為分支鏈狀烷基,以碳原子數3~20者為佳,以碳原子數3~15者為較佳,以碳原子數3~10為最佳。具體例如可舉出1-甲基乙基、1-甲基丙基、2-甲基丙基、1-甲基丁基、2-甲基丁基、3-甲基丁基、1-乙基丁基、2-乙基丁基、1-甲基戊基、2-甲基戊基、3-甲基戊基、4-甲基戊基等。 Chain alkyl groups which may have a substituent: The chain alkyl group as R'201 may be either a straight chain or a branched chain. As a straight chain alkyl group, the number of carbon atoms is preferably 1 to 20, more preferably 1 to 15, and most preferably 1 to 10. As a branched chain alkyl group, the number of carbon atoms is preferably 3 to 20, more preferably 3 to 15, and most preferably 3 to 10. Specific examples include 1-methylethyl, 1-methylpropyl, 2-methylpropyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, and the like.

可具有取代基的鏈狀烯基: 作為R’ 201的鏈狀烯基,亦可為直鏈狀或分支鏈狀中任一者,以碳原子數2~10者為佳,以碳原子數2~5為較佳,以碳原子數2~4為更佳,以碳原子數3為特佳。作為直鏈狀烯基,例如可舉出乙烯基、丙烯基(烯丙基)、丁炔基等。作為分支鏈狀烯基,例如可舉出1-甲基乙烯基、2-甲基乙烯基、1-甲基丙烯基、2-甲基丙烯基等。 作為鏈狀烯基,上述中亦以直鏈狀烯基為佳,以乙烯基、丙烯基為較佳,以乙烯基為特佳。 Chain alkenyl groups which may have a substituent: The chain alkenyl group as R'201 may be either a straight chain or a branched chain, preferably having 2 to 10 carbon atoms, more preferably 2 to 5 carbon atoms, more preferably 2 to 4 carbon atoms, and particularly preferably 3 carbon atoms. Examples of straight chain alkenyl groups include vinyl, propenyl (allyl), butynyl, etc. Examples of branched chain alkenyl groups include 1-methylvinyl, 2-methylvinyl, 1-methylpropenyl, 2-methylpropenyl, etc. Among the above, straight chain alkenyl groups are also preferred, vinyl and propenyl are preferred, and vinyl is particularly preferred.

作為R’ 201的鏈狀烷基或烯基中之取代基,例如可舉出烷氧基、鹵素原子、鹵化烷基、羥基、羰基、硝基、胺基、上述R’ 201中之環式基等。 Examples of the substituent in the chain alkyl or alkenyl group of R'201 include an alkoxy group, a halogen atom, a halogenated alkyl group, a hydroxyl group, a carbonyl group, a nitro group, an amino group, and the cyclic group in the above R'201 .

R’ 201的可具有取代基的環式基、可具有取代基的鏈狀烷基,或可具有取代基的鏈狀烯基如上述者以外,作為可具有取代基的環式基或可具有取代基的鏈狀烷基,亦可舉出與上述式(a1-r-2)所示酸解離性基之相同者。 In addition to the cyclic group which may have a substituent, the chain alkyl group which may have a substituent, or the chain alkenyl group which may have a substituent as represented by R'201 , the cyclic group which may have a substituent or the chain alkyl group which may have a substituent may also be the same as the acid-liquidable group represented by the above formula (a1-r-2).

其中,R’ 201亦以可具有取代基的環式基為佳,以可具有取代基的環狀烴基者為較佳。更具體,例如以自苯基、萘基、聚環烷烴除去1個以上氫原子之基;前述一般式(a2-r-1)~(a2-r-8)各表示的含有內酯的環式基;後述一般式(b5-r-1)~(b5-r-4)各表示的含有-SO 2-的環式基等為佳。 Among them, R'201 is also preferably a cyclic group which may have a substituent, and more preferably a cyclic hydrocarbon group which may have a substituent. More specifically, for example, a group obtained by removing one or more hydrogen atoms from a phenyl group, a naphthyl group, or a polycycloalkane; a cyclic group containing lactone represented by the aforementioned general formulas (a2-r-1) to (a2-r-8); and a cyclic group containing -SO2- represented by the following general formulas (b5-r-1) to (b5-r-4).

上述一般式(ca-1)~(ca-3)中,R 201~R 203、R 206~R 207為彼此鍵結與式中之硫原子共同形成環之情況時,亦可隔著硫原子、氧原子、氮原子等雜原子,或羰基、-SO-、-SO 2-、-SO 3-、-COO-、-CONH-或-N(R N)-(該R N為碳原子數1~5的烷基。)等官能基而鍵結。作為所形成的環,將式中之硫原子含於該環骨架的1個環含有硫原子之3~10員環者為佳,以5~7員環者為特佳。作為所形成的環之具體例子,例如可舉出噻吩環、噻唑環、苯並噻吩環、二苯並噻吩環、9H-噻噸環、噻噸酮環、噻蒽(thianthrene)環、苯氧乙醇(phenoxathiin)環、四氫噻吩鎓環、四氫硫吡喃鎓環等。 In the above general formulas (ca-1) to (ca-3), when R201 to R203 and R206 to R207 are bonded to each other and to form a ring together with the sulfur atom in the formula, they may be bonded via a sulfur atom, an oxygen atom, a nitrogen atom or other heteroatom, or a carbonyl group, -SO-, -SO2- , -SO3- , -COO-, -CONH- or -N( RN )- (wherein RN is an alkyl group having 1 to 5 carbon atoms). The ring formed is preferably a 3- to 10-membered ring containing the sulfur atom in one ring of the ring skeleton, and particularly preferably a 5- to 7-membered ring. Specific examples of the ring formed include a thiophene ring, a thiazole ring, a benzothiophene ring, a dibenzothiophene ring, a 9H-thiadone ring, a thiadone ring, a thianthrene ring, a phenoxathiin ring, a tetrahydrothiophenium ring, and a tetrahydrothiopyranium ring.

R 208~R 209各獨立表示氫原子或碳原子數1~5的烷基,以氫原子或碳原子數1~3的烷基為佳,成為烷基之情況時,亦可彼此鍵結形成環。 R 208 to R 209 each independently represent a hydrogen atom or an alkyl group having 1 to 5 carbon atoms, preferably a hydrogen atom or an alkyl group having 1 to 3 carbon atoms. When they are alkyl groups, they may be bonded to each other to form a ring.

R 210為可具有取代基的芳基、可具有取代基的烷基、可具有取代基的烯基,或可具有取代基的含有-SO 2-的環式基。 作為R 210中之芳基,可舉出碳原子數6~20的無取代之芳基,以苯基、萘基為佳。 作為R 210中之烷基,其為鏈狀或環狀烷基,以碳原子數1~30者為佳。 作為R 210中之烯基,以碳原子數2~10者為佳。 作為R 210中之含有-SO 2-的環式基,雖無特別限定,可使用任意者。具體可舉出下述一般式(b5-r-1)~(b5-r-4)各表示的基,以「含有-SO 2-的多環式基」為佳,以一般式(b5-r-1)所示基為較佳。 R 210 is an aryl group which may have a substituent, an alkyl group which may have a substituent, an alkenyl group which may have a substituent, or a cyclic group containing -SO 2 - which may have a substituent. As the aryl group in R 210 , there can be mentioned an unsubstituted aryl group having 6 to 20 carbon atoms, preferably a phenyl group and a naphthyl group. As the alkyl group in R 210 , it is a chain or cyclic alkyl group, preferably having 1 to 30 carbon atoms. As the alkenyl group in R 210 , it is preferably having 2 to 10 carbon atoms. As the cyclic group containing -SO 2 - in R 210 , there is no particular limitation, and any one can be used. Specifically, the groups represented by the following general formulae (b5-r-1) to (b5-r-4) are mentioned, and "polycyclic groups containing -SO 2 -" are preferred, and the group represented by general formula (b5-r-1) is more preferred.

[式中,Rb’ 51各獨立為氫原子、烷基、烷氧基、鹵素原子、鹵化烷基、羥基、-COOR”、-OC(=O)R”、羥基烷基或氰基;R”為氫原子、烷基、含有內酯的環式基或含有   -SO 2-的環式基;B”可含有氧原子或者硫原子的碳原子數1~5的伸烷基、氧原子或硫原子,n’表示0~2的整數。*表示鍵結位置。] [In the formula, Rb' 51 are each independently a hydrogen atom, an alkyl group, an alkoxy group, a halogen atom, a halogenated alkyl group, a hydroxyl group, -COOR", -OC(=O)R", a hydroxyl alkyl group or a cyano group; R" is a hydrogen atom, an alkyl group, a cyclic group containing a lactone or a cyclic group containing -SO2- ; B" is an alkylene group having 1 to 5 carbon atoms, an oxygen atom or a sulfur atom, and n' represents an integer of 0 to 2. * represents a bonding position.]

前述一般式(b5-r-1)~(b5-r-2)中,B”為可含有氧原子或者硫原子之碳原子數1~5的伸烷基、氧原子或硫原子。 作為B”,以碳原子數1~5的伸烷基或-O-為佳,以碳原子數1~5的伸烷基為較佳,以亞甲基為更佳。 In the above general formulas (b5-r-1) to (b5-r-2), B" is an alkylene group having 1 to 5 carbon atoms, an oxygen atom or a sulfur atom which may contain an oxygen atom or a sulfur atom. As B", an alkylene group having 1 to 5 carbon atoms or -O- is preferred, an alkylene group having 1 to 5 carbon atoms is more preferred, and a methylene group is more preferred.

前述一般式(b5-r-1)~(b5-r-4)中,Rb’ 51各獨立為氫原子、烷基、烷氧基、鹵素原子、鹵化烷基、羥基、-COOR”、-OC(=O)R”、羥基烷基或氰基,其中各獨立以氫原子或氰基者為佳。 In the aforementioned general formulas (b5-r-1) to (b5-r-4), Rb' 51 each independently represents a hydrogen atom, an alkyl group, an alkoxy group, a halogen atom, a halogenated alkyl group, a hydroxyl group, -COOR", -OC(=O)R", a hydroxyalkyl group or a cyano group, wherein each independently represents a hydrogen atom or a cyano group is preferred.

可舉出下述一般式(b5-r-1)~(b5-r-4)各表示的基之具體例子。式中之「Ac」表示乙醯基。Specific examples of the groups represented by the following general formulae (b5-r-1) to (b5-r-4) can be cited: "Ac" in the formulae represents an acetyl group.

作為前述式(ca-1)所示為較佳陽離子,具體可舉出下述化學式各表示的陽離子。As preferred cations represented by the above formula (ca-1), specifically, there can be mentioned cations represented by the following chemical formulas.

[式中,g1、g2、g3表示重複數,g1為1~5的整數,g2為0~20的整數,g3為0~20的整數。] [In the formula, g1, g2, and g3 represent repetition numbers, g1 is an integer from 1 to 5, g2 is an integer from 0 to 20, and g3 is an integer from 0 to 20.]

[式中,R” 201為氫原子或取代基,作為該取代基,可舉出與作為前述R 201~R 207及R 210~R 212可具有的取代基而舉出的相同者。] [In the formula, R" 201 is a hydrogen atom or a substituent, and examples of the substituent include the same substituents as those mentioned above as the substituents which R201 to R207 and R210 to R212 may have.]

作為前述式(ca-2)所示為較佳陽離子,具體可舉出二苯基碘鎓陽離子、雙(4-tert-丁基苯基)碘鎓陽離子等。Specific examples of the preferred cation represented by the above formula (ca-2) include diphenyliodonium cation and bis(4-tert-butylphenyl)iodonium cation.

作為前述式(ca-3)所示為較佳陽離子,具體可舉出下述式(ca-3-1)~(ca-3-6)各表示的陽離子。Specific examples of preferred cations represented by the above formula (ca-3) include cations represented by the following formulas (ca-3-1) to (ca-3-6).

作為M m+的有機陽離子,以選自由前述一般式(ca-1)~(ca-3)各表示的陽離子所成群的至少一種為佳,此等中亦以前述一般式(ca-1)所示陽離子為較佳。 特別由高感度化之點來看,作為前述式(ca-1)所示為較佳陽離子,作為取代基,以具有氟原子、氟化烷基、磺醯基等電子求引性基者為佳,例如以選自由上述化學式(ca-1-44)、(ca-1-71)~(ca-1-84)各表示的陽離子所成群的陽離子特佳。 As the organic cation for M m+ , at least one selected from the group consisting of cations represented by the aforementioned general formulas (ca-1) to (ca-3) is preferred, and among these, the cation represented by the aforementioned general formula (ca-1) is also preferred. In particular, from the viewpoint of high sensitivity, the cation represented by the aforementioned formula (ca-1) is preferred, and as a substituent, it is preferred to have an electron-withdrawing group such as a fluorine atom, a fluorinated alkyl group, a sulfonyl group, etc. For example, a cation selected from the group consisting of cations represented by the aforementioned chemical formulas (ca-1-44), (ca-1-71) to (ca-1-84) is particularly preferred.

以下舉出(B0)成分之具體例子,但限定於此等。Specific examples of the component (B0) are given below, but are not limited to these.

(B0)成分在上述中,亦以選自由上述化學式(B0-1)~(B0-29)各表示的化合物所成群者為佳。 或者(B0)成分在上述中,亦以選自由上述化學式(B0-1)~(B0-12)各表示的化合物所成群者、選自由上述化學式(B0-13)~(B0-18)各表示的化合物所成群者,或選自由上述化學式(B0-19)~(B0-29)各表示的化合物所成群者為佳。此等中,(B0)成分亦以選自由上述化學式(B0-19)~(B0-29)各表示的化合物所成群者為較佳。 The component (B0) in the above is preferably selected from the group consisting of compounds represented by the above chemical formulas (B0-1) to (B0-29). Or the component (B0) in the above is preferably selected from the group consisting of compounds represented by the above chemical formulas (B0-1) to (B0-12), selected from the group consisting of compounds represented by the above chemical formulas (B0-13) to (B0-18), or selected from the group consisting of compounds represented by the above chemical formulas (B0-19) to (B0-29). Among these, the component (B0) is preferably selected from the group consisting of compounds represented by the above chemical formulas (B0-19) to (B0-29).

本實施形態之阻劑組成物中,(B0)成分可為單獨1種,亦可併用2種以上。 本實施形態之阻劑組成物中,(B0)成分的含有量相對於(A)成分100質量份,以5~50質量份者為佳,以10~40質量份者為較佳,以20~35質量份者為更佳。 (B0)成分之含有量若為前述為較佳範圍之下限值以上時,對於阻劑圖型形成,可達成高感度化,且變得容易提高CDU及微細解像性等光刻特性。另一方面,若為前述為較佳範圍的上限值以下時,可良好地維持感度。又,將阻劑組成物之各成分溶解於有機溶劑時,容易得到均勻溶液,因作為阻劑組成物的保存安定性變得良好故為較佳。 In the resist composition of the present embodiment, the component (B0) may be a single type or two or more types may be used in combination. In the resist composition of the present embodiment, the content of the component (B0) is preferably 5 to 50 parts by mass, more preferably 10 to 40 parts by mass, and even more preferably 20 to 35 parts by mass relative to 100 parts by mass of the component (A). If the content of the component (B0) is above the lower limit of the above-mentioned preferred range, high sensitivity can be achieved for resist pattern formation, and it becomes easy to improve lithography characteristics such as CDU and fine resolution. On the other hand, if it is below the upper limit of the above-mentioned preferred range, the sensitivity can be well maintained. In addition, when the components of the resist composition are dissolved in an organic solvent, a uniform solution can be easily obtained, which is preferred because the storage stability of the resist composition is improved.

(B)成分全體之中,(B0)成分之比例,例如為50質量%以上,以70質量%以上為佳,為更佳為95質量%以上。(B)成分全體中之(B0)成分的比例亦可為100質量%。The proportion of the component (B0) in the total amount of the component (B) is, for example, 50% by mass or more, preferably 70% by mass or more, and more preferably 95% by mass or more. The proportion of the component (B0) in the total amount of the component (B) may also be 100% by mass.

・對於(B1)成分 作為本實施形態的阻劑組成物中之(B)成分,亦可含有上述(B0)成分以外的酸產生劑成分(以下亦稱為「(B1)成分」)。 作為(B1)成分,並無特別限定,可使用至今作為化學增幅型阻劑組成物用之酸產生劑而被提案者。 作為如此酸產生劑,可舉出碘鎓鹽或硫鎓鹽等鎓鹽系酸產生劑、肟磺酸鹽系酸產生劑;雙烷基或雙芳基磺醯基重氮甲烷類、聚(雙磺醯基)重氮甲烷類等重氮甲烷系酸產生劑;硝基苯甲基磺酸鹽系酸產生劑、亞胺磺酸鹽系酸產生劑、二碸系酸產生劑等多種者。 ・Regarding component (B1) The component (B) in the resistor composition of this embodiment may contain an acid generator component other than the above-mentioned component (B0) (hereinafter also referred to as "component (B1)"). The component (B1) is not particularly limited, and any acid generator proposed as a chemically amplified resistor composition can be used. As such acid generators, there can be cited onium salt acid generators such as iodonium salts or sulfonium salts, oxime sulfonate acid generators; diazomethane acid generators such as dialkyl or diaryl sulfonyl diazomethanes and poly (disulfonyl) diazomethanes; nitrobenzene sulfonate acid generators, imine sulfonate acid generators, disulfonate acid generators, and the like.

本實施形態之阻劑組成物中,(B1)成分可單獨使用1種,亦可併用2種以上。 本實施形態之阻劑組成物含有(B1)成分之情況時,(B)成分全體中,(B1)成分之比例以未達50質量%者為佳,以40質量%以下為較佳,以30質量%以下為更佳,以未達20質量%為特佳。 In the inhibitor composition of this embodiment, the (B1) component may be used alone or in combination of two or more. When the inhibitor composition of this embodiment contains the (B1) component, the proportion of the (B1) component in the total (B) component is preferably less than 50% by mass, more preferably less than 40% by mass, more preferably less than 30% by mass, and particularly preferably less than 20% by mass.

<其他成分> 本實施形態之阻劑組成物除上述(A)成分及(B)成分以外,亦可進一步含有其他成分。作為其他成分,例如可舉出以下所示的(D)成分、(E)成分、(F)成分、(S)成分等。 ≪鹼成分(D)≫ 本實施形態之阻劑組成物除含有(A)成分及(B)成分以外,亦可含有捕捉藉由曝光而產生的酸(即,控制酸之擴散)的鹼成分((D)成分)。(D)成分為作為阻劑組成物中捕捉藉由曝光而產生的酸之淬滅劑(酸擴散控制劑)而作用者。 作為(D)成分,例如可舉出藉由曝光進行分解而失去酸擴散控制性的光崩壞性鹼(D1)(以下亦稱為「(D1)成分」。)、非相當於該(D1)成分之含氮有機化合物(D2)(以下亦稱為「(D2)成分」。)等。此等中亦由高感度化、粗糙度減低、塗布缺陷產生之抑制的特性皆容易提高之觀念來看,以光崩壞性鹼((D1)成分)為佳。作為後述(D1)成分所例示的化合物亦有藉由與其他化合物之組合而作為上述酸產生劑成分((B)成分)使用的情況。 <Other components> The resist composition of this embodiment may further contain other components in addition to the above-mentioned (A) component and (B) component. Examples of other components include the following components (D), (E), (F), and (S). ≪Alkaline component (D)≫ The resist composition of this embodiment may contain, in addition to the (A) component and (B) component, an alkaline component (component (D)) that captures the acid generated by exposure (i.e., controls the diffusion of the acid). The (D) component acts as a quencher (acid diffusion controller) in the resist composition that captures the acid generated by exposure. As the (D) component, for example, a photodisintegration base (D1) (hereinafter also referred to as "(D1) component") that loses acid diffusion control due to decomposition by exposure, a nitrogen-containing organic compound (D2) (hereinafter also referred to as "(D2) component") that is not equivalent to the (D1) component, etc. Among these, the photodisintegration base ((D1) component) is preferred because the properties of high sensitivity, reduced roughness, and suppression of coating defects are easily improved. The compounds exemplified as the (D1) component described later may also be used as the above-mentioned acid generator component ((B) component) by combining with other compounds.

・對於(D1)成分 作為(D1)成分,若為藉由曝光分解進而失去酸擴散控制性者即可並無特別限定,以選自由下述一般式(d1-1)所示化合物(以下亦稱為「(d1-1)成分」。)、下述一般式(d1-2)所示化合物(以下亦稱為「(d1-2)成分」。)及下述一般式(d1-3)所示化合物(以下亦稱為「(d1-3)成分」。)所成群的1種以上之化合物為佳。 (d1-1)~(d1-3)成分因在阻劑膜之曝光部中進行分解而失去酸擴散控制性(鹼性),故無法作為淬滅劑而發揮其作用,而在阻劑膜之未曝光部中作為淬滅劑而發揮其作用。 ・ Regarding component (D1) Component (D1) is not particularly limited as long as it loses its acid diffusion control property by decomposition due to exposure, and is preferably selected from the group consisting of one or more compounds represented by the following general formula (d1-1) (hereinafter also referred to as "component (d1-1)"), compounds represented by the following general formula (d1-2) (hereinafter also referred to as "component (d1-2)"), and compounds represented by the following general formula (d1-3) (hereinafter also referred to as "component (d1-3)"). Components (d1-1) to (d1-3) lose their acid diffusion control property (alkalinity) by decomposition in the exposed part of the resist film, and therefore cannot function as a quencher, but function as a quencher in the unexposed part of the resist film.

[式中,Rd 1~Rd 4為可具有取代基的環式基、可具有取代基的鏈狀烷基,或可具有取代基的鏈狀烯基。但,式(d1-2)中設定為Rd 2中之鄰接S原子之碳原子上未鍵結氟原子者。Yd 1為單鍵或2價連結基。m為1以上的整數,M m+各獨立為m價有機陽離子。] [In the formula, Rd1 to Rd4 are cyclic groups which may have substituents, chain alkyl groups which may have substituents, or chain alkenyl groups which may have substituents. However, in formula (d1-2), Rd2 is assumed to be a group in which the carbon atom adjacent to the S atom is not bonded to a fluorine atom. Yd1 is a single bond or a divalent linking group. m is an integer greater than 1, and Mm+ is independently an m-valent organic cation.]

{(d1-1)成分} ・・負離子部 式(d1-1)中,Rd 1為可具有取代基的環式基、可具有取代基的鏈狀烷基,或可具有取代基的鏈狀烯基,可舉出與各前述R’ 201之相同者。 此等中,作為Rd 1,以可具有取代基的芳香族烴基、可具有取代基的脂肪族環式基,或可具有取代基的鏈狀烷基為佳。作為可具有此等基的取代基,可舉出羥基、氧代基、烷基、芳基、氟原子、氟化烷基、上述一般式(a2-r-1)~(a2-r-8)各表示的含有內酯的環式基、醚鍵、酯鍵,或此等組合。將醚鍵或酯鍵作為取代基而含有之情況時,可隔著伸烷基,作為該情況的取代基,以上述式(y-al-1)~(y-al-5)各表示的連結基為佳。且,Rd 1中之芳香族烴基、脂肪族環式基或鏈狀烷基中具有取代基之上述一般式(y-al-1)~(y-al-7)各表示的連結基之情況時,上述一般式(y-al-1)~(y-al-7)中,式(d3-1)中Rd 1中之構成芳香族烴基、脂肪族環式基或鏈狀烷基之碳原子所鍵結者為上述一般式(y-al-1)~(y-al-7)中之V’ 101。 作為前述芳香族烴基,較佳可舉出苯基、萘基、含有聯環辛烷骨架之多環結構(由聯環辛烷骨架與此以外的環結構所成的多環結構)。 作為前述脂肪族環式基,以自金剛烷、降冰片烷、異冰片、三環癸烷、四環十二烷等聚環烷烴除去1個以上氫原子之基者為較佳。 作為前述鏈狀烷基,以碳原子數1~10者為佳,具體可舉出甲基、乙基、丙基、丁基、戊基、己基、庚基、辛基、壬基、癸基等直鏈狀烷基;1-甲基乙基、1-甲基丙基、2-甲基丙基、1-甲基丁基、2-甲基丁基、3-甲基丁基、1-乙基丁基、2-乙基丁基、1-甲基戊基、2-甲基戊基、3-甲基戊基、4-甲基戊基等分支鏈狀烷基。 {(d1-1) component} ・・In the negative ion part formula (d1-1), Rd 1 is a cyclic group which may have a substituent, a chain alkyl group which may have a substituent, or a chain alkenyl group which may have a substituent, and examples thereof include the same ones as those for each of the above R' 201. Among these, Rd 1 is preferably an aromatic hydrocarbon group which may have a substituent, an aliphatic cyclic group which may have a substituent, or a chain alkyl group which may have a substituent. Examples of the substituent which may have these groups include a hydroxyl group, an oxo group, an alkyl group, an aryl group, a fluorine atom, a fluorinated alkyl group, a lactone-containing cyclic group represented by each of the above general formulas (a2-r-1) to (a2-r-8), an ether bond, an ester bond, or a combination thereof. When an ether bond or ester bond is contained as a substituent, an alkylene group may be interposed therebetween, and in this case, the substituent is preferably a linking group represented by each of the above formulae (y-al-1) to (y-al-5). Furthermore, when the aromatic alkyl group, aliphatic cyclic group or chain alkyl group in Rd1 has a substituent in the linking group represented by each of the above general formulae (y-al-1) to (y-al-7), in the above general formulae (y-al-1) to (y-al-7), the carbon atom constituting the aromatic alkyl group, aliphatic cyclic group or chain alkyl group in Rd1 in formula (d3-1) is bonded to V'101 in the above general formulae (y-al-1) to (y-al-7). Preferred examples of the aromatic hydrocarbon group include phenyl, naphthyl, and a polycyclic structure containing a bicyclic octane skeleton (a polycyclic structure consisting of a bicyclic octane skeleton and a cyclic structure other than the bicyclic octane skeleton). Preferred examples of the aliphatic cyclic group include a group obtained by removing one or more hydrogen atoms from a polycycloalkane such as adamantane, norbornane, isoborneol, tricyclodecane, tetracyclododecane, etc. The aforementioned chain alkyl group preferably has 1 to 10 carbon atoms, and specific examples include straight chain alkyl groups such as methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, and decyl; and branched chain alkyl groups such as 1-methylethyl, 1-methylpropyl, 2-methylpropyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, and 4-methylpentyl.

前述鏈狀烷基具有作為取代基之氟原子或氟化烷基的氟化烷基之情況時,氟化烷基之碳原子數以1~11為佳,以1~8為較佳,以1~4為更佳。該氟化烷基可含有氟原子以外之原子。作為氟原子以外的原子,例如可舉出氧原子、硫原子、氮原子等。When the chain alkyl group has a fluorine atom or a fluorinated alkyl group as a substituent, the number of carbon atoms of the fluorinated alkyl group is preferably 1 to 11, more preferably 1 to 8, and more preferably 1 to 4. The fluorinated alkyl group may contain atoms other than fluorine atoms. Examples of atoms other than fluorine atoms include oxygen atoms, sulfur atoms, and nitrogen atoms.

以下例示出(d1-1)成分之負離子部的較佳具體例子。Preferred specific examples of the negative ion part of the component (d1-1) are shown below.

・・陽離子部 式(d1-1)中,M m+為m價有機陽離子。 作為M m+之有機陽離子,較佳可舉出與前述一般式(ca-1)~(ca-3)各表示的陽離子之相同者,以前述一般式(ca-1)所示陽離子為較佳,以前述式(ca-1-1)~(ca-1-84)各表示的陽離子為更佳。 (d1-1)成分可單獨使用1種,亦可組合2種以上而使用。 ・・In the cation part formula (d1-1), M m+ is an m-valent organic cation. As the organic cation of M m+ , preferably, there can be cited the same cations as those represented by the aforementioned general formulas (ca-1) to (ca-3), preferably the cation represented by the aforementioned general formula (ca-1), and more preferably the cations represented by the aforementioned formulas (ca-1-1) to (ca-1-84). The component (d1-1) may be used alone or in combination of two or more.

{(d1-2)成分} ・・負離子部 式(d1-2)中,Rd 2為可具有取代基的環式基、可具有取代基的鏈狀烷基,或可具有取代基的鏈狀烯基,可舉出與前述R’ 201之相同者。 但,Rd 2中,設定為於鄰接S原子的碳原子上未鍵結氟原子(未經氟取代)者。藉此,(d1-2)成分之負離子變成適度弱酸負離子,提高作為(D)成分之淬火。 作為Rd 2,以可具有取代基的鏈狀烷基,或可具有取代基的脂肪族環式基者為佳,以可具有取代基的脂肪族環式基者為較佳。 {(d1-2) component} ・・In the negative ion part formula (d1-2), Rd 2 is a cyclic group which may have a substituent, a chain alkyl group which may have a substituent, or a chain alkenyl group which may have a substituent, and the same ones as those for the above-mentioned R' 201 can be cited. However, in Rd 2 , a fluorine atom is not bonded to the carbon atom adjacent to the S atom (not substituted by fluorine). Thereby, the negative ion of the component (d1-2) becomes a moderately weak acid negative ion, and the quenching property as the component (D) is improved. As Rd 2 , a chain alkyl group which may have a substituent, or an aliphatic cyclic group which may have a substituent is preferred, and an aliphatic cyclic group which may have a substituent is more preferred.

作為該鏈狀烷基,以碳原子數1~10者為佳,以3~10者為較佳。 作為該脂肪族環式基,以自金剛烷、降冰片烷、異冰片、三環癸烷、四環十二烷等除去1個以上氫原子的基(亦可具有取代基);自樟腦除去1個以上氫原子的基者為較佳。 The chain alkyl group preferably has 1 to 10 carbon atoms, and more preferably 3 to 10 carbon atoms. As the aliphatic cyclic group, a group obtained by removing one or more hydrogen atoms from adamantane, norbornane, isoborneol, tricyclodecane, tetracyclododecane, etc. (which may also have a substituent); a group obtained by removing one or more hydrogen atoms from camphor are preferred.

Rd 2的烴基亦可具有取代基,作為該取代基,可舉出與前述式(d1-1)的Rd 1中之烴基(芳香族烴基、脂肪族環式基、鏈狀烷基)所具有的取代基之相同者。 The alkyl group of Rd2 may have a substituent, and examples of the substituent include the same substituents as those possessed by the alkyl group (aromatic alkyl group, aliphatic cyclic group, chain alkyl group) in Rd1 of the aforementioned formula (d1-1).

以下表示(d1-2)成分的負離子部之較佳具體例子。Preferred specific examples of the negative ion part of the component (d1-2) are shown below.

・・陽離子部 式(d1-2)中,M m+為m價有機陽離子,與前述式(d1-1)中之M m+相同。 (d1-2)成分可單獨使用1種,亦可組合2種以上使用。 ・・In the cation part formula (d1-2), M m+ is an m-valent organic cation, which is the same as M m+ in the above formula (d1-1). The component (d1-2) may be used alone or in combination of two or more.

{(d1-3)成分} ・・負離子部 式(d1-3)中,Rd 3為可具有取代基的環式基、可具有取代基的鏈狀烷基,或可具有取代基的鏈狀烯基,可舉出與前述R’ 201之相同者,以含有氟原子之環式基、鏈狀烷基或鏈狀烯基者為佳。其中亦以氟化烷基為佳,以與前述Rd 1之氟化烷基的相同者為較佳。 {(d1-3) component} ・・In the negative ion part formula (d1-3), Rd 3 is a cyclic group which may have a substituent, a chain alkyl group which may have a substituent, or a chain alkenyl group which may have a substituent, and the same ones as those for R' 201 mentioned above can be cited, and a cyclic group, a chain alkyl group, or a chain alkenyl group containing a fluorine atom is preferred. Among them, a fluorinated alkyl group is also preferred, and the same ones as the fluorinated alkyl group for Rd 1 mentioned above are more preferred.

式(d1-3)中,Rd 4為可具有取代基的環式基、可具有取代基的鏈狀烷基,或可具有取代基的鏈狀烯基,可舉出與前述R’ 201之相同者。 其中亦以可具有取代基的烷基、烷氧基、烯基、環式基者為佳。 Rd 4中之烷基,以碳原子數1~5的直鏈狀或分支鏈狀烷基為佳,具體可舉出甲基、乙基、丙基、異丙基、n-丁基、異丁基、tert-丁基、戊基、異戊基、新戊基等。Rd 4的烷基之氫原子的一部分亦可由羥基、氰基等取代。 Rd 4中之烷氧基以碳原子數1~5的烷氧基為佳,作為碳原子數1~5的烷氧基,具體可舉出甲氧基、乙氧基、n-丙氧基、iso-丙氧基、n-丁氧基、tert-丁氧基。其中亦以甲氧基、乙氧基為佳。 In formula (d1-3), Rd4 is a cyclic group which may have a substituent, a chain alkyl group which may have a substituent, or a chain alkenyl group which may have a substituent, and examples thereof include the same as those for R'201 above. Among them, an alkyl group, an alkoxy group, an alkenyl group, or a cyclic group which may have a substituent is preferred. The alkyl group in Rd4 is preferably a linear or branched alkyl group having 1 to 5 carbon atoms, and specific examples thereof include methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, tert-butyl, pentyl, isopentyl, and neopentyl. A portion of the hydrogen atoms of the alkyl group in Rd4 may be substituted by a hydroxyl group, a cyano group, or the like. The alkoxy group in Rd 4 is preferably an alkoxy group having 1 to 5 carbon atoms, and specific examples of the alkoxy group having 1 to 5 carbon atoms include methoxy, ethoxy, n-propoxy, iso-propoxy, n-butoxy, and tert-butoxy. Among them, methoxy and ethoxy are preferred.

Rd 4中之烯基,可舉出與前述R’ 201中的烯基之相同者,以乙烯基、丙烯基(烯丙基)、1-甲基丙烯基、2-甲基丙烯基為佳。此等基進一步作為取代基,亦可具有碳原子數1~5的烷基或碳原子數1~5的鹵化烷基。 The alkenyl group in Rd4 may be the same as the alkenyl group in R'201 , preferably vinyl, propenyl (allyl), 1-methylpropenyl, 2-methylpropenyl. These groups may further have an alkyl group having 1 to 5 carbon atoms or a halogenated alkyl group having 1 to 5 carbon atoms as a substituent.

Rd 4中之環式基可舉出與前述R’ 201中之環式基的相同者,以自環戊烷、環己烷、金剛烷、降冰片烷、異冰片、三環癸烷、四環十二烷等環烷烴除去1個以上氫原子之脂環式基或苯基、萘基等芳香族基為佳。Rd 4為脂環式基之情況時,阻劑組成物藉由對於有機溶劑為良好溶解,可使光刻特性變得良好。又,Rd 4為芳香族基之情況時,將EUV等作為曝光光源之光刻中,該阻劑組成物的光吸收效率優異,且感度或光刻特性變得良好。 The cyclic group in Rd 4 may be the same as the cyclic group in R' 201 , preferably an alicyclic group obtained by removing one or more hydrogen atoms from a cycloalkane such as cyclopentane, cyclohexane, adamantane, norbornane, isoborneol, tricyclodecane, tetracyclododecane, or an aromatic group such as phenyl or naphthyl. When Rd 4 is an alicyclic group, the resist composition can be well soluble in an organic solvent, thereby improving the photolithography characteristics. Furthermore, when Rd 4 is an aromatic group, in photolithography using EUV or the like as an exposure light source, the light absorption efficiency of the resist composition is excellent, and the sensitivity or photolithography characteristics are improved.

式(d1-3)中,Yd 1為單鍵或2價連結基。 作為Yd 1中之2價連結基,雖無特別限定,可舉出可具有取代基的2價烴基(脂肪族烴基、芳香族烴基)、含有雜原子的2價連結基等。此等各可舉出與對於上述式(a2-1)中的Ya 21中之2價連結基之說明中所舉出的可具有取代基的2價烴基、含有雜原子的2價連結基之相同者。 作為Yd 1,以羰基、酯鍵、醯胺鍵、伸烷基或此等組合者為佳。作為伸烷基,以直鏈狀或分支鏈狀伸烷基者為較佳,以亞甲基或伸乙基者為更佳。 In formula (d1-3), Yd1 is a single bond or a divalent linking group. As the divalent linking group in Yd1 , there are no particular limitations, and examples thereof include a divalent alkyl group (aliphatic alkyl group, aromatic alkyl group) which may have a substituent, a divalent linking group containing a heteroatom, and the like. Examples of these include the same divalent alkyl group which may have a substituent and a divalent linking group containing a heteroatom as those mentioned in the description of the divalent linking group in Ya21 in formula (a2-1 ). Yd1 is preferably a carbonyl group, an ester bond, an amide bond, an alkylene group, or a combination thereof. As the alkylene group, a linear or branched alkylene group is preferred, and a methylene group or an ethylene group is more preferred.

以下表示(d1-3)成分之負離子部的較佳具體例子。Preferred specific examples of the negative ion part of the component (d1-3) are shown below.

・・陽離子部 式(d1-3)中,M m+為m價有機陽離子,與前述式(d1-1)中之M m+相同。 (d1-3)成分可單獨使用1種,亦可組合2種以上使用。 ・・In the cation part formula (d1-3), M m+ is an m-valent organic cation, which is the same as M m+ in the above formula (d1-1). The component (d1-3) may be used alone or in combination of two or more.

(D1)成分可僅使用上述(d1-1)~(d1-3)成分中任1種,亦可組合2種以上而使用。 阻劑組成物為含有(D1)成分之情況時,阻劑組成物中之(D1)成分的含有量相對於(A)成分100質量份而言,以0.5~15質量份為佳,以1~12質量份為較佳,以2~10質量份為更佳。 The component (D1) may be any one of the components (d1-1) to (d1-3) mentioned above, or may be used in combination of two or more. When the resist composition contains the component (D1), the content of the component (D1) in the resist composition is preferably 0.5 to 15 parts by mass, more preferably 1 to 12 parts by mass, and even more preferably 2 to 10 parts by mass relative to 100 parts by mass of the component (A).

(D1)成分以含有上述(d1-1)成分者為佳。 (D1)成分全體中,(d1-1)成分之含有量以50質量%以上者為佳,以70質量%以上者為較佳,以90質量%以上者為更佳,(D1)成分亦可僅由化合物(d1-1)成分所成者。 The component (D1) preferably contains the above-mentioned component (d1-1). The content of the component (d1-1) in the whole component (D1) is preferably 50% by mass or more, more preferably 70% by mass or more, and even more preferably 90% by mass or more. The component (D1) may also consist only of the compound (d1-1).

(D1)成分之製造方法: 前述(d1-1)成分、(d1-2)成分之製造方法並無特別限定,可藉由公知方法而製造。 又,(d1-3)成分之製造方法並無特別限定,例如可藉由與US2012-0149916號公報所記載的相同方法而製造。 (D1) Production method of component: The production method of the aforementioned components (d1-1) and (d1-2) is not particularly limited and can be produced by a known method. In addition, the production method of component (d1-3) is not particularly limited and can be produced, for example, by the same method as described in US2012-0149916.

・對於(D2)成分 作為(D)成分,亦可含有非相當於上述(D1)成分之含氮有機化合物成分(以下亦稱為「(D2)成分」。)。 作為(D2)成分,其為作為酸擴散控制劑而發揮作用者,且未相當於(D1)成分者即可並無特別限定,亦可使用任意選自公知者。其中,亦以脂肪族胺為佳,其中特別以第2級脂肪族胺或第3級脂肪族胺為佳。 所謂脂肪族胺表示具有1個以上之脂肪族基的胺,該脂肪族基以碳原子數1~12者為佳。 作為脂肪族胺,可舉出將氨NH 3的氫原子之至少1個由碳原子數12以下之烷基或者羥基烷基進行取代的胺(烷基胺或者烷基醇胺)或環式胺。 作為烷基胺及烷基醇胺之具體例子,可舉出n-己基胺、n-庚基胺、n-辛基胺、n-壬基胺、n-癸基胺等單烷基胺;二乙基胺、二-n-丙基胺、二-n-庚基胺、二-n-辛基胺、二環己基胺等二烷基胺;三甲基胺、三乙基胺、三-n-丙基胺、三-n-丁基胺、三-n-戊基胺、三-n-己基胺、三-n-庚基胺、三-n-辛基胺、三-n-壬基胺、三-n-癸基胺、三-n-十二烷基胺等三烷基胺;二乙醇胺、三乙醇胺、二異丙醇胺、三異丙醇胺、二-n-辛醇胺、三-n-辛醇胺等烷基醇胺。此等中亦以碳原子數6~30的三烷基胺為更佳,以三-n-戊基胺或三-n-辛基胺為特佳。 ・As for the component (D2), as the component (D), a nitrogen-containing organic compound component not equivalent to the above-mentioned component (D1) (hereinafter also referred to as "component (D2)" may be contained. The component (D2) is not particularly limited as long as it functions as an acid diffusion control agent and is not equivalent to the component (D1), and any known component may be used. Among them, aliphatic amines are also preferred, and secondary aliphatic amines or tertiary aliphatic amines are particularly preferred. The so-called aliphatic amine means an amine having one or more aliphatic groups, and the aliphatic group preferably has 1 to 12 carbon atoms. Examples of the aliphatic amine include amines (alkylamines or alkylolamines) or cyclic amines in which at least one hydrogen atom of ammonia NH 3 is substituted by an alkyl group or a hydroxyalkyl group having 12 or less carbon atoms. Specific examples of the alkylamines and alkylolamines include monoalkylamines such as n-hexylamine, n-heptylamine, n-octylamine, n-nonylamine, and n-decylamine; dialkylamines such as diethylamine, di-n-propylamine, di-n-heptylamine, di-n-octylamine, and dicyclohexylamine; trialkylamines such as trimethylamine, triethylamine, tri-n-propylamine, tri-n-butylamine, tri-n-pentylamine, tri-n-hexylamine, tri-n-heptylamine, tri-n-octylamine, tri-n-nonylamine, tri-n-decylamine, and tri-n-dodecylamine; and alkylolamines such as diethanolamine, triethanolamine, diisopropanolamine, triisopropanolamine, di-n-octanolamine, and tri-n-octanolamine. Among these, trialkylamines having 6 to 30 carbon atoms are more preferred, and tri-n-pentylamine or tri-n-octylamine is particularly preferred.

作為環式胺,例如舉出作為雜原子含有氮原子之雜環化合物。作為該雜環化合物,可為單環式者(脂肪族單環式胺),亦可為多環式者(脂肪族多環式胺)。 作為脂肪族單環式胺,具體可舉出哌啶、哌嗪等。 作為脂肪族多環式胺,以碳原子數6~10者為佳,具體可舉出1,5-二氮雜雙環[4.3.0]-5-壬烯、1,8-二氮雜雙環[5.4.0]-7-十一碳烯、六亞甲基四胺、1,4-二氮雜雙環[2.2.2]辛烷等。 Examples of cyclic amines include heterocyclic compounds containing nitrogen atoms as heteroatoms. The heterocyclic compounds may be monocyclic (aliphatic monocyclic amines) or polycyclic (aliphatic polycyclic amines). Specific examples of aliphatic monocyclic amines include piperidine and piperazine. Specific examples of aliphatic polycyclic amines include those having 6 to 10 carbon atoms, and specific examples include 1,5-diazabicyclo[4.3.0]-5-nonene, 1,8-diazabicyclo[5.4.0]-7-undecene, hexamethylenetetramine, and 1,4-diazabicyclo[2.2.2]octane.

作為其他脂肪族胺,可舉出參(2-甲氧基甲氧基乙基)胺、參{2-(2-甲氧基乙氧基)乙基}胺、參{2-(2-甲氧基乙氧基甲氧基)乙基}胺、參{2-(1-甲氧基乙氧基)乙基}胺、參{2-(1-乙氧基乙氧基)乙基}胺、參{2-(1-乙氧基丙氧基)乙基}胺、參[2-{2-(2-羥基乙氧基)乙氧基}乙基]胺、三乙醇胺三乙酸酯等,以三乙醇胺三乙酸酯為佳。As other aliphatic amines, there can be mentioned tris(2-methoxymethoxyethyl)amine, tris{2-(2-methoxyethoxy)ethyl}amine, tris{2-(2-methoxyethoxymethoxy)ethyl}amine, tris{2-(1-methoxyethoxy)ethyl}amine, tris{2-(1-ethoxyethoxy)ethyl}amine, tris{2-(1-ethoxypropoxy)ethyl}amine, tris[2-{2-(2-hydroxyethoxy)ethoxy}ethyl]amine, triethanolamine triacetate, and the like, with triethanolamine triacetate being preferred.

又,作為(D2)成分,亦可使用芳香族胺。 作為芳香族胺,可舉出4-二甲基胺基吡啶、吡咯、吲哚、吡唑、咪唑或此等衍生物、三苯甲基胺、2,6-二異丙基苯胺、N-tert-丁氧基羰基吡咯烷、2,6-二-tert-丁基吡啶等。 Furthermore, aromatic amines may be used as component (D2). Examples of aromatic amines include 4-dimethylaminopyridine, pyrrole, indole, pyrazole, imidazole or derivatives thereof, tritylamine, 2,6-diisopropylaniline, N-tert-butoxycarbonylpyrrolidine, and 2,6-di-tert-butylpyridine.

(D2)成分可單獨使用1種,亦可組合2種以上而使用。 阻劑組成物含有(D2)成分之情況時,阻劑組成物中,(D2)成分之含有量相對於(A)成分100質量份,通常在0.01~5質量份之範圍下使用。藉由設定在上述範圍,可提高阻劑圖型形狀、預置經時穩定性等。 The component (D2) may be used alone or in combination of two or more. When the resist composition contains the component (D2), the content of the component (D2) in the resist composition is usually in the range of 0.01 to 5 parts by mass relative to 100 parts by mass of the component (A). By setting it within the above range, the shape of the resist pattern and the stability over time can be improved.

≪選自由有機羧酸、磷的含氧酸及其衍生物所成群的至少1種化合物(E)≫ 本實施形態的阻劑組成物中,以感度劣化之防止或阻劑圖型形狀、預置經時穩定性等提高的目的下,作為任意成分,可含有選自由有機羧酸、磷的含氧酸及其衍生物所成群的至少1種化合物(E)(以下亦稱為「(E)成分」)。 作為有機羧酸,具體可舉出乙酸、丙二酸、檸檬酸、蘋果酸、琥珀酸、安息香酸、水楊酸等,其中亦以水楊酸為佳。 作為磷的含氧酸,可舉出磷酸、膦酸、次膦酸(phosphinic acid)等,此等中亦以膦酸為特佳。 ≪At least one compound (E) selected from the group consisting of organic carboxylic acids, phosphorus oxygen acids and their derivatives≫ The resist composition of the present embodiment may contain, as an optional component, at least one compound (E) selected from the group consisting of organic carboxylic acids, phosphorus oxygen acids and their derivatives (hereinafter also referred to as "(E) component") for the purpose of preventing sensitivity degradation or improving resist pattern shape, preset stability over time, etc. Specific examples of organic carboxylic acids include acetic acid, malonic acid, citric acid, malic acid, succinic acid, benzoic acid, salicylic acid, etc., among which salicylic acid is preferred. Examples of phosphorus oxygen acids include phosphoric acid, phosphonic acid, phosphinic acid, etc., among which phosphonic acid is particularly preferred.

本實施形態之阻劑組成物中,(E)成分可單獨使用1種,亦可併用2種以上。 阻劑組成物含有(E)成分之情況時,(E)成分之含有量相對於(A)成分100質量份,以0.01~5質量份為佳,以0.05~3質量份為較佳。藉由上述範圍,可進一步提高光刻特性。 In the resist composition of this embodiment, the (E) component may be used alone or in combination of two or more. When the resist composition contains the (E) component, the content of the (E) component is preferably 0.01 to 5 parts by mass, and more preferably 0.05 to 3 parts by mass, relative to 100 parts by mass of the (A) component. By the above range, the photolithography characteristics can be further improved.

≪氟添加劑成分(F)≫ 本實施形態之阻劑組成物中作為疏水性樹脂亦可含有氟添加劑成分(以下亦稱為「(F)成分」)。(F)成分使用於對阻劑膜賦予撥水性,作為(A)成分之其他樹脂而使用時,可提高光刻特性。 作為(F)成分,例如可使用日本特開2010-002870號公報、日本特開2010-032994號公報、日本特開2010-277043號公報、日本特開2011-13569號公報、日本特開2011-128226號公報所記載的含氟高分子化合物。 作為(F)成分,更具體可舉出具有下述一般式(f1-1)所示構成單位(f1)的聚合物。作為該聚合物,以僅由下述式(f1-1)所示構成單位(f1)所成的聚合物(均聚物);該構成單位(f1)與前述構成單位(a1)之共聚物;該構成單位(f1)與由丙烯酸或甲基丙烯酸所衍生的構成單位與前述構成單位(a1)之共聚物者為佳,以該構成單位(f1)與前述構成單位(a1)之共聚物者為較佳。其中,作為與該構成單位(f1)進行共聚合的前述構成單位(a1),以由1-乙基-1-環辛基(甲基)丙烯酸酯所衍生的構成單位、由1-甲基-1-金剛烷基(甲基)丙烯酸酯所衍生的構成單位為佳,以由1-乙基-1-環辛基(甲基)丙烯酸酯所衍生的構成單位為較佳。 ≪Fluorine additive component (F)≫ The resist composition of this embodiment may also contain a fluorine additive component (hereinafter also referred to as "(F) component") as a hydrophobic resin. The (F) component is used to impart hydrophobicity to the resist film, and when used as another resin of the (A) component, it can improve the photolithography characteristics. As the (F) component, for example, the fluorine-containing polymer compounds described in Japanese Patent Publication No. 2010-002870, Japanese Patent Publication No. 2010-032994, Japanese Patent Publication No. 2010-277043, Japanese Patent Publication No. 2011-13569, and Japanese Patent Publication No. 2011-128226 can be used. More specifically, as the component (F), there can be cited a polymer having a constituent unit (f1) represented by the following general formula (f1-1). The polymer is preferably a polymer (homopolymer) consisting only of the constituent unit (f1) represented by the following formula (f1-1); a copolymer of the constituent unit (f1) and the aforementioned constituent unit (a1); a copolymer of the constituent unit (f1) and a constituent unit derived from acrylic acid or methacrylic acid and the aforementioned constituent unit (a1); and a copolymer of the constituent unit (f1) and the aforementioned constituent unit (a1) is more preferred. Among them, the aforementioned constituent unit (a1) copolymerized with the constituent unit (f1) is preferably a constituent unit derived from 1-ethyl-1-cyclooctyl (meth)acrylate or a constituent unit derived from 1-methyl-1-adamantyl (meth)acrylate, and more preferably a constituent unit derived from 1-ethyl-1-cyclooctyl (meth)acrylate.

[式中,R與前述相同,Rf 102及Rf 103各獨立表示氫原子、鹵素原子、碳原子數1~5的烷基或碳原子數1~5的鹵化烷基,Rf 102及Rf 103可為相同亦可為相異。nf 1為0~5的整數,Rf 101為含有氟原子的有機基。] [In the formula, R is the same as above, Rf102 and Rf103 each independently represent a hydrogen atom, a halogen atom, an alkyl group having 1 to 5 carbon atoms, or a halogenated alkyl group having 1 to 5 carbon atoms, and Rf102 and Rf103 may be the same or different. nf1 is an integer from 0 to 5, and Rf101 is an organic group containing a fluorine atom.]

式(f1-1)中,鍵結於α位碳原子之R與前述相同。作為R,以氫原子或甲基為佳。 式(f1-1)中,作為Rf 102及Rf 103的鹵素原子,以氟原子為佳。作為Rf 102及Rf 103的碳原子數1~5的烷基,可舉出與上述R的碳原子數1~5的烷基之相同者,以甲基或乙基為佳。作為Rf 102及Rf 103的碳原子數1~5的鹵化烷基,具體可舉出碳原子數1~5的烷基之氫原子的一部分或全部由鹵素原子進行取代之基。作為該鹵素原子,以氟原子為佳。其中作為Rf 102及Rf 103,亦以氫原子、氟原子或碳原子數1~5的烷基為佳,以氫原子、氟原子、甲基或乙基為較佳,以氫原子為更佳。 式(f1-1)中,nf 1為0~5的整數,以0~3的整數為佳,以1或2者為較佳。 In the formula (f1-1), R bonded to the carbon atom at the α position is the same as described above. As R, a hydrogen atom or a methyl group is preferred. In the formula (f1-1), as the halogen atom of Rf 102 and Rf 103 , a fluorine atom is preferred. As the alkyl group having 1 to 5 carbon atoms of Rf 102 and Rf 103 , the same as the alkyl group having 1 to 5 carbon atoms of the above R can be cited, and a methyl group or an ethyl group is preferred. As the halogenated alkyl group having 1 to 5 carbon atoms of Rf 102 and Rf 103 , specifically, a group in which a part or all of the hydrogen atoms of the alkyl group having 1 to 5 carbon atoms are substituted by a halogen atom can be cited. As the halogen atom, a fluorine atom is preferred. Rf102 and Rf103 are preferably hydrogen atom, fluorine atom or alkyl group having 1 to 5 carbon atoms, preferably hydrogen atom, fluorine atom, methyl group or ethyl group, and more preferably hydrogen atom. In formula (f1-1), nf1 is an integer of 0 to 5, preferably an integer of 0 to 3, and more preferably 1 or 2.

式(f1-1)中,Rf 101為含有氟原子的有機基,以含有氟原子的烴基者為佳。 作為含有氟原子的烴基,亦可為直鏈狀、分支鏈狀或環狀中任一者,以碳原子數1~20者為佳,以碳原子數1~15者為較佳,以碳原子數1~10為特佳。 又,含有氟原子的烴基中,以該烴基中之氫原子的25%以上進行氟化者為佳,以50%以上進行氟化者為較佳,以60%以上進行氟化時,因可提高浸漬曝光時之阻劑膜的疏水性而特佳。 其中,作為Rf 101,亦以碳原子數1~6的氟化烴基為較佳,以三氟甲基、-CH 2-CF 3、-CH 2-CF 2-CF 3、-CH(CF 3) 2、-CH 2-CH 2-CF 3、-CH 2-CH 2-CF 2-CF 2-CF 2-CF 3為特佳。 In formula (f1-1), Rf101 is an organic group containing a fluorine atom, preferably a fluorine-containing alkyl group. The fluorine-containing alkyl group may be any of a linear chain, a branched chain or a ring, preferably having 1 to 20 carbon atoms, more preferably 1 to 15 carbon atoms, and particularly preferably 1 to 10 carbon atoms. In addition, among the fluorine-containing alkyl groups, it is preferred that 25% or more of the hydrogen atoms in the alkyl group are fluorinated, more preferably 50% or more, and particularly preferably 60% or more are fluorinated because the hydrophobicity of the resist film during immersion exposure can be improved. Among them, Rf101 is preferably a fluorinated alkyl group having 1 to 6 carbon atoms, and particularly preferably a trifluoromethyl group, -CH2 - CF3 , -CH2 - CF2 - CF3 , -CH( CF3 ) 2 , -CH2 - CH2 - CF3 , and -CH2 - CH2 - CF2 - CF2 - CF2 - CF3 .

(F)成分之重量平均分子量(Mw)(藉由凝膠滲透層析法之聚苯乙烯換算基準)以1000~50000為佳,以5000~40000為較佳,以10000~30000為最佳。設定在該範圍之上限值以下時,作為阻劑使用時對阻劑用溶劑具有充分溶解性,設定在該範圍之下限值以上時,阻劑膜之撥水性為良好。 (F)成分之分散度(Mw/Mn)以1.0~5.0為佳,以1.0~3.0為較佳,以1.0~2.5為最佳。 The weight average molecular weight (Mw) of the (F) component (based on polystyrene conversion by gel permeation chromatography) is preferably 1,000 to 50,000, more preferably 5,000 to 40,000, and most preferably 10,000 to 30,000. When it is set below the upper limit of the range, it has sufficient solubility in the resist solvent when used as a resist, and when it is set above the lower limit of the range, the water repellency of the resist film is good. The dispersion degree (Mw/Mn) of the (F) component is preferably 1.0 to 5.0, more preferably 1.0 to 3.0, and most preferably 1.0 to 2.5.

本實施形態之阻劑組成物中,(F)成分可單獨使用1種,亦可併用2種以上。 阻劑組成物具有(F)成分之情況時,(F)成分之含有量相對於(A)成分100質量份,以0.5~10質量份者為佳,以1~10質量份者為較佳。 In the resist composition of this embodiment, the (F) component may be used alone or in combination of two or more. When the resist composition contains the (F) component, the content of the (F) component is preferably 0.5 to 10 parts by mass, and more preferably 1 to 10 parts by mass, relative to 100 parts by mass of the (A) component.

≪有機溶劑成分(S)≫ 本實施形態之阻劑組成物可由將阻劑材料溶解於有機溶劑成分(以下稱為「(S)成分」)而製造。 本實施形態之阻劑組成物中,(S)成分可單獨使用1種,亦可作為2種以上之混合溶劑使用。其中亦以丙二醇單甲基醚乙酸酯(PGMEA)、丙二醇單甲基醚(PGME)、γ-丁內酯、乳酸乙酯(EL)、環己酮為佳。 ≪Organic solvent component (S)≫ The resist composition of this embodiment can be produced by dissolving the resist material in an organic solvent component (hereinafter referred to as "(S) component"). In the resist composition of this embodiment, the (S) component can be used alone or as a mixed solvent of two or more. Among them, propylene glycol monomethyl ether acetate (PGMEA), propylene glycol monomethyl ether (PGME), γ-butyrolactone, ethyl lactate (EL), and cyclohexanone are preferred.

又,作為(S)成分,亦以混合PGMEA與極性溶劑之混合溶劑為佳。該配合比(質量比)若考慮到PGMEA與極性溶劑之相溶性等而適宜地決定即可。 作為(S)成分以選自PGMEA及EL之中的至少1種與γ-丁內酯之混合溶劑為佳。此時,作為混合比例,前者與後者之質量比設定在70:30~95:5為佳。 (S)成分之使用量並無特別限定,可塗布於基板等之濃度可配合塗布膜厚而適宜地設定。一般使用(S)成分而使阻劑組成物之固體成分濃度成為0.1~20質量%,較佳為成為0.2~15質量%之範圍內。 In addition, as the (S) component, a mixed solvent of PGMEA and a polar solvent is also preferred. The mixing ratio (mass ratio) can be appropriately determined by taking into account the compatibility of PGMEA and the polar solvent. As the (S) component, a mixed solvent of at least one selected from PGMEA and EL and γ-butyrolactone is preferred. At this time, as a mixing ratio, the mass ratio of the former to the latter is preferably set at 70:30 to 95:5. The amount of the (S) component used is not particularly limited, and the concentration that can be applied to the substrate can be appropriately set according to the coating film thickness. Generally, the (S) component is used to make the solid component concentration of the resist composition 0.1 to 20 mass%, preferably in the range of 0.2 to 15 mass%.

本實施形態之阻劑組成物可在將上述阻劑材料溶解於(S)成分後,使用聚醯亞胺多孔質膜、聚醯胺醯亞胺多孔質膜等,進行雜質等除去。例如亦可使用由聚醯亞胺多孔質膜所成的濾器、由聚醯胺醯亞胺多孔質膜所成的濾器、由聚醯亞胺多孔質膜及聚醯胺醯亞胺多孔質膜所成的濾器等,進行阻劑組成物之過濾。作為前述聚醯亞胺多孔質膜及前述聚醯胺醯亞胺多孔質膜,例如可例示出日本特開2016-155121號公報所記載者。The resist composition of this embodiment can be removed from impurities, etc. by using a polyimide porous membrane, a polyamide imide porous membrane, etc. after dissolving the above-mentioned resist material in the (S) component. For example, a filter formed by a polyimide porous membrane, a filter formed by a polyamide imide porous membrane, a filter formed by a polyimide porous membrane and a polyamide imide porous membrane, etc. can also be used to filter the resist composition. As the aforementioned polyimide porous membrane and the aforementioned polyamide imide porous membrane, for example, those described in Japanese Patent Publication No. 2016-155121 can be exemplified.

以上說明的本實施形態之阻劑組成物中含有基材成分(A)與一般式(b0)所示化合物(B0)。 化合物(B0)因具有碘原子,故EUV(極端紫外線)及EB(電子線)等之吸收為高。另一方面,若具有碘原子時,材料本身的疏水性變強,有著對鹼顯影液之溶解性減少的傾向。在本實施形態所採用的化合物(B0)因於該結構中具有鹼分解性基(R b),故藉由鹼顯影液(鹼)之作用會進行水解,故可使阻劑膜對於鹼顯影液之溶解性提高。即,阻劑組成物中,藉由含有同時具有碘原子與鹼分解性基之化合物(B0),可提高感度及微細解像性。 又,化合物(B0)因具有環狀有機基(Rl 0),其為比較大體積的結構,將酸的擴散長抑制至適當程度,進而可使與基材成分之親和性亦可調整成高。因此,提高圖型尺寸之面內均勻性(CDU)。 因此,若為含有化合物(B0)之本實施形態的阻劑組成物,可推測到在形成阻劑圖型時可達成高感度化,且可提高CDU及微細解像性等光刻特性。 The resist composition of the present embodiment described above contains a base component (A) and a compound (B0) represented by the general formula (b0). Since the compound (B0) has an iodine atom, it has high absorption of EUV (extreme ultraviolet) and EB (electron beam). On the other hand, if it has an iodine atom, the hydrophobicity of the material itself becomes stronger, and there is a tendency for the solubility in alkaline developer to decrease. Since the compound (B0) used in the present embodiment has an alkali-degradable group (R b ) in its structure, it will be hydrolyzed by the action of the alkaline developer (alkali), thereby improving the solubility of the resist film in the alkaline developer. That is, in the resist composition, by containing a compound (B0) having both an iodine atom and an alkali-degradable group, the sensitivity and fine resolution can be improved. In addition, since compound (B0) has a cyclic organic group ( R10 ), which is a relatively large structure, the diffusion length of the acid can be suppressed to an appropriate degree, and the affinity with the substrate component can be adjusted to be high. Therefore, the in-plane uniformity (CDU) of the pattern size is improved. Therefore, if the resist composition of the present embodiment containing compound (B0) can achieve high sensitivity when forming a resist pattern, it can be inferred that the photolithography characteristics such as CDU and fine resolution can be improved.

(阻劑圖型形成方法) 有關本發明之第2態樣的阻劑圖型形成方法係具有,於支持體上使用上述有關本發明的第1態樣之阻劑組成物,形成阻劑膜之步驟、使前述阻劑膜曝光的步驟,及將前述曝光後之阻劑膜進行顯影而形成阻劑圖型的步驟之方法。 作為該阻劑圖型形成方法之一實施形態,例如可舉出如以下進行的阻劑圖型形成方法。 (Resist pattern forming method) The resist pattern forming method of the second aspect of the present invention comprises the steps of forming a resist film on a support using the resist composition of the first aspect of the present invention, exposing the resist film, and developing the exposed resist film to form a resist pattern. As one embodiment of the resist pattern forming method, for example, a resist pattern forming method performed as follows can be cited.

首先,將上述實施形態的阻劑組成物,於支持體上藉由旋轉器等進行塗布,將經燒烤(塗後烘烤(PAB))處理例如在80~150℃之溫度條件下實施40~120秒,較佳為實施60~90秒而形成阻劑膜。 其次,相對於該阻劑膜,例如使用電子線描繪裝置、ArF曝光裝置等曝光裝置,藉由隔著形成有所定圖型之掩膜(光罩圖型)而進行曝光或未隔著光罩圖型藉由電子線之直接照射而描繪等進行選擇性曝光後,將燒烤(曝光後烘烤(PEB))處理例如在80~150℃的溫度條件下實施40~120秒,較佳為實施60~90秒。 其次,對前述阻劑膜實施顯影處理。顯影處理在鹼顯影製程之情況時,使用鹼顯影液,在溶劑顯影製程之情況時,使用含有有機溶劑的顯影液(有機系顯影液)而進行。 First, the resist composition of the above-mentioned implementation form is applied on a support by a spinner, etc., and then baked (post-exposure baking (PAB)) for example, at a temperature of 80 to 150°C for 40 to 120 seconds, preferably for 60 to 90 seconds to form a resist film. Second, the resist film is selectively exposed by exposing through a mask (mask pattern) formed with a certain pattern or by direct exposure of electron beams without a mask pattern, etc., and then baked (post-exposure baking (PEB)) for example, at a temperature of 80 to 150°C for 40 to 120 seconds, preferably for 60 to 90 seconds. Next, the resist film is subjected to a developing process. In the case of an alkaline developing process, the developing process is performed using an alkaline developer, and in the case of a solvent developing process, a developer containing an organic solvent (organic developer) is used.

顯影處理後,較佳進行漂洗(rinse)處理。漂洗處理在鹼顯影製程之情況時,以使用純水的水漂洗為佳,在溶劑顯影製程之情況時,使用含有有機溶劑之漂洗液者為佳。 在溶劑顯影製程之情況時,亦可於前述顯影處理或漂洗處理之後,將附著於圖型上之顯影液或漂洗液藉由超臨界流體進行除去處理。 顯影處理後或漂洗處理後進行乾燥。又,依據情況,於上述顯影處理後亦可進行燒烤處理(後烘烤)。 After the development process, it is preferred to perform a rinse process. In the case of an alkaline development process, it is preferred to use pure water for the rinse process, and in the case of a solvent development process, it is preferred to use a rinse solution containing an organic solvent. In the case of a solvent development process, after the above-mentioned development process or rinse process, the developer or rinse solution attached to the pattern can also be removed by a supercritical fluid. After the development process or rinse process, drying is performed. In addition, according to the situation, a baking process (post-baking) can also be performed after the above-mentioned development process.

作為支持體,並無特別限定,可使用過去公知者,例如可舉出電子零件用之基板或於此形成為所定配線圖型者等。更具體可舉出矽晶圓、銅、鉻、鐵、鋁等金屬製基板或玻璃基板等。作為配線圖型之材料,例如可使用銅、鋁、鎳、金等。The support is not particularly limited, and any known support may be used, such as a substrate for electronic components or a substrate on which a predetermined wiring pattern is formed. More specifically, a silicon wafer, a metal substrate such as copper, chromium, iron, aluminum, or a glass substrate may be used. As a material for the wiring pattern, copper, aluminum, nickel, gold, etc. may be used.

使用於曝光之波長並無特別限定,可使用ArF準分子激光、KrF準分子激光、F 2準分子激光、EUV (極端紫外線)、VUV(真空紫外線)、EB(電子線)、X線、軟X線等放射線而進行。 The wavelength used for exposure is not particularly limited, and radiation such as ArF excimer laser, KrF excimer laser, F2 excimer laser, EUV (extreme ultraviolet), VUV (vacuum ultraviolet), EB (electron beam), X-ray, soft X-ray, etc. can be used.

阻劑膜之曝光方法可為在空氣或氮等惰性氣體中所進行的一般曝光(乾曝光),亦可為液浸曝光(Liquid Immersion Lithography)。 液浸曝光為,預先將阻劑膜與曝光裝置之最下位置的鏡片間,裝滿具有比空氣大之折射率的溶劑(液浸媒體),在該狀態下進行曝光(浸漬曝光)的曝光方法。 作為液浸媒體,以具有比空氣之折射率大,且比經曝光的阻劑膜之折射率小之折射率的溶劑為佳,例如可舉出水、氟系惰性液體、矽系溶劑、烴系溶劑等。 作為液浸媒體,較佳為使用水。 The exposure method of the resist film can be general exposure (dry exposure) in an inert gas such as air or nitrogen, or liquid immersion exposure (Liquid Immersion Lithography). Liquid immersion exposure is an exposure method in which a solvent (liquid immersion medium) having a refractive index greater than that of air is filled between the resist film and the lens at the lowest position of the exposure device in advance, and exposure is performed in this state (immersion exposure). As the liquid immersion medium, a solvent having a refractive index greater than that of air and smaller than that of the exposed resist film is preferred, such as water, fluorine-based inert liquid, silicon-based solvent, hydrocarbon-based solvent, etc. As the liquid immersion medium, water is preferably used.

作為在鹼顯影製程使用於顯影處理之鹼顯影液,例如可舉出0.1~10質量%四甲基銨氫氧化物(TMAH)水溶液。 作為在溶劑顯影製程使用於顯影處理之有機系顯影液所含有的有機溶劑,若為可溶解(A)成分(曝光前之(A)成分)者即可,可適宜地選擇公知有機溶劑中者。具體可舉出酮系溶劑、酯系溶劑、醇系溶劑、腈系溶劑、醯胺系溶劑、醚系溶劑等極性溶劑、烴系溶劑等。 As an alkaline developer used in the alkaline developing process, for example, a 0.1-10 mass % tetramethylammonium hydroxide (TMAH) aqueous solution can be cited. As an organic solvent contained in an organic developer used in the solvent developing process, any organic solvent that can dissolve the (A) component (the (A) component before exposure) can be selected appropriately from known organic solvents. Specifically, polar solvents such as ketone solvents, ester solvents, alcohol solvents, nitrile solvents, amide solvents, and ether solvents, hydrocarbon solvents, etc. can be cited.

作為酯系溶劑,例如可舉出乙酸甲酯、乙酸丁酯、乙酸乙酯、乙酸異丙酯、乙酸戊酯、乙酸異戊酯、乙酸戊酯、丙二醇單甲基醚乙酸酯、乙二醇單乙基醚乙酸酯、二乙二醇單丁基醚乙酸酯、二乙二醇單乙基醚乙酸酯、乙基-3-乙氧基丙酸酯、3-甲氧基丁基乙酸酯、3-甲基-3-甲氧基丁基乙酸酯、甲酸甲酯、甲酸乙酯、甲酸丁酯、甲酸丙酯、乳酸乙酯、乳酸丁酯、乳酸丙酯、丁烷酸丁酯、2-羥基異丁酸甲酯、乙酸異戊酯、異丁酸異丁酯及丙酸丁酯。Examples of the ester solvent include methyl acetate, butyl acetate, ethyl acetate, isopropyl acetate, amyl acetate, isoamyl acetate, amyl acetate, propylene glycol monomethyl ether acetate, ethylene glycol monoethyl ether acetate, diethylene glycol monobutyl ether acetate, diethylene glycol monoethyl ether acetate, ethyl-3-ethoxypropionate, 3-methoxybutyl acetate, 3-methyl-3-methoxybutyl acetate, methyl formate, ethyl formate, butyl formate, propyl formate, ethyl lactate, butyl lactate, propyl lactate, butyl butanoate, methyl 2-hydroxyisobutyrate, isoamyl acetate, isobutyl isobutyrate, and butyl propionate.

作為腈系溶劑,例如可舉出乙腈、丙腈、戊腈、丁腈等。Examples of the nitrile solvent include acetonitrile, propionitrile, valeronitrile, butyronitrile and the like.

於有機系顯影液中,視必要可添加公知的添加劑。作為該添加劑,例如可舉出界面活性劑。作為界面活性劑,雖無特別限定,例如可使用離子性或非離子性之氟系及/或矽系界面活性劑等。A known additive may be added to the organic developer as necessary. As such an additive, for example, a surfactant may be mentioned. As the surfactant, there is no particular limitation, for example, an ionic or non-ionic fluorine-based and/or silicon-based surfactant may be used.

顯影處理可藉由公知顯影方法實施,例如可舉出於顯影液中浸漬支持體一定時間之方法(浸漬法)、於支持體表面將顯影液藉由表面張力裝滿並靜置一定時間的方法(攪拌法)、對於支持體表面噴霧顯影液之方法(噴霧法)、以一定速度進行轉動的支持體上以一定速度一邊掃描顯影液塗布噴嘴而一邊繼續塗佈顯影液之方法(動態分配方法)等。The developing process can be carried out by a known developing method, for example, a method of immersing a support in a developer for a certain period of time (immersion method), a method of filling the surface of a support with the developer by surface tension and leaving it for a certain period of time (stirring method), a method of spraying the developer on the surface of a support (spraying method), a method of continuously coating the developer on a support rotating at a certain speed while scanning a developer coating nozzle at a certain speed (dynamic distribution method), etc.

作為在溶劑顯影製程使用於顯影處理後之漂洗處理的漂洗液所含有的有機溶劑,例如作為使用於前述有機系顯影液之有機溶劑所舉出的有機溶劑中,可適宜地選擇不容易溶解阻劑圖型者而使用。通常使用選自烴系溶劑、酮系溶劑、酯系溶劑、醇系溶劑、醯胺系溶劑及醚系溶劑的至少1種類溶劑。 此等有機溶劑可單獨使用任一種,亦可併用2種以上。又亦可使用混合上述以外有機溶劑或水者。 As an organic solvent contained in the rinse solution used in the rinse treatment after the development process in the solvent development process, for example, among the organic solvents listed as the organic solvents used in the aforementioned organic developer, those that do not easily dissolve the resist pattern can be appropriately selected and used. Usually, at least one type of solvent selected from hydrocarbon solvents, ketone solvents, ester solvents, alcohol solvents, amide solvents and ether solvents is used. These organic solvents can be used alone or in combination of two or more. It is also possible to use a mixture of organic solvents other than the above or water.

使用漂洗液之漂洗處理(洗淨處理)可藉由公知漂洗方法實施。作為該漂洗處理之方法,例如可舉出在以一定速度進行轉動的支持體上繼續塗佈漂洗液之方法(轉動塗布法)、於漂洗液中將支持體浸漬一定時間之方法(浸漬法)、於支持體表面上噴霧漂洗液之方法(噴霧法)等。The rinsing treatment (cleaning treatment) using the rinsing liquid can be carried out by a known rinsing method. Examples of the rinsing treatment method include a method of continuously applying the rinsing liquid to a support body rotating at a certain speed (rotation coating method), a method of immersing the support body in the rinsing liquid for a certain period of time (immersion method), and a method of spraying the rinsing liquid on the surface of the support body (spraying method).

依據以上說明的本實施形態之阻劑圖型形成方法,因使用上述阻劑組成物,形成阻劑圖型時可達成高感度化,且可形成CDU及微細解像性等光刻特性提高的阻劑圖型。According to the resist pattern forming method of the present embodiment described above, by using the above-mentioned resist composition, high sensitivity can be achieved when forming a resist pattern, and a resist pattern with improved lithography characteristics such as CDU and fine resolution can be formed.

上述實施形態之阻劑組成物及在上述實施形態之圖型形成方法中所使用的各種材料(例如阻劑溶劑、顯影液、漂洗液、反射防止膜形成用組成物、面漆形成用組成物等)以未含有金屬、含有鹵素的金屬鹽、酸、鹼、硫原子或磷原子的成分等雜質者為佳。其中,作為含有金屬原子的雜質,可舉出Na、K、Ca、Fe、Cu、Mn、Mg、Al、Cr、Ni、Zn、Ag、Sn、Pb、Li或此等鹽等。作為含於此等材料的雜質之含有量,以200ppb以下為佳,以1ppb以下為較佳,以100ppt(parts per trillion)以下為更佳,以10ppt以下為特佳,以實質上未含有者(在測定裝置之檢測極限以下)為最佳。The resist composition of the above-mentioned embodiment and the various materials used in the pattern forming method of the above-mentioned embodiment (such as the resist solvent, the developer, the rinse solution, the anti-reflection film forming composition, the topcoat forming composition, etc.) preferably do not contain impurities such as metal, metal salt containing halogen, acid, base, sulfur atom or phosphorus atom. Among them, as impurities containing metal atoms, Na, K, Ca, Fe, Cu, Mn, Mg, Al, Cr, Ni, Zn, Ag, Sn, Pb, Li or salts thereof can be cited. The impurity content of these materials is preferably 200 ppb or less, more preferably 1 ppb or less, more preferably 100 ppt (parts per trillion) or less, particularly preferably 10 ppt or less, and most preferably substantially free (below the detection limit of the measuring device).

(一般式(b0)所示化合物) 有關本發明之第3態樣的化合物為下述一般式(b0)所示化合物(化合物(B0))。 (Compound represented by general formula (b0)) The compound of the third embodiment of the present invention is a compound represented by the following general formula (b0) (compound (B0)).

[式中,R b為鹼分解性基。L 03為2價連結基。Rl 0為可具有取代基的環狀有機基。L 02為2價連結基。I為碘原子。R m1為碘原子以外之取代基。L 01為2價連結基或單鍵。Vb 0為伸烷基、氟化伸烷基或單鍵。但,L 01與Vb 0不會同時成為單鍵。R 0為碳數1~5的氟化烷基、氟原子或氫原子。nb1為1~4的整數,nb2為1~4的整數,nb3為0~3的整數。但,2≦nb1+nb2+nb3≦5。M m+表示m價有機陽離子。m為1以上的整數。] [In the formula, Rb is an alkali-decomposable group. L03 is a divalent linking group. Rl0 is a cyclic organic group which may have a substituent. L02 is a divalent linking group. I is an iodine atom. Rm1 is a substituent other than an iodine atom. L01 is a divalent linking group or a single bond. Vb0 is an alkylene group, a fluorinated alkylene group or a single bond. However, L01 and Vb0 will not simultaneously form a single bond. R0 is a fluorinated alkylene group having 1 to 5 carbon atoms, a fluorine atom or a hydrogen atom. nb1 is an integer from 1 to 4, nb2 is an integer from 1 to 4, and nb3 is an integer from 0 to 3. However, 2≦nb1+nb2+nb3≦5. Mm+ represents an m-valent organic cation. m is an integer greater than 1.]

上述一般式(b0)所示化合物與上述本發明之第1態樣的阻劑組成物中之(B0)成分相同。 對於前述式(b0)中之R b、L 03、Rl 0、L 02、R m1、L 01、Vb 0、R 0、nb1、nb2、nb3、M m+及m之說明與上述說明相同。 對於本實施形態中之化合物,以上述一般式(b0)中之R b具有含有內酯的環式基之基者為佳,以上述一般式(a2-r-1)~(a2-r-8)各表示的基為較佳,以上述一般式(a2-r-1)~(a2-r-2)各表示的基為更佳,以上述一般式(a2-r-1)所示基特佳。 對於本實施形態中之化合物,上述一般式(b0)中之  -L 01-Vb 0-以下述一般式(b0-r-1)~(b0-r-7)中任一所示連結基者為佳。式(b0-r-1)、(b0-r-2)及(b0-r-5)~(b0-r-7)中,對於L 012的說明與上述說明相同。作為上述一般式(b0)中之-L 01-Vb 0-,其中亦以一般式(b0-r-1)~(b0-r-2)中任一所示連結基特佳。 The compound represented by the general formula (b0) is the same as the component (B0) in the inhibitor composition of the first aspect of the present invention. The descriptions of R b , L 03 , R1 0 , L 02 , R m1 , L 01 , Vb 0 , R 0 , nb1 , nb2 , nb3 , M m+ and m in the general formula (b0) are the same as those described above. For the compound in this embodiment, it is preferred that R b in the general formula (b0) has a cyclic group containing a lactone , and it is more preferred that it is a group represented by each of the general formulas (a2-r-1) to (a2-r-8), and it is more preferred that it is a group represented by each of the general formulas (a2-r-1) to (a2-r-2), and it is particularly preferred that it is a group represented by the general formula (a2-r-1). In the compounds of this embodiment, -L 01 -Vb 0 - in the general formula (b0) is preferably a linking group represented by any one of the following general formulas (b0-r-1) to (b0-r-7). In formulas (b0-r-1), (b0-r-2) and (b0-r-5) to (b0-r-7), the description of L 012 is the same as the above description. As -L 01 -Vb 0 - in the general formula (b0), a linking group represented by any one of the general formulas (b0-r-1) to (b0-r-2) is particularly preferred.

[式中,L 011為碳原子數1~5的伸烷基或單鍵。L 012為碳原子數1~30的2價飽和烴基或單鍵。Vb 01為碳原子數1~4的氟化伸烷基或單鍵。但,L 012與Vb 01不會同時成為單鍵。] [In the formula, L 011 is an alkylene group having 1 to 5 carbon atoms or a single bond. L 012 is a divalent saturated alkyl group having 1 to 30 carbon atoms or a single bond. Vb 01 is a fluorinated alkylene group having 1 to 4 carbon atoms or a single bond. However, L 012 and Vb 01 cannot be single bonds at the same time.]

作為本實施形態之化合物的具體例子,可舉出負離子部為上述化學式(b0-an-101)~(b0-an-129)各表示的負離子之化合物(前述式(b0)中之Rl 0為苯環之情況)、負離子部為上述化學式(b0-an-201)~(b0-an-223)各表示的負離子之化合物(前述式(b0)中之Rl 0為降冰片烯環之情況)、負離子部為上述化學式(b0-an-301)~(b0-an-322)各表示的負離子之化合物(前述式(b0)中之Rl 0為聯環辛烷環之情況)。 作為本實施形態之化合物的具體例子,進一步較佳可舉出上述化學式(B0-1)~(B0-29)各表示的化合物。 As specific examples of the compounds of this embodiment, there can be cited the compounds whose negative ion part is the negative ion represented by the above chemical formulas (b0-an-101) to (b0-an-129) (when R10 in the above formula (b0) is a benzene ring), the compounds whose negative ion part is the negative ion represented by the above chemical formulas (b0-an-201) to (b0-an-223) (when R10 in the above formula (b0) is a norbornene ring), and the compounds whose negative ion part is the negative ion represented by the above chemical formulas (b0-an-301) to (b0-an-322) (when R10 in the above formula (b0) is a bicyclic octane ring). As specific examples of the compounds of this embodiment, more preferably, there can be mentioned the compounds represented by the above chemical formulas (B0-1) to (B0-29).

[一般式(b0)所示化合物之製造方法] (B0)成分可使用公知製造方法而製造。 例如藉由下述一般式(Bpre)所示前驅物Bpre與下述一般式(S-0)所示化合物S0之鹽交換反應而可得到(B0)成分。 [Production method of the compound represented by general formula (b0)] Component (B0) can be produced using a known production method. For example, component (B0) can be obtained by salt exchange reaction of a precursor Bpre represented by the following general formula (Bpre) and a compound S0 represented by the following general formula (S-0).

[式中,R b為鹼分解性基。L 03為2價連結基。Rl 0為可具有取代基的環狀有機基。L 02為2價連結基。I為碘原子。R m1為碘原子以外之取代基。L 01為2價連結基或單鍵。Vb 0為伸烷基、氟化伸烷基或單鍵。但,L 01與Vb 0不會同時成為單鍵。R 0為碳數1~5的氟化烷基、氟原子或氫原子。nb1為1~4的整數,nb2為1~4的整數,nb3為0~3的整數。(M 1m+) 1/m為銨陽離子。Z -為非求核性離子。M m+表示m價有機陽離子。m為1以上的整數。] [In the formula, Rb is an alkali-decomposable group. L03 is a divalent linking group. Rl0 is a cyclic organic group which may have a substituent. L02 is a divalent linking group. I is an iodine atom. Rm1 is a substituent other than an iodine atom. L01 is a divalent linking group or a single bond. Vb0 is an alkylene group, a fluorinated alkylene group or a single bond. However, L01 and Vb0 will not simultaneously form a single bond. R0 is a fluorinated alkylene group having 1 to 5 carbon atoms, a fluorine atom or a hydrogen atom. nb1 is an integer from 1 to 4, nb2 is an integer from 1 to 4, and nb3 is an integer from 0 to 3. ( M1 " m+ ) 1/m is an ammonium cation. Z- is a non-nuclear ion. Mm+ represents an m-valent organic cation. m is an integer greater than 1.]

上述鹽交換反應更具體為,將前驅物Bpre與鹽交換用之化合物S0在水、二氯甲烷、乙腈或氯仿等溶劑下進行反應,藉由將前驅物Bpre之陽離子與化合物S0之陽離子進行交換後得到(B0)成分之步驟。More specifically, the salt exchange reaction is a step of reacting the precursor Bpre with the compound S0 for salt exchange in a solvent such as water, dichloromethane, acetonitrile or chloroform to obtain the component (B0) by exchanging the cation of the precursor Bpre with the cation of the compound S0.

上述式中,(M 1m+) 1/m為銨陽離子,作為該銨陽離子,可為來自脂肪族胺之銨陽離子,亦可來自芳香族胺的銨陽離子。 In the above formula, (M 1m+ ) 1/m is an ammonium cation. The ammonium cation may be an ammonium cation derived from an aliphatic amine or an ammonium cation derived from an aromatic amine.

上述式中,作為Z -可舉出可變得比前驅物Bpre的酸性度更低之酸的離子,具體可舉出溴離子、氯離子等鹵素離子;BF 4 -、AsF 6 -、SbF 6 -、PF 6 -、ClO 4 -等。 In the above formula, as Z- , there can be mentioned ions which can become an acid with lower acidity than the precursor Bpre, specifically, halogen ions such as bromine ion and chlorine ion; BF4- , AsF6- , SbF6- , PF6- , ClO4- , etc.

反應溫度,例如0~100℃,反應時間,例如10分鐘以上24小時以下。The reaction temperature is, for example, 0 to 100° C., and the reaction time is, for example, from 10 minutes to 24 hours.

鹽交換反應終了後,可進行反應液中之化合物(B0)的分離及純化。 對於分離及純化可利用過去公知方法,例如可使用適當組合濃縮、溶劑萃取、蒸餾、結晶化、再結晶、層析法等者。 如上述所得的化合物之結構可藉由 1H-核磁共振(NMR)光譜法、 13C-NMR光譜法、 19F-NMR光譜法、紅外線吸收(IR)光譜法、質量分析(MS)法、元素分析法、X線結晶衍射法等一般的有機分析法進行鑑定。 After the salt exchange reaction is completed, the compound (B0) in the reaction solution can be isolated and purified. For the isolation and purification, conventionally known methods can be used, for example, a suitable combination of concentration, solvent extraction, distillation, crystallization, recrystallization, chromatography, etc. can be used. The structure of the compound obtained as described above can be identified by general organic analysis methods such as 1 H-nuclear magnetic resonance (NMR) spectroscopy, 13 C-NMR spectroscopy, 19 F-NMR spectroscopy, infrared absorption (IR) spectroscopy, mass analysis (MS), elemental analysis, X-ray crystallography, etc.

作為前驅物Bpre之製造方法,例如可舉出以下所示前驅物Bpre之製造方法1等。As a method for producing the precursor Bpre, for example, the following method 1 for producing the precursor Bpre can be cited.

前驅物Bpre之製造方法1: 前驅物Bpre之製造方法1具有:使下述一般式(CA-00)所示化合物(以下稱為「化合物(CA00)」)與下述一般式(X-00)所示化合物(以下稱為「化合物(X00)」)進行反應,得到下述一般式(Y-00)所示化合物(以下稱為「化合物(Y00)」)之步驟(步驟A),與使化合物(Y00)與下述一般式(Al-00)所示化合物(以下稱為「化合物(Al00)」)進行反應,得到下述一般式(Bpre’)所示前驅物Bpre’之步驟(步驟B)。 前驅物Bpre’為欲得到化合物(B0)而使用的化合物,一般式(b0)中之L 01及L 02為各酯鍵(-C(=O)-O-)之情況時的化合物。 Method 1 for producing precursor Bpre: Method 1 for producing precursor Bpre comprises: a step (step A) of reacting a compound represented by the following general formula (CA-00) (hereinafter referred to as "compound (CA00)") with a compound represented by the following general formula (X-00) (hereinafter referred to as "compound (X00)") to obtain a compound represented by the following general formula (Y-00) (hereinafter referred to as "compound (Y00)"), and a step (step B) of reacting compound (Y00) with a compound represented by the following general formula (Al-00) (hereinafter referred to as "compound (Al00)") to obtain precursor Bpre' represented by the following general formula (Bpre'). The precursor Bpre' is a compound used to obtain the compound (B0), and is a compound in which L01 and L02 in the general formula (b0) are ester bonds (-C(=O)-O-).

[式中,R m1為碘原子以外之取代基。nb1為1~4的整數,nb2為1~4的整數,nb3為0~3的整數。但,2≦nb1+nb2+nb3≦5。Vb 0為伸烷基、氟化伸烷基或單鍵。R 0為碳數1~5的氟化烷基、氟原子或氫原子。(M 1m+) 1/m為銨陽離子。m為1以上的整數。R b為鹼分解性基。L 03為2價連結基。Rl 0為可具有取代基的環狀有機基。] [In the formula, Rm1 is a substituent other than an iodine atom. nb1 is an integer from 1 to 4, nb2 is an integer from 1 to 4, and nb3 is an integer from 0 to 3. However, 2≦nb1+nb2+nb3≦5. Vb0 is an alkylene group, a fluorinated alkylene group, or a single bond. R0 is a fluorinated alkylene group having 1 to 5 carbon atoms, a fluorine atom, or a hydrogen atom. ( M1m+ ) 1/m is an ammonium cation. m is an integer greater than 1. Rb is an alkali-decomposable group. L03 is a divalent linking group. Rl0 is a cyclic organic group which may have a substituent.]

步驟A: 步驟A為,例如使化合物(CA00)與化合物(X00)在有機溶劑(乙腈、四氫呋喃、己烷等)中進行反應後得到化合物(Y00)之步驟。 Step A: Step A is a step of obtaining compound (Y00) by reacting compound (CA00) with compound (X00) in an organic solvent (acetonitrile, tetrahydrofuran, hexane, etc.).

對於步驟A中之反應,可使用縮合劑、鹼性觸媒等。 作為縮合劑,具體可舉出N,N’-二環己基碳二亞胺、N,N’-二異丙基碳二亞胺(DIC)、1-乙基-3-(3-二甲基胺基丙基)碳二亞胺鹽酸鹽、羰基二咪唑(CDI)等。 作為鹼性觸媒,具體可舉出三甲基胺、三乙基胺、三丁基胺等之三級胺類;吡啶、二甲基胺基吡啶(DMAP)、吡咯烷吡啶等之芳香族胺類;二氮雜雙環壬烯(DBN)、二氮雜雙環十一碳烯(DBU)等。 For the reaction in step A, a condensation agent, an alkaline catalyst, etc. can be used. As the condensation agent, N,N'-dicyclohexylcarbodiimide, N,N'-diisopropylcarbodiimide (DIC), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride, carbonyldiimidazole (CDI), etc. can be specifically mentioned. As the alkaline catalyst, tertiary amines such as trimethylamine, triethylamine, and tributylamine; aromatic amines such as pyridine, dimethylaminopyridine (DMAP), and pyrrolidinepyridine; diazabicyclononene (DBN), diazabicycloundecene (DBU), etc. can be specifically mentioned.

反應溫度例如為0~80℃,反應時間例如為10分鐘以上24小時以下。The reaction temperature is, for example, 0 to 80° C., and the reaction time is, for example, 10 minutes to 24 hours.

步驟B: 步驟B例如為使化合物(Y00)與化合物(Al00)在有機溶劑(二氯甲烷等)中進行反應而得到前驅物Bpre’之步驟。 Step B: Step B is, for example, a step of reacting compound (Y00) with compound (Al00) in an organic solvent (such as dichloromethane) to obtain precursor Bpre'.

步驟B中,與步驟A同樣地亦可使用縮合劑、鹼性觸媒等。 步驟B之反應溫度,例如為0~50℃,反應時間,例如為10分鐘以上24小時以下。 In step B, a condensing agent, an alkaline catalyst, etc. may be used similarly to step A. The reaction temperature of step B is, for example, 0 to 50°C, and the reaction time is, for example, more than 10 minutes and less than 24 hours.

化合物(Al00)可由,含有與環狀有機基(Rl 0)之相同結構的乙酸酐經烷基化(例如tert-丁基酯化)之化合物,與含有與鹼分解性基(R b)之相同結構的醇(例如內酯醇)之反應而得。 Compound (A100) can be obtained by reacting a compound containing acetic anhydride having the same structure as the cyclic organic group ( R10 ) by alkylation (eg, tert-butyl esterification) with an alcohol having the same structure as the alkali-degradable group ( Rb ) (eg, lactone alcohol).

以上說明的本實施形態之化合物可作為上述本發明之第1態樣的阻劑組成物用之酸產生劑之較佳化合物。又,本實施形態之化合物可作為後述第4態樣的酸產生劑而使用。The compound of the present embodiment described above can be used as a preferred compound of the acid generator for the inhibitor composition of the first aspect of the present invention. In addition, the compound of the present embodiment can be used as an acid generator of the fourth aspect described below.

(酸產生劑) 本發明之第4態樣的酸產生劑含有前述第3態樣之化合物(化合物(B0))。 本實施形態之酸產生劑可特別適合作為上述第1態樣之阻劑組成物用的酸產生劑成分。 [實施例] (Acid Generator) The acid generator of the fourth embodiment of the present invention contains the compound of the third embodiment (compound (B0)). The acid generator of this embodiment is particularly suitable as an acid generator component for the inhibitor composition of the first embodiment. [Example]

以下,藉由實施例更詳細說明本發明,本發明並非受限於此等例子。The present invention is described in more detail below through examples, but the present invention is not limited to these examples.

<化合物之製造> [中間體之合成例(1):中間體-H1~H4的合成] 中間體-H1之合成: 於容積300mL之三口燒瓶中,投入1,1’-羰基二咪唑(CDI)(4.60g,28.4mmol)及乙腈(20g)後,將溶解3-羥基-4-碘安息香酸(CA1)(6.74g,25.5mmol)於乙腈(20g)者經30分鐘滴入並進行1小時反應。 其後,投入化合物(I-1)(9.5g,30.6mmol),在65℃進行3小時反應。冷卻後加入超純水(250g),進行30分鐘攪拌後,過濾析出的固體。將過濾物再次溶解於甲醇(100g),滴入於甲基tert-丁基醚(MTBE)(500g),過濾析出的固體。將過濾物藉由減壓乾燥後得到中間體-H1(9.5g,產率67.0%)。 <Production of compounds> [Synthesis example of intermediates (1): Synthesis of intermediates-H1 to H4] Synthesis of intermediate-H1: In a 300 mL three-necked flask, 1,1'-carbonyldiimidazole (CDI) (4.60 g, 28.4 mmol) and acetonitrile (20 g) were added, and 3-hydroxy-4-iodobenzoic acid (CA1) (6.74 g, 25.5 mmol) dissolved in acetonitrile (20 g) was added dropwise over 30 minutes and reacted for 1 hour. Thereafter, compound (I-1) (9.5 g, 30.6 mmol) was added and reacted at 65°C for 3 hours. After cooling, ultrapure water (250 g) was added, and after stirring for 30 minutes, the precipitated solid was filtered. The filtrate was dissolved in methanol (100 g) again, added dropwise to methyl tert-butyl ether (MTBE) (500 g), and the precipitated solid was filtered. The filtrate was dried under reduced pressure to obtain intermediate-H1 (9.5 g, yield 67.0%).

中間體-H2~H4的合成: 將3-羥基-4-碘安息香酸(CA1)在等莫耳下,變更為各下述羧酸(CA2)~(CA4),進行與中間體-H1之合成的相同合成,得到中間體-H2(12.0g,產率69.0%)、中間體-H3 (11.9g,產率68.5%)、中間體-H4(15.2g,產率73.5%)。 Synthesis of intermediates-H2 to H4: 3-Hydroxy-4-iodobenzoic acid (CA1) was converted to the following carboxylic acids (CA2) to (CA4) at an equimolar ratio, and the same synthesis as that of intermediate-H1 was performed to obtain intermediate-H2 (12.0 g, yield 69.0%), intermediate-H3 (11.9 g, yield 68.5%), and intermediate-H4 (15.2 g, yield 73.5%).

[中間體之合成例(2):中間體-H5~H7之合成] 中間體-H5的合成: 將3-羥基-4-碘安息香酸(CA1)(6.74g,25.5mmol)在羧酸(CA2)(10.0g,25.5mmol)中,將化合物(I-1)(9.5g,30.6 mmol)各變更為化合物(I-2)(11.6g,30.6mmol)以外,進行與中間體-H1之合成的相同合成,得到中間體-H5(13.8g,產率72.0%)。 [Synthesis Example of Intermediate (2): Synthesis of Intermediates-H5 to H7] Synthesis of Intermediate-H5: 3-Hydroxy-4-iodobenzoic acid (CA1) (6.74 g, 25.5 mmol) was added to carboxylic acid (CA2) (10.0 g, 25.5 mmol) and the same synthesis as that of Intermediate-H1 was performed except that Compound (I-1) (9.5 g, 30.6 mmol) was replaced with Compound (I-2) (11.6 g, 30.6 mmol) to obtain Intermediate-H5 (13.8 g, yield 72.0%).

中間體-H6之合成: 將3-羥基-4-碘安息香酸(CA1)(6.74g,25.5mmol)於羧酸(CA2)(10.0g,25.5mmol)中,將化合物(I-1)(9.5g,30.6 mmol)各變更為化合物(I-3)(11.0g,30.6mmol)以外,進行與中間體-H1之合成的相同合成,得到中間體-H6(13.0g,產率70.0%)。 Synthesis of Intermediate-H6: 3-Hydroxy-4-iodobenzoic acid (CA1) (6.74 g, 25.5 mmol) was added to carboxylic acid (CA2) (10.0 g, 25.5 mmol), and the same synthesis as that of Intermediate-H1 was performed except that Compound (I-1) (9.5 g, 30.6 mmol) was replaced with Compound (I-3) (11.0 g, 30.6 mmol) to obtain Intermediate-H6 (13.0 g, yield 70.0%).

中間體-H7之合成: 將3-羥基-4-碘安息香酸(CA1)(6.74g,25.5mmol)於羧酸(CA2)(10.0g,25.5mmol)中,將化合物(I-1)(9.5g,30.6 mmol)各變更為化合物(I-4)(11.5g,30.6mmol)以外,進行與中間體-H1之合成的相同合成,得到中間體-H7(13.6g,產率71.0%)。 Synthesis of intermediate-H7: 3-Hydroxy-4-iodobenzoic acid (CA1) (6.74 g, 25.5 mmol) was added to carboxylic acid (CA2) (10.0 g, 25.5 mmol), and the same synthesis as that of intermediate-H1 was performed except that compound (I-1) (9.5 g, 30.6 mmol) was replaced with compound (I-4) (11.5 g, 30.6 mmol) to obtain intermediate-H7 (13.6 g, yield 71.0%).

[中間體之合成例(3):中間體-AA、BA、NA之合成] 中間體-AA之合成: 於容積500mL之三口燒瓶中,投入1.06M鋰二異丙基醯胺(LDA)之四氫呋喃(THF)/己烷溶液(87mL,92.3 mmol),冷卻至5℃後,投入將tert-丁基醇(8.0g,108.6 mmol)溶解於THF(30g)者,在5℃以下進行2小時反應。 其後,投入將化合物(M-1)(15.0g,54.3mmol)溶解於THF(225g)者,在5℃以下進行2小時反應。將反應液對超純水(205g)經30分鐘投入後,加入庚烷(205g),經30分鐘攪拌後除去有機層。將水層以庚烷(100g)洗淨3次後,加入MTBE(150g)與10%檸檬酸水溶液(205g,106.1mmol),經30分鐘攪拌後除去水層。將回收的有機層以超純水(150g)洗淨3次,將該有機層使用旋轉式蒸發器進行濃縮。將濃縮物以乙酸乙酯進行再結晶,得到中間體-AA (11.1g,產率58.3%)。 [Synthesis Example of Intermediates (3): Synthesis of Intermediates-AA, BA, and NA] Synthesis of Intermediate-AA: In a 500 mL three-necked flask, add a 1.06 M solution of lithium diisopropylamide (LDA) in tetrahydrofuran (THF)/hexane (87 mL, 92.3 mmol), cool to 5°C, add tert-butyl alcohol (8.0 g, 108.6 mmol) dissolved in THF (30 g), and react at 5°C or below for 2 hours. Thereafter, add compound (M-1) (15.0 g, 54.3 mmol) dissolved in THF (225 g), and react at 5°C or below for 2 hours. After the reaction solution was added to ultrapure water (205g) for 30 minutes, heptane (205g) was added, and the organic layer was removed after stirring for 30 minutes. After the aqueous layer was washed with heptane (100g) 3 times, MTBE (150g) and 10% citric acid aqueous solution (205g, 106.1mmol) were added, and the aqueous layer was removed after stirring for 30 minutes. The recovered organic layer was washed with ultrapure water (150g) 3 times, and the organic layer was concentrated using a rotary evaporator. The concentrate was recrystallized with ethyl acetate to obtain the intermediate -AA (11.1g, yield 58.3%).

中間體-BA、NA之合成: 將化合物(M-1)在等莫耳下,各變更為下述化合物(M-2)、(M-3),進行與中間體-AA之合成的相同合成,得到中間體-BA、中間體-NA。 Synthesis of intermediates-BA and NA: Compound (M-1) was replaced with the following compounds (M-2) and (M-3) at equimolar ratios, and the same synthesis as that of intermediate-AA was performed to obtain intermediates-BA and intermediates-NA.

[中間體之合成例(4):中間體-LAA、LBA、LNA之合成] 中間體-LAA1之合成: 於容積200mL之三口燒瓶中,投入中間體-AA(11.2、32.2mmol)、α-羥基-γ-丁內酯(內酯醇1)(3.5g,34.0mmol)與二氯甲烷(180g),在室溫下進行攪拌而溶解。 其次,投入二異丙基碳二亞胺(DIC)(6.2g,48.4mmol)與二甲基胺基吡啶(0.4g,3.2mmol),在室溫下進行5小時反應。過濾反應液,將經回收的有機層移至容積300mL之三口燒瓶。 其後,投入三氟乙酸(TFA)(22g,193.2mmol),在室溫下進行24小時攪拌。過濾所析出的固體。將過濾物再次溶解於甲醇(60g),滴入於超純水(600g),過濾所析出之固體。將該操作重複2次後,將過濾物藉由進行減壓乾燥,得到中間體-LAA1(9.1g,產率75.0%)。 [Synthesis example of intermediate (4): Synthesis of intermediates-LAA, LBA, LNA] Synthesis of intermediate-LAA1: In a 200mL three-necked flask, add intermediate-AA (11.2, 32.2mmol), α-hydroxy-γ-butyrolactone (lactone alcohol 1) (3.5g, 34.0mmol) and dichloromethane (180g), stir and dissolve at room temperature. Next, add diisopropylcarbodiimide (DIC) (6.2g, 48.4mmol) and dimethylaminopyridine (0.4g, 3.2mmol) and react at room temperature for 5 hours. Filter the reaction solution and transfer the recovered organic layer to a 300mL three-necked flask. Then, trifluoroacetic acid (TFA) (22 g, 193.2 mmol) was added and stirred at room temperature for 24 hours. The precipitated solid was filtered. The filtrate was dissolved in methanol (60 g) again, added dropwise to ultrapure water (600 g), and the precipitated solid was filtered. After repeating this operation twice, the filtrate was dried under reduced pressure to obtain the intermediate -LAA1 (9.1 g, yield 75.0%).

中間體-LAA2、LAA3之合成: 將內酯醇1在等莫耳下各變更為下述內酯醇2、內酯醇3,進行與中間體-LAA1之合成的相同合成,得到中間體-LAA2、中間體-LAA3。 Synthesis of intermediates-LAA2 and LAA3: Lactone alcohol 1 was changed to the following lactone alcohol 2 and lactone alcohol 3 at equimolar ratio, and the same synthesis as the synthesis of intermediate-LAA1 was carried out to obtain intermediates-LAA2 and intermediates-LAA3.

中間體-LBA1、LBA2、LBA3之合成: 將中間體-AA在等莫耳下變更為中間體-BA,使用各內酯醇1~3,進行與中間體-LAA1之合成的相同合成,得到中間體-LBA1、LBA2、LBA3。 Synthesis of intermediates-LBA1, LBA2, and LBA3: Intermediate-AA was converted to intermediate-BA at equimolar concentration, and each lactone alcohol 1 to 3 was used to perform the same synthesis as that of intermediate-LAA1 to obtain intermediates-LBA1, LBA2, and LBA3.

中間體-LNA1、LNA2之合成: 將中間體-AA在等莫耳下變更為中間體-NA,使用各內酯醇1、內酯醇3,進行與中間體-LAA1之合成的相同合成,得到中間體-LNA1、LNA2。 Synthesis of intermediates-LNA1 and LNA2: Intermediate-AA was converted to intermediate-NA at equimolar concentration, and lactone alcohol 1 and lactone alcohol 3 were used to perform the same synthesis as that of intermediate-LAA1 to obtain intermediates-LNA1 and LNA2.

[前驅物之合成例(1):前驅物(Bpre-01)~(Bpre-09)之合成] 前驅物(Bpre-01)之合成: 於容積200mL之三口燒瓶中,投入中間體-LBA1 (4.0、16.1mmol)、中間體-H1(8.1g,14.5mmol)與二氯甲烷(180g),在室溫下進行攪拌並使其溶解。 其次,投入二異丙基碳二亞胺(DIC)(3.1g,24.2mmol)與二甲基胺基吡啶(0.2g,1.6mmol),在室溫下進行5小時反應。過濾反應液,將濾液使用旋轉式蒸發器進行濃縮。將濃縮物以乙腈(40g)進行溶解後,滴入於MTBE(200g),過濾所析出的固體。將過濾物再次以乙腈(50g)溶解,滴入於MTBE(400g),過濾經析出的固體。將該操作重複2次後,將過濾物藉由減壓乾燥後得到前驅物(Bpre-01) (8.6g,產率75.5%)。 [Synthesis Example of Precursor (1): Synthesis of Precursor (Bpre-01) to (Bpre-09)] Synthesis of Precursor (Bpre-01): In a 200 mL three-necked flask, intermediate-LBA1 (4.0, 16.1 mmol), intermediate-H1 (8.1 g, 14.5 mmol) and dichloromethane (180 g) were added and stirred at room temperature to dissolve. Next, diisopropylcarbodiimide (DIC) (3.1 g, 24.2 mmol) and dimethylaminopyridine (0.2 g, 1.6 mmol) were added and reacted at room temperature for 5 hours. The reaction solution was filtered and the filtrate was concentrated using a rotary evaporator. The concentrate was dissolved in acetonitrile (40 g), then dripped into MTBE (200 g), and the precipitated solid was filtered. The filtrate was dissolved in acetonitrile (50 g) again, then dripped into MTBE (400 g), and the precipitated solid was filtered. This operation was repeated twice, and the filtrate was dried under reduced pressure to obtain the precursor (Bpre-01) (8.6 g, yield 75.5%).

前驅物(Bpre-02)~(Bpre-09)之合成: 使用各中間體-LBA1~LBA3之羧酸群(16.1mmol)與中間體-H1~H7之酚型群(14.5mmol),進行與前驅物(Bpre-01)之合成的相同合成,得到前驅物(Bpre-02)~(Bpre-09)。 欲得到各前驅物而使用的羧酸與中間體之組合如以下所示。 前驅物(Bpre-01):中間體-LBA1與中間體-H1之組合 前驅物(Bpre-02):中間體-LBA1與中間體-H2之組合 前驅物(Bpre-03):中間體-LBA1與中間體-H3之組合 前驅物(Bpre-04):中間體-LBA1與中間體-H4之組合 前驅物(Bpre-05):中間體-LBA3與中間體-H2之組合 前驅物(Bpre-06):中間體-LBA2與中間體-H2之組合 前驅物(Bpre-07):中間體-LBA1與中間體-H5之組合 前驅物(Bpre-08):中間體-LBA1與中間體-H6之組合 前驅物(Bpre-09):中間體-LBA1與中間體-H7之組合 Synthesis of promotors (Bpre-02) to (Bpre-09): Using the carboxylic acid group (16.1 mmol) of each intermediate -LBA1 to LBA3 and the phenolic group (14.5 mmol) of the intermediate -H1 to H7, the same synthesis as the synthesis of the promotor (Bpre-01) was carried out to obtain promotors (Bpre-02) to (Bpre-09). The combination of carboxylic acid and intermediate used to obtain each promotor is shown below. Prodriver (Bpre-01): Combination of intermediate-LBA1 and intermediate-H1 Prodriver (Bpre-02): Combination of intermediate-LBA1 and intermediate-H2 Prodriver (Bpre-03): Combination of intermediate-LBA1 and intermediate-H3 Prodriver (Bpre-04): Combination of intermediate-LBA1 and intermediate-H4 Prodriver (Bpre-05): Combination of intermediate-LBA3 and intermediate-H2 Prodriver (Bpre-06): Combination of intermediate-LBA2 and intermediate-H2 Prodriver (Bpre-07): Combination of intermediate-LBA1 and intermediate-H5 Prodriver (Bpre-08): Combination of intermediate-LBA1 and intermediate-H6 Prodriver (Bpre-09): Combination of intermediate-LBA1 and intermediate-H7

[前驅物之合成例(2):前驅物(Bpre-13)~(Bpre-17)之合成] 使用各中間體-LNA1、LNA2之羧酸群(16.1mmol)與中間體-H1、H2、H4、H5的酚型群(14.5mmol),進行與前驅物(Bpre-01)之合成的相同合成,得到前驅物(Bpre-13)~(Bpre-17)。 將欲得到各前驅物而使用的羧酸與中間體之組合如以下所示。 前驅物(Bpre-13):中間體-LNA1與中間體-H1之組合 前驅物(Bpre-14):中間體-LNA1與中間體-H2之組合 前驅物(Bpre-15):中間體-LNA1與中間體-H4之組合 前驅物(Bpre-16):中間體-LNA2與中間體-H2之組合 前驅物(Bpre-17):中間體-LNA1與中間體-H5之組合 [Synthesis Example of Precursor (2): Synthesis of Precursors (Bpre-13) to (Bpre-17)] Using the carboxylic acid group (16.1 mmol) of each intermediate - LNA1, LNA2 and the phenolic group (14.5 mmol) of the intermediate - H1, H2, H4, H5, the same synthesis as the synthesis of the precursor (Bpre-01) was carried out to obtain precursors (Bpre-13) to (Bpre-17). The combination of carboxylic acid and intermediate used to obtain each precursor is shown below. Prodriver (Bpre-13): Combination of intermediate-LNA1 and intermediate-H1 Prodriver (Bpre-14): Combination of intermediate-LNA1 and intermediate-H2 Prodriver (Bpre-15): Combination of intermediate-LNA1 and intermediate-H4 Prodriver (Bpre-16): Combination of intermediate-LNA2 and intermediate-H2 Prodriver (Bpre-17): Combination of intermediate-LNA1 and intermediate-H5

[前驅物之合成例(3):前驅物(Bpre-19)~(Bpre-26)之合成] 使用各中間體-LAA1、LAA2、LAA3之羧酸群(16.1 mmol)與中間體-H1、H2、H4、H5、H6、H7之酚型群(14.5mmol),進行與前驅物(Bpre-01)之合成的相同合成,得到前驅物(Bpre-19)~(Bpre-26)。 欲得到各前驅物而使用的羧酸與中間體之組合如以下所示。 前驅物(Bpre-19):中間體-LAA1與中間體-H1之組合 前驅物(Bpre-20):中間體-LAA1與中間體-H2之組合 前驅物(Bpre-21):中間體-LAA1與中間體-H4之組合 前驅物(Bpre-22):中間體-LAA2與中間體-H2之組合 前驅物(Bpre-23):中間體-LAA3與中間體-H2之組合 前驅物(Bpre-24):中間體-LAA1與中間體-H5之組合 前驅物(Bpre-25):中間體-LAA1與中間體-H6之組合 前驅物(Bpre-26):中間體-LAA1與中間體-H7之組合 [Synthesis Example of Precursor (3): Synthesis of Precursors (Bpre-19) to (Bpre-26)] Using the carboxylic acid group (16.1 mmol) of each intermediate - LAA1, LAA2, LAA3 and the phenolic group (14.5 mmol) of the intermediate - H1, H2, H4, H5, H6, H7, the same synthesis as the synthesis of the precursor (Bpre-01) was carried out to obtain the precursors (Bpre-19) to (Bpre-26). The combination of carboxylic acid and intermediate used to obtain each precursor is shown below. Prodriver (Bpre-19): Combination of intermediate-LAA1 and intermediate-H1 Prodriver (Bpre-20): Combination of intermediate-LAA1 and intermediate-H2 Prodriver (Bpre-21): Combination of intermediate-LAA1 and intermediate-H4 Prodriver (Bpre-22): Combination of intermediate-LAA2 and intermediate-H2 Prodriver (Bpre-23): Combination of intermediate-LAA3 and intermediate-H2 Prodriver (Bpre-24): Combination of intermediate-LAA1 and intermediate-H5 Prodriver (Bpre-25): Combination of intermediate-LAA1 and intermediate-H6 Promotor (Bpre-26): Combination of intermediate-LAA1 and intermediate-H7

[化合物(B0)之合成例:化合物(B0-1)~化合物(B0-29)之合成] 化合物(B0-1)之合成: 將前驅物(Bpre-01)(7.9g,10.0mmol)與鹽交換用化合物A(3.8g,11.0mmol)溶解於二氯甲烷(120g),加入超純水(120g),在室溫下進行30分鐘反應。反應終了後除去水相後,將有機相以超純水(120g)洗淨4次。將有機相使用旋轉式蒸發器藉由濃縮乾固後得到化合物(B0-1)(8.7g,產率96.5%)。 [Synthesis example of compound (B0): Synthesis of compound (B0-1) to compound (B0-29)] Synthesis of compound (B0-1): The precursor (Bpre-01) (7.9 g, 10.0 mmol) and salt exchange compound A (3.8 g, 11.0 mmol) were dissolved in dichloromethane (120 g), ultrapure water (120 g) was added, and the reaction was carried out at room temperature for 30 minutes. After the reaction was completed, the aqueous phase was removed, and the organic phase was washed 4 times with ultrapure water (120 g). The organic phase was concentrated and dried using a rotary evaporator to obtain compound (B0-1) (8.7 g, yield 96.5%).

化合物(B0-2)~化合物(B0-29)之合成: 變更為上述前驅物(Bpre-02)~(Bpre-09)、前驅物(Bpre-13)~(Bpre-17)、前驅物(Bpre-19)~(Bpre-26)與下述鹽交換用化合物A~鹽交換用化合物D的組合以外,進行與化合物(B0-1)之合成的相同合成,得到化合物(B0-2)~化合物(B0-29)。 Synthesis of Compounds (B0-2) to (B0-29): Except for changing the above-mentioned promotors (Bpre-02) to (Bpre-09), promotors (Bpre-13) to (Bpre-17), promotors (Bpre-19) to (Bpre-26) and the following salt exchange compounds A to D, the same synthesis as the synthesis of compound (B0-1) was carried out to obtain compounds (B0-2) to (B0-29).

對於所得的各化合物,進行NMR測定,由以下分析結果對各結構進行鑑定。Each of the obtained compounds was subjected to NMR measurement, and each structure was identified from the following analysis results.

化合物(B0-1):前驅物(Bpre-01)與鹽交換用化合物A之組合 1H-NMR(DMSO, 400MHz):δ(ppm)=7.67-7.90 (m, ArH+Ar-I, 17H), 7.53-7.63 (d, ArH, 4H), 6.94 (d, Ar-I, 1H), 5.39 (m, CH (內酯), 1H), 4.51-4.68 (m, CF2CH2, 2H), 4.41 (m, CH2 (內酯), 1H), 4.25 (m, CH2 (內酯), 1H), 2.65 (m, CH2 (內酯), 1H), 2.25 (m, CH2 (內酯), 1H) Compound (B0-1): Combination of precursor (Bpre-01) and salt exchange compound A 1 H-NMR (DMSO, 400MHz): δ(ppm)=7.67-7.90 (m, ArH+Ar-I, 17H), 7.53-7.63 (d, ArH, 4H), 6.94 (d, Ar-I, 1H), 5.39 (m, CH (lactone), 1H), 4.51-4.68 (m, CF2CH2, 2H), 4.41 (m, CH2 (lactone), 1H), 4.25 (m, CH2 (lactone), 1H), 2.65 (m, CH2 (lactone), 1H), 2.25 (m, CH2 (lactone), 1H)

化合物(B0-2):前驅物(Bpre-02)與鹽交換用化合物A之組合 1H-NMR(DMSO,400MHz):δ(ppm)=7.99 (d, Ar-I, 1H), 7.74-7.90 (m, ArH+Ar-I, 16H), 7.53-7.63 (d, ArH, 4H), 5.39 (m, CH (內酯), 1H), 4.51-4.68 (m, CF2CH2, 2H), 4.41 (m, CH2 (內酯), 1H), 4.25 (m, CH2 (內酯), 1H), 2.65 (m, CH2 (內酯), 1H), 2.25 (m, CH2 (內酯), 1H) Compound (B0-2): Combination of precursor (Bpre-02) and salt exchange compound A 1 H-NMR (DMSO, 400MHz): δ (ppm) = 7.99 (d, Ar-I, 1H), 7.74-7.90 (m, ArH+Ar-I, 16H), 7.53-7.63 (d, ArH, 4H), 5.39 (m, CH (lactone), 1H), 4.51-4.68 (m, CF2CH2, 2H), 4.41 (m, CH2 (lactone), 1H), 4.25 (m, CH2 (lactone), 1H), 2.65 (m, CH2 (lactone), 1H), 2.25 (m, CH2 (lactone), 1H)

化合物(B0-3):前驅物(Bpre-03)與鹽交換用化合物A之組合 1H-NMR(DMSO,400MHz):δ(ppm)=9.48 (s, NH, 1H), 8.12 (m, Ar-I, 1H), 8.01 (d, Ar-I, 1H), 7.74-7.90 (m, ArH, 15H), 7.53-7.63 (d, ArH, 4H), 5.39 (m, CH (內酯), 1H), 4.51-4.68 (m, CF2CH2, 2H), 4.41 (m, CH2 (內酯), 1H), 4.25 (m, CH2 (內酯), 1H), 2.65 (m, CH2 (內酯), 1H), 2.25 (m, CH2 (內酯), 1H) Compound (B0-3): Combination of precursor (Bpre-03) and salt exchange compound A 1 H-NMR (DMSO, 400MHz): δ (ppm) = 9.48 (s, NH, 1H), 8.12 (m, Ar-I, 1H), 8.01 (d, Ar-I, 1H), 7.74-7.90 (m, ArH, 15H), 7.53-7.63 (d, ArH, 4H), 5.39 (m, CH (lactone), 1H), 4.51-4.68 (m, CF2CH2, 2H), 4.41 (m, CH2 (lactone), 1H), 4.25 (m, CH2 (lactone), 1H), 2.65 (m, CH2 (lactone), 1H), 2.25 (m, CH2 (Lactone), 1H)

化合物(B0-4):前驅物(Bpre-04)與鹽交換用化合物A之組合 1H-NMR(DMSO,400MHz):δ(ppm)=8.12 (d, Ar-I, 1H), 7.74-7.90 (m, ArH, 15H), 7.53-7.63 (d, ArH, 4H), 5.39 (m, CH (內酯), 1H), 4.51-4.68 (m, CF2CH2, 2H), 4.41 (m, CH2 (內酯), 1H), 4.25 (m, CH2 (內酯), 1H), 2.65 (m, CH2 (內酯), 1H), 2.25 (m, CH2, 1H) Compound (B0-4): Combination of precursor (Bpre-04) and salt exchange compound A 1 H-NMR (DMSO, 400MHz): δ (ppm) = 8.12 (d, Ar-I, 1H), 7.74-7.90 (m, ArH, 15H), 7.53-7.63 (d, ArH, 4H), 5.39 (m, CH (lactone), 1H), 4.51-4.68 (m, CF2CH2, 2H), 4.41 (m, CH2 (lactone), 1H), 4.25 (m, CH2 (lactone), 1H), 2.65 (m, CH2 (lactone), 1H), 2.25 (m, CH2, 1H)

化合物(B0-5):前驅物(Bpre-05)與鹽交換用化合物A之組合 1H-NMR(DMSO,400MHz):δ(ppm)=7.99 (d, Ar-I, 1H), 7.74-7.90 (m, ArH+Ar-I, 16H), 7.53-7.63 (d, ArH, 4H), 4.51-4.68 (m, CF2CH2+CH (內酯), 4H), 3.31 (m, CH (內酯), 1H), 2.59 (m, CH (內酯), 2H), 1.63-2.10 (m, CH2 (內酯), 4H) Compound (B0-5): Combination of precursor (Bpre-05) and salt exchange compound A 1 H-NMR (DMSO, 400MHz): δ (ppm) = 7.99 (d, Ar-I, 1H), 7.74-7.90 (m, ArH+Ar-I, 16H), 7.53-7.63 (d, ArH, 4H), 4.51-4.68 (m, CF2CH2+CH (lactone), 4H), 3.31 (m, CH (lactone), 1H), 2.59 (m, CH (lactone), 2H), 1.63-2.10 (m, CH2 (lactone), 4H)

化合物(B0-6):前驅物(Bpre-06)與鹽交換用化合物A之組合 1H-NMR(DMSO,400MHz):δ(ppm)=7.99 (d, Ar-I, 1H), 7.74-7.90(m, ArH+Ar-I, 16H), 7.53-7.63 (d, ArH, 4H), 5.51 (m, CH (內酯), 1H), 4.51-4.68 (m, CF2CH2, 2H), 4.50 (m, CH2 (內酯), 1H), 4.37 (m, CH2 (內酯), 1H), 2.86 (m, CH2 (內酯), 1H), 2.66 (m, CH2 (內酯), 1H) Compound (B0-6): Combination of precursor (Bpre-06) and salt exchange compound A 1 H-NMR (DMSO, 400MHz): δ (ppm) = 7.99 (d, Ar-I, 1H), 7.74-7.90 (m, ArH+Ar-I, 16H), 7.53-7.63 (d, ArH, 4H), 5.51 (m, CH (lactone), 1H), 4.51-4.68 (m, CF2CH2, 2H), 4.50 (m, CH2 (lactone), 1H), 4.37 (m, CH2 (lactone), 1H), 2.86 (m, CH2 (lactone), 1H), 2.66 (m, CH2 (lactone), 1H)

化合物(B0-7):前驅物(Bpre-07)與鹽交換用化合物A之組合 1H-NMR(DMSO,400MHz):δ(ppm)=7.99 (d, Ar-I, 1H), 7.74-7.90(m, ArH+Ar-I, 16H), 7.53-7.63 (d, ArH, 4H), 5.90 (m, CF3CH, 1H), 5.39 (m, CH (內酯), 1H), 4.41 (m, CH2 (內酯), 1H), 4.25 (m, CH2 (內酯), 1H), 2.65 (m, CH2 (內酯), 1H), 2.25 (m, CH2 (內酯), 1H) Compound (B0-7): Combination of procatalyst (Bpre-07) and salt exchange compound A 1 H-NMR (DMSO, 400MHz): δ (ppm) = 7.99 (d, Ar-I, 1H), 7.74-7.90 (m, ArH+Ar-I, 16H), 7.53-7.63 (d, ArH, 4H), 5.90 (m, CF3CH, 1H), 5.39 (m, CH (lactone), 1H), 4.41 (m, CH2 (lactone), 1H), 4.25 (m, CH2 (lactone), 1H), 2.65 (m, CH2 (lactone), 1H), 2.25 (m, CH2 (lactone), 1H)

化合物(B0-8):前驅物(Bpre-08)與鹽交換用化合物A之組合 1H-NMR(DMSO,400MHz):δ(ppm)=7.99 (d, Ar-I, 1H), 7.74-7.90(m, ArH+Ar-I, 16H), 7.53-7.63 (d, ArH, 4H), 5.39 (m, CH (內酯), 1H), 4.91-5.20 (m, CFCH, 1H), 4.41 (m, CH2 (內酯), 1H), 4.25 (m, CH2 (內酯), 1H),3.95-4.20 (m, COOCH2CH2, 2H), 2.65 (m, CH2 (內酯), 1H), 2.30-2.45(m, COOCH2CH2, 1H), 2.25 (m, CH2(內酯), 1H), 2.05 (m, COOCH2CH2, 1H) Compound (B0-8): Combination of procatalyst (Bpre-08) and salt exchange compound A 1 H-NMR (DMSO, 400MHz): δ (ppm) = 7.99 (d, Ar-I, 1H), 7.74-7.90 (m, ArH+Ar-I, 16H), 7.53-7.63 (d, ArH, 4H), 5.39 (m, CH (lactone), 1H), 4.91-5.20 (m, CFCH, 1H), 4.41 (m, CH2 (lactone), 1H), 4.25 (m, CH2 (lactone), 1H), 3.95-4.20 (m, COOCH2CH2, 2H), 2.65 (m, CH2 (lactone), 1H), 2.30-2.45 (m, COOCH2CH2, 1H), 2.25 (m, CH2(lactone), 1H), 2.05 (m, COOCH2CH2, 1H)

化合物(B0-9):前驅物(Bpre-09)與鹽交換用化合物A之組合 1H-NMR(DMSO,400MHz):δ(ppm)=7.99 (d, Ar-I, 1H), 7.74-7.90(m, ArH+Ar-I, 16H), 7.53-7.63 (d, ArH, 4H), 5.39 (m, CH (內酯), 1H), 4.41 (m, CH2 (內酯), 1H), 4.05-4.25 (m, COOCH2CH2+CH2 (內酯), 3H), 2.63-2.73 (m, COOCH2CH2+CH2 (內酯), 3H), 2.25 (m, CH2 (內酯), 1H) Compound (B0-9): Combination of precursor (Bpre-09) and salt exchange compound A 1 H-NMR (DMSO, 400MHz): δ (ppm) = 7.99 (d, Ar-I, 1H), 7.74-7.90 (m, ArH+Ar-I, 16H), 7.53-7.63 (d, ArH, 4H), 5.39 (m, CH (lactone), 1H), 4.41 (m, CH2 (lactone), 1H), 4.05-4.25 (m, COOCH2CH2+CH2 (lactone), 3H), 2.63-2.73 (m, COOCH2CH2+CH2 (lactone), 3H), 2.25 (m, CH2 (lactone), 1H)

化合物(B0-10):前驅物(Bpre-02)與鹽交換用化合物B之組合 1H-NMR(DMSO,400MHz):δ(ppm)=7.70-8.22 (m, ArH+Ar-I, 16H), 7.53-7.63 (d, ArH, 4H), 5.39 (m, CH (內酯), 1H), 4.51-4.68 (m, CF2CH2, 2H), 4.41 (m, CH2 (內酯), 1H), 4.25 (m, CH2 (內酯), 1H), 3.30-3.45 (m, SO2CH,1H), 2.65 (m, CH2 (內酯), 1H), 2.25 (m, CH2 (內酯), 1H), 1.09-1.90 (m, cyclohexyl, 10H) Compound (B0-10): Combination of precursor (Bpre-02) and salt exchange compound B 1 H-NMR (DMSO, 400MHz): δ (ppm) = 7.70-8.22 (m, ArH+Ar-I, 16H), 7.53-7.63 (d, ArH, 4H), 5.39 (m, CH (lactone), 1H), 4.51-4.68 (m, CF2CH2, 2H), 4.41 (m, CH2 (lactone), 1H), 4.25 (m, CH2 (lactone), 1H), 3.30-3.45 (m, SO2CH,1H), 2.65 (m, CH2 (lactone), 1H), 2.25 (m, CH2 (lactone), 1H), 1.09-1.90 (m, cyclohexyl, 10H)

化合物(B0-11):前驅物(Bpre-02)與鹽交換用化合物C之組合 1H-NMR(DMSO,400MHz):δ(ppm)=7.77-7.99 (m, ArH+Ar-I, 13H), 7.53-7.63 (d, ArH, 4H), 5.39 (m, CH (內酯), 1H), 4.51-4.68 (m, CF2CH2, 2H), 4.41 (m, CH2 (內酯), 1H), 4.25 (m, CH2 (內酯), 1H), 2.65 (m, CH2 (內酯), 1H), 2.25 (m, CH2 (內酯), 1H) Compound (B0-11): Combination of procatalyst (Bpre-02) and salt exchange compound C 1 H-NMR (DMSO, 400MHz): δ (ppm) = 7.77-7.99 (m, ArH+Ar-I, 13H), 7.53-7.63 (d, ArH, 4H), 5.39 (m, CH (lactone), 1H), 4.51-4.68 (m, CF2CH2, 2H), 4.41 (m, CH2 (lactone), 1H), 4.25 (m, CH2 (lactone), 1H), 2.65 (m, CH2 (lactone), 1H), 2.25 (m, CH2 (lactone), 1H)

化合物(B0-12):前驅物(Bpre-02)與鹽交換用化合物D之組合 1H-NMR(DMSO,400MHz):δ(ppm)=8.50 (d, ArH, 2H), 8.37 (d, ArH, 2H), 7.99 (d, Ar-I, 1H), 7.93 (t, ArH, 2H) 7.84 (d, Ar-I, 1H), 7.53-7.75 (d, ArH, 11H), 5.39 (m, CH (內酯), 1H), 4.51-4.68 (m, CF2CH2, 2H), 4.41 (m, CH2 (內酯), 1H), 4.25 (m, CH2 (內酯), 1H), 2.65 (m, CH2 (內酯), 1H), 2.25 (m, CH2 (內酯), 1H) Compound (B0-12): Combination of procatalyst (Bpre-02) and salt exchange compound D 1 H-NMR (DMSO, 400MHz): δ (ppm) = 8.50 (d, ArH, 2H), 8.37 (d, ArH, 2H), 7.99 (d, Ar-I, 1H), 7.93 (t, ArH, 2H) 7.84 (d, Ar-I, 1H), 7.53-7.75 (d, ArH, 11H), 5.39 (m, CH (lactone), 1H), 4.51-4.68 (m, CF2CH2, 2H), 4.41 (m, CH2 (lactone), 1H), 4.25 (m, CH2 (lactone), 1H), 2.65 (m, CH2 (lactone), 1H), 2.25 (m, CH2 (lactone), 1H)

化合物(B0-13):前驅物(Bpre-13)與鹽交換用化合物A之組合 1H-NMR(DMSO,400MHz):δ(ppm)=7.74-7.90 (m, ArH+Ar-I, 17H), 6.94 (d, Ar-I, 1H), 6.30 (d, CH, 1H), 6.10 (d, CH, 1H), 5.39 (m, CH (內酯), 1H), 4.51-4.68 (m, CF2CH2, 2H), 4.41 (m, CH2 (內酯), 1H), 4.25 (m, CH2 (內酯), 1H), 3.15 (m, CH, 2H), 3.00 (m, CH, 1H), 2.65 (m, CH2 (內酯), 1H), 2.38 (m, CH, 1H), 2.25 (m, CH2 (內酯), 1H), 1.30-1.50 (m, CH2, 2H) Compound (B0-13): Combination of procatalyst (Bpre-13) and salt exchange compound A 1 H-NMR (DMSO, 400MHz): δ (ppm) = 7.74-7.90 (m, ArH+Ar-I, 17H), 6.94 (d, Ar-I, 1H), 6.30 (d, CH, 1H), 6.10 (d, CH, 1H), 5.39 (m, CH (lactone), 1H), 4.51-4.68 (m, CF2CH2, 2H), 4.41 (m, CH2 (lactone), 1H), 4.25 (m, CH2 (lactone), 1H), 3.15 (m, CH, 2H), 3.00 (m, CH, 1H), 2.65 (m, CH2 (lactone), 1H), 2.38 (m, CH, 1H), 2.25 (m, CH2 (lactone), 1H), 1.30-1.50 (m, CH2, 2H)

化合物(B0-14):前驅物(Bpre-14)與鹽交換用化合物A之組合 1H-NMR(DMSO,400MHz):δ(ppm)=7.99 (d, Ar-I, 1H), 7.74-7.90 (m, ArH+Ar-I, 16H), 6.30 (d, CH, 1H), 6.10 (d, CH, 1H), 5.39 (m, CH (內酯), 1H), 4.51-4.68 (m, CF2CH2, 2H), 4.41 (m, CH2 (內酯), 1H), 4.25 (m, CH2 (內酯), 1H), 3.15 (m, CH, 2H), 3.00 (m, CH, 1H), 2.65 (m, CH2 (內酯), 1H), 2.38 (m, CH, 1H), 2.25 (m, CH2 (內酯), 1H), 1.30-1.50 (m, CH2, 2H) Compound (B0-14): Combination of procatalyst (Bpre-14) and salt exchange compound A 1 H-NMR (DMSO, 400MHz): δ (ppm) = 7.99 (d, Ar-I, 1H), 7.74-7.90 (m, ArH+Ar-I, 16H), 6.30 (d, CH, 1H), 6.10 (d, CH, 1H), 5.39 (m, CH (lactone), 1H), 4.51-4.68 (m, CF2CH2, 2H), 4.41 (m, CH2 (lactone), 1H), 4.25 (m, CH2 (lactone), 1H), 3.15 (m, CH, 2H), 3.00 (m, CH, 1H), 2.65 (m, CH2 (lactone), 1H), 2.38 (m, CH, 1H), 2.25 (m, CH2 (lactone), 1H), 1.30-1.50 (m, CH2, 2H)

化合物(B0-15):前驅物(Bpre-15)與鹽交換用化合物A之組合 1H-NMR(DMSO,400MHz):δ(ppm)=8.12 (d, Ar-I, 1H), 7.74-7.90 (m, ArH, 15H), 6.30 (d, CH, 1H), 6.10 (d, CH, 1H), 5.39 (m, CH (內酯), 1H), 4.51-4.68 (m, CF2CH2, 2H), 4.41 (m, CH2 (內酯), 1H), 4.25 (m, CH2 (內酯), 1H), 3.15 (m, CH, 2H), 3.00 (m, CH, 1H), 2.65 (m, CH2 (內酯), 1H),2.38 (m, CH, 1H), 2.25 (m, CH2 (內酯), 1H), 1.30-1.50 (m, CH2, 2H) Compound (B0-15): Combination of procatalyst (Bpre-15) and salt exchange compound A 1 H-NMR (DMSO, 400MHz): δ (ppm) = 8.12 (d, Ar-I, 1H), 7.74-7.90 (m, ArH, 15H), 6.30 (d, CH, 1H), 6.10 (d, CH, 1H), 5.39 (m, CH (lactone), 1H), 4.51-4.68 (m, CF2CH2, 2H), 4.41 (m, CH2 (lactone), 1H), 4.25 (m, CH2 (lactone), 1H), 3.15 (m, CH, 2H), 3.00 (m, CH, 1H), 2.65 (m, CH2 (lactone), 1H), 2.38 (m, CH, 1H), 2.25 (m, CH2 (lactone), 1H), 1.30-1.50 (m, CH2, 2H)

化合物(B0-16):前驅物(Bpre-16)與鹽交換用化合物A之組合 1H-NMR(DMSO,400MHz):δ(ppm)=7.99 (d, Ar-I, 1H), 7.74-7.90 (m, ArH+Ar-I, 16H), 6.30 (d, CH, 1H), 6.10 (d, CH, 1H), 4.51-4.68 (m, CF2CH2+CH (內酯), 4H), 3.31 (m, CH (內酯), 1H), 3.15 (m, CH, 2H), 3.00 (m, CH, 1H), 2.59 (m, CH (內酯), 2H), 2.38 (m, CH, 1H), 1.63-2.10 (m, CH2 (降冰片烯)+CH2 (內酯), 6H) Compound (B0-16): Combination of procatalyst (Bpre-16) and salt exchange compound A 1 H-NMR (DMSO, 400MHz): δ (ppm) = 7.99 (d, Ar-I, 1H), 7.74-7.90 (m, ArH+Ar-I, 16H), 6.30 (d, CH, 1H), 6.10 (d, CH, 1H), 4.51-4.68 (m, CF2CH2+CH (lactone), 4H), 3.31 (m, CH (lactone), 1H), 3.15 (m, CH, 2H), 3.00 (m, CH, 1H), 2.59 (m, CH (lactone), 2H), 2.38 (m, CH, 1H), 1.63-2.10 (m, CH2 (Norbornene)+CH2 (lactone), 6H)

化合物(B0-17):前驅物(Bpre-17)與鹽交換用化合物A之組合 1H-NMR(DMSO,400MHz):δ(ppm)=7.99 (d, Ar-I, 1H), 7.74-7.90 (m, ArH+Ar-I, 16H), 6.30 (d, CH, 1H), 6.10 (d, CH, 1H), 5.90 (m, CF3CH, 1H), 5.39 (m, CH (內酯), 1H), 4.41 (m, CH2 (內酯), 1H), 4.25 (m, CH2 (內酯), 1H), 3.15 (m, CH, 2H), 3.00 (m, CH, 1H), 2.65 (m, CH2 (內酯), 1H),2.38 (m, CH, 1H), 2.25 (m, CH2 (內酯), 1H), 1.30-1.50 (m, CH2, 2H) Compound (B0-17): Combination of procatalyst (Bpre-17) and salt exchange compound A 1 H-NMR (DMSO, 400MHz): δ (ppm) = 7.99 (d, Ar-I, 1H), 7.74-7.90 (m, ArH+Ar-I, 16H), 6.30 (d, CH, 1H), 6.10 (d, CH, 1H), 5.90 (m, CF3CH, 1H), 5.39 (m, CH (lactone), 1H), 4.41 (m, CH2 (lactone), 1H), 4.25 (m, CH2 (lactone), 1H), 3.15 (m, CH, 2H), 3.00 (m, CH, 1H), 2.65 (m, CH2 (lactone), 1H),2.38 (m, CH, 1H), 2.25 (m, CH2 (lactone), 1H), 1.30-1.50 (m, CH2, 2H)

化合物(B0-18):前驅物(Bpre-17)與鹽交換用化合物C之組合 1H-NMR(DMSO,400MHz):δ(ppm)=7.77-7.99 (m, ArH, 13H), 6.30 (d, CH, 1H), 6.10 (d, CH, 1H), 5.90 (m, CF3CH, 1H), 5.39 (m, CH (內酯), 1H), 4.41 (m, CH2 (內酯), 1H), 4.25 (m, CH2 (內酯), 1H), 3.15 (m, CH, 2H), 3.00 (m, CH, 1H), 2.65 (m, CH2 (內酯), 1H),2.38 (m, CH, 1H), 2.25 (m, CH2 (內酯), 1H), 1.30-1.50 (m, CH2, 2H) Compound (B0-18): Combination of procatalyst (Bpre-17) and salt exchange compound C 1 H-NMR (DMSO, 400MHz): δ(ppm)=7.77-7.99 (m, ArH, 13H), 6.30 (d, CH, 1H), 6.10 (d, CH, 1H), 5.90 (m, CF3CH, 1H), 5.39 (m, CH (lactone), 1H), 4.41 (m, CH2 (lactone), 1H), 4.25 (m, CH2 (lactone), 1H), 3.15 (m, CH, 2H), 3.00 (m, CH, 1H), 2.65 (m, CH2 (lactone), 1H),2.38 (m, CH, 1H), 2.25 (m, CH2 (lactone), 1H), 1.30-1.50 (m, CH2, 2H)

化合物(B0-19):前驅物(Bpre-19)與鹽交換用化合物A之組合 1H-NMR(DMSO,400MHz):δ(ppm)=7.74-7.90 (m, ArH+Ar-I, 17H), 7.01-7.47 (m, ArH, 8H), 6.94 (d, Ar-I, 1H), 5.39 (m, CH (內酯), 1H), 4.70-4.85 (m, -OCO-CH-CH-COO-, 2H), 4.51-4.68 (m, CF2CH2, 2H), 4.41 (m, CH2 (內酯), 1H), 4.25 (m, CH2 (內酯), 1H), 3.15-3.40 (m, CH, 2H), 2.65 (m, CH2 (內酯), 1H), 2.25 (m, CH2 (內酯), 1H) Compound (B0-19): Combination of procatalyst (Bpre-19) and salt exchange compound A 1 H-NMR (DMSO, 400MHz): δ (ppm) = 7.74-7.90 (m, ArH+Ar-I, 17H), 7.01-7.47 (m, ArH, 8H), 6.94 (d, Ar-I, 1H), 5.39 (m, CH (lactone), 1H), 4.70-4.85 (m, -OCO-CH-CH-COO-, 2H), 4.51-4.68 (m, CF2CH2, 2H), 4.41 (m, CH2 (lactone), 1H), 4.25 (m, CH2 (lactone), 1H), 3.15-3.40 (m, CH, 2H), 2.65 (m, CH2 (lactone), 1H), 2.25 (m, CH2 (lactone), 1H)

化合物(B0-20):前驅物(Bpre-20)與鹽交換用化合物A之組合 1H-NMR(DMSO,400MHz):δ(ppm)=7.99 (m, Ar-I, 1H), 7.74-7.90 (m, ArH+ Ar-I, 16H), 7.01-7.47(m, ArH, 8H), 5.39 (m, CH (內酯), 1H), 4.70-4.85 (m, -OCO-CH-CH-COO-, 2H), 4.51-4.68 (m, CF2CH2, 2H), 4.41 (m, CH2 (內酯), 1H), 4.25 (m, CH2 (內酯), 1H), 3.15-3.40 (m, CH, 2H), 2.65 (m, CH2 (內酯), 1H), 2.25 (m, CH2 (內酯), 1H) Compound (B0-20): Combination of procatalyst (Bpre-20) and salt exchange compound A 1 H-NMR (DMSO, 400MHz): δ (ppm) = 7.99 (m, Ar-I, 1H), 7.74-7.90 (m, ArH+ Ar-I, 16H), 7.01-7.47 (m, ArH, 8H), 5.39 (m, CH (lactone), 1H), 4.70-4.85 (m, -OCO-CH-CH-COO-, 2H), 4.51-4.68 (m, CF2CH2, 2H), 4.41 (m, CH2 (lactone), 1H), 4.25 (m, CH2 (lactone), 1H), 3.15-3.40 (m, CH, 2H), 2.65 (m, CH2 (lactone), 1H), 2.25 (m, CH2 (lactone), 1H)

化合物(B0-21):前驅物(Bpre-21)與鹽交換用化合物A之組合 1H-NMR(DMSO,400MHz):δ(ppm)=8.12 (m, Ar-I, 1H), 7.74-7.90 (m, ArH, 15H),7.01-7.47(m, ArH, 8H), 5.39 (m, CH (內酯), 1H), 4.70-4.85 (m, -OCO-CH-CH-COO-, 2H), 4.51-4.68 (m, CF2CH2, 2H), 4.41 (m, CH2 (內酯), 1H), 4.25 (m, CH2 (內酯), 1H), 3.15-3.40 (m, CH, 2H), 2.65 (m, CH2 (內酯), 1H), 2.25 (m, CH2 (內酯), 1H) Compound (B0-21): Combination of procatalyst (Bpre-21) and salt exchange compound A 1 H-NMR (DMSO, 400MHz): δ (ppm) = 8.12 (m, Ar-I, 1H), 7.74-7.90 (m, ArH, 15H), 7.01-7.47 (m, ArH, 8H), 5.39 (m, CH (lactone), 1H), 4.70-4.85 (m, -OCO-CH-CH-COO-, 2H), 4.51-4.68 (m, CF2CH2, 2H), 4.41 (m, CH2 (lactone), 1H), 4.25 (m, CH2 (lactone), 1H), 3.15-3.40 (m, CH, 2H), 2.65 (m, CH2 (lactone), 1H), 2.25 (m, CH2 (lactone), 1H)

化合物(B0-22):前驅物(Bpre-22)與鹽交換用化合物A之組合 1H-NMR(DMSO,400MHz):δ(ppm)=7.99 (m, Ar-I, 1H), 7.74-7.90 (m, ArH+Ar-I, 16H), 7.01-7.47(m, ArH, 8H), 5.51 (m, CH (內酯), 1H), 4.70-4.85 (m, -OCO-CH-CH-COO-, 2H), 4.51-4.68 (m, CF2CH2, 2H), 4.50 (m, CH2 (內酯), 1H), 4.37 (m, CH2 (內酯), 1H), 3.15-3.40 (m, CH, 2H), 2.86 (m, CH2 (內酯), 1H), 2.66 (m, CH2 (內酯), 1H) Compound (B0-22): Combination of procatalyst (Bpre-22) and salt exchange compound A 1 H-NMR (DMSO, 400MHz): δ (ppm) = 7.99 (m, Ar-I, 1H), 7.74-7.90 (m, ArH+Ar-I, 16H), 7.01-7.47 (m, ArH, 8H), 5.51 (m, CH (lactone), 1H), 4.70-4.85 (m, -OCO-CH-CH-COO-, 2H), 4.51-4.68 (m, CF2CH2, 2H), 4.50 (m, CH2 (lactone), 1H), 4.37 (m, CH2 (lactone), 1H), 3.15-3.40 (m, CH, 2H), 2.86 (m, CH2 (lactone), 1H), 2.66 (m, CH2 (lactone), 1H)

化合物(B0-23):前驅物(Bpre-23)與鹽交換用化合物A之組合 1H-NMR(DMSO,400MHz):δ(ppm)=7.99 (m, Ar-I, 1H), 7.74-7.90 (m, ArH+Ar-I, 16H), 7.01-7.47(m, ArH, 8H), 4.70-4.85 (m, -OCO-CH-CH-COO-, 2H), 4.51-4.68 (m, CF2CH2+ CH (內酯), 4H), 3.15-3.40 (m, CH, 3H), 2.59 (m, CH (內酯), 2H), 1.63-2.10 (m, CH2 (內酯), 4H) Compound (B0-23): Combination of procatalyst (Bpre-23) and salt exchange compound A 1 H-NMR (DMSO, 400MHz): δ (ppm) = 7.99 (m, Ar-I, 1H), 7.74-7.90 (m, ArH+Ar-I, 16H), 7.01-7.47 (m, ArH, 8H), 4.70-4.85 (m, -OCO-CH-CH-COO-, 2H), 4.51-4.68 (m, CF2CH2+ CH (lactone), 4H), 3.15-3.40 (m, CH, 3H), 2.59 (m, CH (lactone), 2H), 1.63-2.10 (m, CH2 (lactone), 4H)

化合物(B0-24):前驅物(Bpre-24)與鹽交換用化合物A之組合 1H-NMR(DMSO,400MHz):δ(ppm)=7.99 (m, Ar-I, 1H), 7.74-7.90 (m, ArH+Ar-I, 16H), 7.01-7.47(m, ArH, 8H), 5.90 (m, CF3CH, 1H), 5.51 (m, CH (內酯), 1H), 4.70-4.85 (m,   -OCO-CH-CH-COO-, 2H), 4.50 (m, CH2 (內酯), 1H), 4.37 (m, CH2 (內酯), 1H), 3.15-3.40 (m, CH, 2H), 2.86 (m, CH2 (內酯), 1H), 2.66 (m, CH2 (內酯), 1H) Compound (B0-24): Combination of procatalyst (Bpre-24) and salt exchange compound A 1 H-NMR (DMSO, 400MHz): δ (ppm) = 7.99 (m, Ar-I, 1H), 7.74-7.90 (m, ArH+Ar-I, 16H), 7.01-7.47 (m, ArH, 8H), 5.90 (m, CF3CH, 1H), 5.51 (m, CH (lactone), 1H), 4.70-4.85 (m, -OCO-CH-CH-COO-, 2H), 4.50 (m, CH2 (lactone), 1H), 4.37 (m, CH2 (lactone), 1H), 3.15-3.40 (m, CH, 2H), 2.86 (m, CH2 (lactone), 1H), 2.66 (m, CH2 (lactone), 1H)

化合物(B0-25):前驅物(Bpre-25)與鹽交換用化合物A之組合 1H-NMR(DMSO,400MHz):δ(ppm)=7.99 (d, Ar-I, 1H), 7.74-7.90 (m, ArH+Ar-I, 16H), 7.01-7.47 (m, ArH, 8H), 5.39 (m, CH (內酯), 1H), 4.91-5.20 (m, CFCH, 1H), 4.70-4.85 (m, -OCO-CH-CH-COO-, 2H), 4.41 (m, CH2 (內酯), 1H), 4.25 (m, CH2 (內酯), 1H), 3.15-3.40 (m, CH, 2H), 3.95-4.20 (m, COOCH2CH2, 2H), 2.65 (m, CH2 (內酯), 1H),2.30-2.45(m, COOCH2CH2, 1H), 2.25 (m, CH2(內酯), 1H), 2.05 (m, COOCH2CH2, 1H) Compound (B0-25): Combination of precursor (Bpre-25) and salt exchange compound A 1 H-NMR (DMSO, 400MHz): δ (ppm) = 7.99 (d, Ar-I, 1H), 7.74-7.90 (m, ArH+Ar-I, 16H), 7.01-7.47 (m, ArH, 8H), 5.39 (m, CH (lactone), 1H), 4.91-5.20 (m, CFCH, 1H), 4.70-4.85 (m, -OCO-CH-CH-COO-, 2H), 4.41 (m, CH2 (lactone), 1H), 4.25 (m, CH2 (lactone), 1H), 3.15-3.40 (m, CH, 2H), 3.95-4.20 (m, COOCH2CH2, 2H), 2.65 (m, CH2 (lactone), 1H), 2.30-2.45 (m, COOCH2CH2, 1H), 2.25 (m, CH2 (lactone), 1H), 2.05 (m, COOCH2CH2, 1H)

化合物(B0-26):前驅物(Bpre-26)與鹽交換用化合物A之組合 1H-NMR(DMSO,400MHz):δ(ppm)=7.99 (d, Ar-I, 1H), 7.74-7.90 (m, ArH+Ar-I, 16H), 7.01-7.47 (m, ArH, 8H), 5.39 (m, CH (內酯), 1H),4.70-4.85 (m, -OCO-CH-CH-COO-, 2H)4.41 (m, CH2 (內酯), 1H), 4.05-4.25 (m, COOCH2CH2+ CH2 (內酯), 3H), 3.15-3.40 (m, CH, 2H), 2.63-2.73 (m, COOCH2CH2+CH2 (內酯), 3H), 2.25 (m, CH2 (內酯), 1H) Compound (B0-26): Combination of procatalyst (Bpre-26) and salt exchange compound A 1 H-NMR (DMSO, 400MHz): δ (ppm) = 7.99 (d, Ar-I, 1H), 7.74-7.90 (m, ArH+Ar-I, 16H), 7.01-7.47 (m, ArH, 8H), 5.39 (m, CH (lactone), 1H), 4.70-4.85 (m, -OCO-CH-CH-COO-, 2H) 4.41 (m, CH2 (lactone), 1H), 4.05-4.25 (m, COOCH2CH2+ CH2 (lactone), 3H), 3.15-3.40 (m, CH, 2H), 2.63-2.73 (m, COOCH2CH2+CH2 (lactone), 3H), 2.25 (m, CH2 (lactone), 1H)

化合物(B0-27):前驅物(Bpre-20)與鹽交換用化合物B之組合 1H-NMR(DMSO,400MHz):δ(ppm)=7.70-8.22 (m, ArH+Ar-I, 16H), 7.01-7.47(m, ArH, 8H), 5.39 (m, CH (內酯), 1H), 4.70-4.85 (m, -OCO-CH-CH-COO-, 2H), 4.51-4.68 (m, CF2CH2, 2H), 4.41 (m, CH2 (內酯), 1H), 4.25 (m, CH2 (內酯), 1H), 3.15-3.45 (m, SO2CH+CH, 3H), 2.65 (m, CH2 (內酯), 1H), 2.25 (m, CH2 (內酯), 1H), 1.09-1.90 (m, cyclohexyl, 10H) Compound (B0-27): Combination of precursor (Bpre-20) and salt exchange compound B 1 H-NMR (DMSO, 400MHz): δ (ppm) = 7.70-8.22 (m, ArH+Ar-I, 16H), 7.01-7.47 (m, ArH, 8H), 5.39 (m, CH (lactone), 1H), 4.70-4.85 (m, -OCO-CH-CH-COO-, 2H), 4.51-4.68 (m, CF2CH2, 2H), 4.41 (m, CH2 (lactone), 1H), 4.25 (m, CH2 (lactone), 1H), 3.15-3.45 (m, SO2CH+CH, 3H), 2.65 (m, CH2 (lactone), 1H), 2.25 (m, CH2 (lactone), 1H), 1.09-1.90 (m, cyclohexyl, 10H)

化合物(B0-28):前驅物(Bpre-20)與鹽交換用化合物C之組合 1H-NMR(DMSO,400MHz):δ(ppm)=7.77-7.99 (m, ArH+Ar-I, 13H), 7.01-7.47(m, ArH, 8H), 5.39 (m, CH (內酯), 1H), 4.70-4.85 (m, -OCO-CH-CH-COO-, 2H), 4.51-4.68 (m, CF2CH2, 2H), 4.41 (m, CH2 (內酯), 1H), 4.25 (m, CH2 (內酯), 1H), 3.15-3.40 (m, CH, 2H), 2.65 (m, CH2 (內酯), 1H), 2.25 (m, CH2 (內酯), 1H) Compound (B0-28): Combination of precursor (Bpre-20) and salt exchange compound C 1 H-NMR (DMSO, 400MHz): δ(ppm)=7.77-7.99 (m, ArH+Ar-I, 13H), 7.01-7.47(m, ArH, 8H), 5.39 (m, CH (lactone), 1H), 4.70-4.85 (m, -OCO-CH-CH-COO-, 2H), 4.51-4.68 (m, CF2CH2, 2H), 4.41 (m, CH2 (lactone), 1H), 4.25 (m, CH2 (lactone), 1H), 3.15-3.40 (m, CH, 2H), 2.65 (m, CH2 (lactone), 1H), 2.25 (m, CH2 (lactone), 1H)

化合物(B0-29):前驅物(Bpre-20)與鹽交換用化合物D之組合 1H-NMR(DMSO,400MHz):δ(ppm)=8.50 (d, ArH, 2H), 8.37 (d, ArH, 2H), 7.99 (m, Ar-I, 1H), 7.93 (t, ArH, 2H), 7.84 (d, Ar-I, 1H), 7.55-7.75 (m, ArH, 7H), 7.01-7.47(m, ArH, 8H), 5.39 (m, CH (內酯), 1H), 4.70-4.85 (m, -OCO-CH-CH-COO-, 2H), 4.51-4.68 (m, CF2CH2, 2H), 4.41 (m, CH2 (內酯), 1H), 4.25 (m, CH2 (內酯), 1H), 3.15-3.40 (m, CH, 2H), 2.65 (m, CH2 (內酯), 1H), 2.25 (m, CH2 (內酯), 1H) Compound (B0-29): Combination of procatalyst (Bpre-20) and salt exchange compound D 1 H-NMR (DMSO, 400MHz): δ (ppm) = 8.50 (d, ArH, 2H), 8.37 (d, ArH, 2H), 7.99 (m, Ar-I, 1H), 7.93 (t, ArH, 2H), 7.84 (d, Ar-I, 1H), 7.55-7.75 (m, ArH, 7H), 7.01-7.47 (m, ArH, 8H), 5.39 (m, CH (lactone), 1H), 4.70-4.85 (m, -OCO-CH-CH-COO-, 2H), 4.51-4.68 (m, CF2CH2, 2H), 4.41 (m, CH2 (lactone), 1H), 4.25 (m, CH2 (lactone), 1H), 3.15-3.40 (m, CH, 2H), 2.65 (m, CH2 (lactone), 1H), 2.25 (m, CH2 (lactone), 1H)

<阻劑組成物之調製> (實施例1~33、比較例1~4) 混合表1~5所示的各成分並溶解後得調製出各例的阻劑組成物。 <Preparation of Resistant Composition> (Examples 1 to 33, Comparative Examples 1 to 4) The respective components shown in Tables 1 to 5 are mixed and dissolved to prepare the respective resist compositions.

表1~5中,各簡稱表示具有各以下意思。[ ]內之數值為配合量(質量份)。 (A)-1:下述化學式(A1-1)所示高分子化合物。對於該高分子化合物(A1-1),藉由GPC測定所求得之標準聚苯乙烯換算的重量平均分子量(Mw)為5800,分子量分散度(Mw/Mn)為1.54。藉由 13C-NMR所求得之共聚合組成比(結構式中之各構成單位之比例(莫耳比))為l/m=50/50。 (A)-2:下述化學式(A1-2)所示高分子化合物。對於該高分子化合物(A1-2),藉由GPC測定所求得之標準聚苯乙烯換算之重量平均分子量(Mw)為6000,分子量分散度(Mw/Mn)為1.55。藉由 13C-NMR所求得之共聚合組成比(結構式中之各構成單位之比例(莫耳比))為l/m=50/50。 (A)-3:下述化學式(A1-3)所示高分子化合物。對於該高分子化合物(A1-3),藉由GPC測定所求得之標準聚苯乙烯換算之重量平均分子量(Mw)為5900,分子量分散度(Mw/Mn)為1.54。藉由 13C-NMR所求之共聚合組成比(結構式中之各構成單位之比例(莫耳比))為l/m=50/50。 In Tables 1 to 5, each abbreviation has the following meaning. The values in [ ] are the compounding amounts (parts by mass). (A)-1: A polymer compound represented by the following chemical formula (A1-1). For the polymer compound (A1-1), the weight average molecular weight (Mw) converted to standard polystyrene obtained by GPC measurement is 5800, and the molecular weight dispersion (Mw/Mn) is 1.54. The copolymer composition ratio (the ratio of each constituent unit in the structural formula (molar ratio)) obtained by 13 C-NMR is l/m=50/50. (A)-2: A polymer compound represented by the following chemical formula (A1-2). For the polymer compound (A1-2), the weight average molecular weight (Mw) converted to standard polystyrene obtained by GPC measurement is 6000, and the molecular weight dispersion (Mw/Mn) is 1.55. The copolymer composition ratio (the ratio of each constituent unit in the structural formula (molar ratio)) determined by 13 C-NMR is l/m=50/50. (A)-3: A polymer compound represented by the following chemical formula (A1-3). The weight average molecular weight (Mw) of the polymer compound (A1-3) determined by GPC measurement was 5900 in terms of standard polystyrene, and the molecular weight dispersion (Mw/Mn) was 1.54. The copolymer composition ratio (the ratio of each constituent unit in the structural formula (molar ratio)) determined by 13 C-NMR is l/m=50/50.

(B)-31:由下述化合物(B1-1)所成的酸產生劑。 (B)-32:由下述化合物(B1-2)所成的酸產生劑。 (B)-33:由下述化合物(B1-3)所成的酸產生劑。 (B)-34:由下述化合物(B1-4)所成的酸產生劑。 (B)-1~(B)-29:上述化合物(B0-1)~化合物(B0-29)。 (B)-31: Acid generator formed from the following compound (B1-1). (B)-32: Acid generator formed from the following compound (B1-2). (B)-33: Acid generator formed from the following compound (B1-3). (B)-34: Acid generator formed from the following compound (B1-4). (B)-1 to (B)-29: Compounds (B0-1) to (B0-29) above.

(D)-1:下述化合物(D1-1)所成的酸擴散控制劑。(D)-1: Acid diffusion control agent composed of the following compound (D1-1).

(S)-1:丙二醇單甲基醚乙酸酯/丙二醇單甲基醚=60/40(質量比)之混合溶劑。(S)-1: A mixed solvent of propylene glycol monomethyl ether acetate/propylene glycol monomethyl ether = 60/40 (mass ratio).

<阻劑圖型之形成> 在施予六甲基二矽氮烷(HMDS)處理之8英吋矽基板上,將各例之阻劑組成物使用旋轉器進行塗布,並在加熱板上進行在溫度110℃的60秒之預熱(PAB)處理,藉由乾燥後形成膜厚50nm之阻劑膜。 其次,對於前述阻劑膜,使用電子線繪畫裝置JEOL-JBX-9300FS(日本電子股份有限公司製),在加速電壓100Kv下,進行直徑32nm之孔以等間隔(間距64nm)配置的接觸孔圖型(以下稱為「CH圖型」。)的繪影(曝光)。 其後,在100℃進行60秒的曝光後加熱(PEB)處理。 其次,在23℃使用2.38質量%四甲基銨氫氧化物(TMAH)水溶液「NMD-3」(商品名,東京應化工業股份有限公司製),進行60秒的鹼顯影。 其後,使用純水,進行15秒的水漂洗。 其結果,形成直徑32nm之孔配置成等間隔(間距64nm)之CH圖型。 <Formation of Resist Pattern> On an 8-inch silicon substrate treated with hexamethyldisilazane (HMDS), the resist composition of each example was applied using a spinner, and a preheating (PAB) treatment was performed on a hot plate at a temperature of 110°C for 60 seconds, and a resist film with a film thickness of 50nm was formed by drying. Next, for the above-mentioned resist film, an electron beam drawing device JEOL-JBX-9300FS (manufactured by JEOL Ltd.) was used to draw (expose) a contact hole pattern (hereinafter referred to as "CH pattern") in which holes with a diameter of 32nm were arranged at equal intervals (pitch 64nm) at an accelerating voltage of 100Kv. Thereafter, a post-exposure heating (PEB) treatment was performed at 100°C for 60 seconds. Next, alkaline development was performed at 23°C for 60 seconds using a 2.38 mass% tetramethylammonium hydroxide (TMAH) aqueous solution "NMD-3" (trade name, manufactured by Tokyo Ohka Industry Co., Ltd.). Thereafter, pure water was used for 15 seconds of water rinsing. As a result, a CH pattern was formed in which holes with a diameter of 32nm were arranged at equal intervals (spacing 64nm).

[感度之評估] 藉由上述<阻劑圖型之形成>求得形成目標規模之CH圖型的最適曝光量Eop(μC/cm 2)。其結果以「Eop(μC/cm 2)」表示於表6~7。 [Evaluation of Sensitivity] The optimum exposure Eop (μC/cm 2 ) for forming a CH pattern of a target scale was obtained through the above <Formation of Resist Pattern>. The results are shown in Tables 6-7 as "Eop (μC/cm 2 ) ".

[圖型尺寸之面內均勻性(CDU)的評估] 對於藉由上述<阻劑圖型之形成>所形成的CH圖型,藉由測長SEM(掃描型電子顯微鏡,加速電壓500V,商品名:CG5000、Hitachi High Technologies Co., Ltd.製),由CH圖型上面進行觀察,測定各孔之孔直徑(nm)。然後,由該測定結果求得算出的標準偏差(σ)之3倍值(3σ)。將該結果以「CDU(nm)」表示於表6~7。 如此所求得之3σ的值越小,表示形成為該阻劑膜的複數孔之尺寸(CD)均勻性越高的意思。 [Evaluation of in-plane uniformity of pattern size (CDU)] For the CH pattern formed by the above <Formation of resist pattern>, the CH pattern was observed from the top by length measurement SEM (scanning electron microscope, accelerating voltage 500V, trade name: CG5000, manufactured by Hitachi High Technologies Co., Ltd.), and the pore diameter (nm) of each pore was measured. Then, the 3 times value (3σ) of the calculated standard deviation (σ) was obtained from the measurement result. The result is expressed as "CDU (nm)" in Tables 6 to 7. The smaller the value of 3σ obtained in this way, the higher the uniformity of the size (CD) of the multiple pores formed in the resist film.

[極限解像性之評估] 藉由上述<阻劑圖型之形成>形成有CH圖型的最適曝光量(Eop)中之極限解像度,具體為,自最適曝光量(Eop)逐次稍微減少曝光量而形成CH圖型時,將經解像的圖型之孔直徑(nm)使用掃描型電子顯微鏡(商品名:S-9380、Hitachi High Technologies Co., Ltd.製)而求得。將其結果以「極限解像性(nm)」表示於表6~7。 [Evaluation of Ultimate Resolution] The ultimate resolution at the optimal exposure (Eop) of the CH pattern formed by the above <Formation of Resist Pattern> is specifically obtained by using a scanning electron microscope (trade name: S-9380, manufactured by Hitachi High Technologies Co., Ltd.) to obtain the aperture diameter (nm) of the resolved pattern when the CH pattern is formed by gradually reducing the exposure from the optimal exposure (Eop). The results are shown in Tables 6 to 7 as "Ultimate Resolution (nm)".

由表6~7所示結果可確認到,藉由實施例1~33與比較例1~4之對比,適用本發明的實施例1~33之阻劑組成物時可達成兼具高感度化與圖型尺寸之面內均勻性(CDU)及微細解像性之效果。 另外,實施例1~33之阻劑組成物與比較例1~4的阻劑組成物做比較時,確認到實施例1~33之阻劑組成物的CDU及微細解像性皆高。 From the results shown in Tables 6 to 7, it can be confirmed that by comparing Examples 1 to 33 with Comparative Examples 1 to 4, the use of the resist compositions of Examples 1 to 33 of the present invention can achieve the effects of high sensitivity and in-plane uniformity (CDU) of pattern size and fine resolution. In addition, when the resist compositions of Examples 1 to 33 are compared with the resist compositions of Comparative Examples 1 to 4, it is confirmed that the CDU and fine resolution of the resist compositions of Examples 1 to 33 are both high.

以上說明本發明之較佳實施例,但本發明並非僅限定於此等實施例。在不脫離本發明之主旨的範圍下,可進行構成之加成、省略、取代及其他變更。本發明並非僅限定於前述說明者,僅限定於所記載的申請專利範圍。The above describes the preferred embodiments of the present invention, but the present invention is not limited to these embodiments. Additions, omissions, substitutions and other changes can be made without departing from the scope of the present invention. The present invention is not limited to the above description, but is limited to the scope of the patent application recorded.

Claims (8)

一種阻劑組成物,其為藉由曝光產生酸,且藉由酸的作用對於顯影液的溶解性產生變化之阻劑組成物,其中含有藉由酸的作用對於顯影液的溶解性產生變化的基材成分(A),與下述一般式(b0)所示化合物(B0)與, [式中,R b為鹼分解性基;L 03為2價連結基;Rl 0為可具有取代基的環狀有機基;L 02為2價連結基;I為碘原子;R m1為碘原子以外之取代基;L 01為2價連結基或單鍵;Vb 0為伸烷基、氟化伸烷基或單鍵;但,L 01與Vb 0不會同時成為單鍵;R 0為碳數1~5的氟化烷基、氟原子或氫原子;nb1為1~4的整數,nb2為1~4的整數,nb3為0~3的整數;但,2≦nb1+nb2+nb3≦5;M m+表示m價有機陽離子;m為1以上的整數]。 A resist composition that generates acid by exposure and changes its solubility in a developer by the action of the acid, wherein the resist composition comprises a base component (A) whose solubility in a developer changes by the action of the acid, and a compound (B0) represented by the following general formula (b0), [In the formula, Rb is an alkali-decomposable group; L03 is a divalent linking group; Rl0 is a cyclic organic group which may have a substituent; L02 is a divalent linking group; I is an iodine atom; Rm1 is a substituent other than an iodine atom; L01 is a divalent linking group or a single bond; Vb0 is an alkylene group, a fluorinated alkylene group or a single bond; however, L01 and Vb0 will not simultaneously form a single bond; R0 is a fluorinated alkylene group having 1 to 5 carbon atoms, a fluorine atom or a hydrogen atom; nb1 is an integer from 1 to 4, nb2 is an integer from 1 to 4, and nb3 is an integer from 0 to 3; however, 2≦nb1+nb2+nb3≦5; Mm + represents an m-valent organic cation; m is an integer greater than 1]. 如請求項1之阻劑組成物,其中前述一般式(b0)中之R b具有含有內酯的環式基。 The inhibitor composition of claim 1, wherein R b in the aforementioned general formula (b0) has a cyclic group containing a lactone. 如請求項1或2之阻劑組成物,其中前述一般式(b0)中之-L 01-Vb 0-為下述一般式(b0-r-1)~(b0-r-7)中任一所示連結基, [式中,L 011為碳原子數1~5的伸烷基或單鍵;L 012為碳原子數1~30的2價飽和烴基或單鍵;Vb 01為碳原子數1~4的氟化伸烷基或單鍵;但,L 012與Vb 01不會同時成為單鍵]。 The inhibitor composition of claim 1 or 2, wherein -L 01 -Vb 0 - in the aforementioned general formula (b0) is a linking group represented by any one of the following general formulas (b0-r-1) to (b0-r-7), [In the formula, L 011 is an alkylene group having 1 to 5 carbon atoms or a single bond; L 012 is a divalent saturated alkyl group having 1 to 30 carbon atoms or a single bond; Vb 01 is a fluorinated alkylene group having 1 to 4 carbon atoms or a single bond; however, L 012 and Vb 01 will not be a single bond at the same time]. 一種阻劑圖型形成方法,其中具有於支持體上,使用如請求項1或2之阻劑組成物而形成阻劑膜之步驟、將前述阻劑膜進行曝光的步驟,及使前述曝光後之阻劑膜顯影而形成阻劑圖型之步驟。A method for forming a resist pattern comprises the steps of forming a resist film on a support using a resist composition as claimed in claim 1 or 2, exposing the resist film, and developing the exposed resist film to form a resist pattern. 一種下述一般式(b0)所示化合物, [式中,R b為鹼分解性基;L 03為2價連結基;Rl 0為可具有取代基的環狀有機基;L 02為2價連結基;I為碘原子;R m1為碘原子以外之取代基;L 01為2價連結基或單鍵;Vb 0為伸烷基、氟化伸烷基或單鍵;但,L 01與Vb 0不會同時成為單鍵;R 0為碳數1~5的氟化烷基、氟原子或氫原子;nb1為1~4的整數,nb2為1~4的整數,nb3為0~3的整數;但,2≦nb1+nb2+nb3≦5;M m+表示m價有機陽離子;m為1以上的整數]。 A compound represented by the following general formula (b0), [In the formula, Rb is an alkali-decomposable group; L03 is a divalent linking group; Rl0 is a cyclic organic group which may have a substituent; L02 is a divalent linking group; I is an iodine atom; Rm1 is a substituent other than an iodine atom; L01 is a divalent linking group or a single bond; Vb0 is an alkylene group, a fluorinated alkylene group or a single bond; however, L01 and Vb0 will not simultaneously form a single bond; R0 is a fluorinated alkylene group having 1 to 5 carbon atoms, a fluorine atom or a hydrogen atom; nb1 is an integer from 1 to 4, nb2 is an integer from 1 to 4, and nb3 is an integer from 0 to 3; however, 2≦nb1+nb2+nb3≦5; Mm + represents an m-valent organic cation; m is an integer greater than 1]. 如請求項5之化合物,其中前述一般式(b0)中之R b為具有含有內酯的環式基之基。 The compound of claim 5, wherein R b in the aforementioned general formula (b0) is a group having a cyclic group containing a lactone. 如請求項5或6之化合物,其中前述一般式(b0)中之-L 01-Vb 0-為下述一般式(b0-r-1)~(b0-r-7)中任一所示連結基, [式中,L 011為碳原子數1~5的伸烷基或單鍵;L 012為碳原子數1~30的2價飽和烴基或單鍵;Vb 01為碳原子數1~4的氟化伸烷基或單鍵;但,L 012與Vb 01不會同時成為單鍵]。 The compound of claim 5 or 6, wherein -L 01 -Vb 0 - in the aforementioned general formula (b0) is a linking group represented by any one of the following general formulas (b0-r-1) to (b0-r-7), [In the formula, L 011 is an alkylene group having 1 to 5 carbon atoms or a single bond; L 012 is a divalent saturated alkyl group having 1 to 30 carbon atoms or a single bond; Vb 01 is a fluorinated alkylene group having 1 to 4 carbon atoms or a single bond; however, L 012 and Vb 01 will not be a single bond at the same time]. 一種酸產生劑,其中含有如請求項5或6之化合物。An acid generator comprising the compound of claim 5 or 6.
TW112146884A 2022-12-06 2023-12-01 Resist composition, resist pattern forming method, compound and acid generator TW202432530A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2022-195214 2022-12-06

Publications (1)

Publication Number Publication Date
TW202432530A true TW202432530A (en) 2024-08-16

Family

ID=

Similar Documents

Publication Publication Date Title
WO2023176546A1 (en) Resist composition, resist pattern forming method, compound, and acid generator
WO2023162907A1 (en) Resist composition, resist pattern formation method, compound, and acid generation agent
TW202432530A (en) Resist composition, resist pattern forming method, compound and acid generator
JP7523500B2 (en) Resist composition and method for forming resist pattern
JP7466597B2 (en) Resist composition, method for forming a resist pattern, and compound and intermediate thereof
WO2024122425A1 (en) Resist composition, resist pattern formation method, compound, and acid diffusion control agent
WO2024122423A1 (en) Resist composition, resist pattern forming method, compound, and acid generator
WO2024071125A1 (en) Resist composition, method for forming resist pattern, compound, and acid diffusion control agent
WO2024058075A1 (en) Resist composition, resist pattern forming method, compound and acid diffusion control agent
WO2023223865A1 (en) Resist composition, resist pattern formation method, compound, and acid diffusion control agent
WO2024166788A1 (en) Resist composition, method for forming resist pattern, compound and polymer compound
WO2024176701A1 (en) Resist composition, resist pattern formation method, compound, and polymer compound
WO2024116780A1 (en) Resist composition, resist pattern formation method, compound, and acid diffusion control agent
TW202436273A (en) Resist composition, resist pattern forming method, compound and acid diffusion control agent
WO2024176696A1 (en) Resist composition, resist pattern formation method, compound, and polymer compound
TW202428562A (en) Resist composition, method for forming resist pattern, compound, and polymer compound
JP2024112755A (en) Resist composition, method for forming resist pattern, compound and polymer compound
TW202432516A (en) Resist composition, resist pattern forming method, compound and acid diffusion control agent
WO2024117106A1 (en) Resist composition, resist pattern formation method, compound, and acid generator
WO2024190919A1 (en) Resist composition, resist pattern formation method, compound, and acid diffusion control agent
TW202432634A (en) Resist composition, resist pattern forming method and compound
KR20240154543A (en) Resist composition, resist pattern forming method, compound, and acid generator
JP2024065677A (en) Resist composition, resist pattern forming method, compound, and acid diffusion control agent
JP2024119270A (en) Resist composition, method for forming resist pattern, compound and polymer compound
JP2024130062A (en) Resist composition, method for forming resist pattern, fluorine-containing polymer compound, and compound